• Abeywardena MY, Head RJ. Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc. Res. 52: 361-371 (2001). *

• Ablin J, Shalev O, Okon E, Karmeli F, Rachmilewitz D. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm. Bowel Dis. 5: 253-261 (1999). *

• Aboul-Enein F, Weiser P, Hoftberger R, Lassmann H, Bradl M. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol. (Berl.) 111: 539-547 (2006).

• Abraldes J, Albillos A, Banares R, Turnes J, Gonzalez R, Garcia-Pagan J, Bosch J. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 136: 1651-1658 (2009). *

• Abraldes JG, Rodriguez-Vilarrupla A, Graupera M, Zafra C, Garcia-Caldero H, Garcia-Pagan JC, Bosch J. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl(4) cirrhotic rats. J. Hepatol. 46: 1040-1046 (2007). *

• Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis. Adv. Drug Deliv. Rev. 58: 212-225 (2006). *

• Ackerman Z, Karmeli F, Cohen P, Rachmilewitz D. Experimental colitis in rats with portal hypertension and liver disease. Inflamm. Bowel Dis. 9: 18-24 (2003). *

• Acton JD, Wilmott RW. Phenotype of CF and the effects of possible modifier genes. Paediatr. Respir. Rev. 2: 332-339 (2001).

• Agger EM, Cassidy JP, Brady J, Korsholm KS, Vingsbo-Lundberg C, Andersen P. Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection. Immunology 124: 175-185 (2008). *

• Agius LM. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. J. Theor. Biol. 227: 219-228 (2004). *

• Agrawal YP. Low dose naltrexone therapy in multiple sclerosis. Med. Hypotheses 64: 721-724 (2005). *

• Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, Bhansali A, Khullar M. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol. Cell. Biochem. 314: 9-17 (2008). *

• Ahmad R, Rasheed Z, Ahsan H. Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon. Immunopharmacol. Immunotoxicol. 31: 388-396 (2009).

• Ahmadi K, McCruden AB. Macrophage may responses to androgen via its receptor. Med. Sci. Monit. 12: BR15-BR20 (2005). *

• Aihara H, Hiwatashi N. Salazosulfapyridine and 5-aminosalicylic acid agents for the treatment of ulcerative colitis. Nippon Rinsho 57: 2476-2480 (1999).

• Ait-Belgnaoui A, Han W, Lamine F, Eutamene H, Fioramonti J, Bueno L, Theodorou V. Lactobacillus farciminis treatment suppresses stress-induced visceral hypersensitivity: a possible action through interaction with epithelial cells cytoskeleton contraction. Gut 55: 1090-1094 (2006). *

• Ajamieh HH, Menendez S, Martinez-Sanchez G, Candelario-Jalil E, Re L, Giuliani A, Fernandez OS. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 24: 55-62 (2004). *

• Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M. Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J. Leukoc. Biol. 76: 227-236 (2004). *

• Akar CA, Feinstein DL. Modulation of inducible nitric oxide synthase expression by sumoylation. J. Neuroinflammation 6: 12 (2009).

• Akgun E, Caliskan C, Celik HA, Ozutemiz AO, Tuncyurek M, Aydin HH. Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats. J. Int. Med. Res. 33: 196-206 (2005).

• Akomolafe A, Lunetta K, Erlich P, Cupples L, Baldwin C, Huyck M, Green R, Farrer L; MIRAGE Study Group. Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin. Genet. 70: 49-56 (2006). *

• Aksu B, Umit H, Kanter M, Guzel A, Aktas C, Civelek S, Uzun H. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Acta Histochem. Feb 12 [Epub ahead of print] (2009).

• Aksu B, Umit H, Kanter M, Guzel A, Inan M, Civelek S, Aktas C, Uzun H. Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. J. Pediatr. Surg. 44: 702-710 (2009).

• Alberati-Giani D, Malherbe P, Ricciardi-Castagnoli P, Kohler C, Denis-Donini S, Cesura AM. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells. J. Immunol. 159: 419-426 (1997).

• Albillos A, Banares R, Gonzalez M, Catalina MV, Pastor O, Gonzalez R, Ripoll C, Bosch J. The extent of the collateral circulation influences the postprandial increase in portal pressure in cirrhotic patient. Gut 56: 259-264 (2007). *

• Alcaraz A, Hernandez D, Iyu D, Mota R, Ortiz AJ, Atucha NM, Garcia-Estan J, Ortiz MC. Effects of chronic L-NAME on nitrotyrosine expression and renal vascular reactivity in rats with chronic bile duct ligation. Clin. Sci. (Lond.) 115: 57-68 (2008). *

• Alderman BM, McCaffrey GJ, Yeomans ND. Nonsteroidal antiinflammatory drugs and the stomach. Curr. Opin. Gastroenterol. 18: 658-662 (2002).

• Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta. FASEB J. 20: 326-328 (2006). *

• Ali S, Roberts PR. Nutrients with immune-modulating effects: what role should they play in the intensive care unit? Curr. Opin. Anaesthesiol. 19: 132-139 (2006).

• Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am. J. Physiol. 270: G225-G237 (1996).

• Alkam T, Nitta A, Mizoguchi H, Saito K, Seshima M, Itoh A, Yamada K, Nabeshima T. Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice. Behav. Brain Res. 189: 100-106 (2008).

• Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin. Chim. Acta 350: 51-55 (2004). *

• Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J. Leukoc. Biol. 71: 677-685 (2002). *

• Allie N, Alexopoulou L, Quesniaux VJ, Fick L, Kranidioti K, Kollias G, Ryffel B, Jacobs M. Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection. Immunology 125: 522-534 (2008). *

• Alvarez-Pellitero P. Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects. Vet. Immunol. Immunopathol. 126: 171-198 (2008).

• Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470 (2006).

• Alves-Filho JC, Tavares-Murta BM, Barja-Fidalgo C, Benjamim CF, Basile-Filho A, Arraes SM, Cunha FQ. Neutrophil function in severe sepsis. Endocr. Metab. Immune Disord. Drug Targets 6: 151-158 (2006).

• Amaral JF, Gomes-Santos AC, Paula-Silva J, Nicoli JR, Vieira LQ, Faria AM, Menezes JS. Antigenic dietary protein guides maturation of the host immune system promoting resistance to Leishmania major infection in C57BL/6 mice. Immunology 129: 455-464 (2010). *

• Ambrozova G, Pekarova M, Lojek A. Effect of polyunsaturated fatty acids on the reactive oxygen and nitrogen species production by raw 264.7 macrophages. Eur. J. Nutr. Sep 26 [Epub ahead of print] (2009).

• Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U.S.A. 93: 14014-14019 (1996). *

• Amin AR, Patel RN, Thakker GD, Lowenstein CJ, Attur MG, Abramson SB. Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett. 410: 259-264 (1997).

• Amini-Shirazi N, Hoseini A, Ranjbar A, Mohammadirad A, Khoshakhlagh P, Yasa N, Abdollahi M. Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphora clinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice. Toxicol. Mech. Methods 19: 183-189 (2009).

• Amith SR, Jayanth P, Franchuk S, Siddiqui S, Seyrantepe V, Gee K, Basta S, Beyaert R, Pshezhetsky AV, Szewczuk MR. Dependence of pathogen molecule-induced Toll-like receptor activation and cell function on Neu1 sialidase. Glycoconj. J. 26: 1197-1212 (2009). *

• Andersen K, Pedersen BK. The role of inflammation in vascular insulin resistance with focus on IL-6. Horm. Metab. Res. 40: 635-639 (2008).

• Andersson M, Svenungsson E, Khademi M, Lampa J, Brundin L, Wallstrom E. No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab. Ann. Rheum. Dis. 65: 1237-1240 (2006). *

• Andresen L, Jorgensen VL, Perner A, Hansen A, Eugen-Olsen J, Rask-Madsen J. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 54: 503-509 (2005). *

• Anegawa G, Kawanaka H, Yoshida D, Konishi K, Yamaguchi S, Kinjo N, Taketomi A, Hashizume M, Shimokawa H, Maehara Y. Defective endothelial nitric oxide synthase signaling is mediated by Rho-kinase activation in rats with secondary biliary cirrhosis. Hepatology 47: 966-977 (2008). *

• Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr. Gastroenterol. Rep. 4: 37-44 (2002).

• Antoniades C, Shirodaria C, Leeson P, Baarholm OA, Van-Assche T, Cunnington C, Pillai R, Ratnatunga C, Tousoulis D, Stefanadis C, Refsum H, Channon KM. MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119: 2507-2515 (2009). *

• Antonioli L, Fornai M, Colucci R, Ghisu N, Blandizzi C, Del Tacca M. A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis. Inflamm. Bowel Dis. 12: 117-122 (2006). *

• Antunes F, Boveris A, Cadenas E. On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 101: 16774-16779 (2004). *

• Aoki K, Nakajima M, Hoshi Y, Saso N, Kato S, Sugiyama Y, Sato H. Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors. Biol. Pharm. Bull. 31: 412-420 (2008). *

• Aoki K, Saso N, Kato S, Sugiyama Y, Sato H. Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices. Biol. Pharm. Bull. 31: 1882-1887 (2008). *

• Aquila S, Rojano B, Recio MC, Giner RM, Schinella GR, Debenedetti SL, Saez J, Rios JL. Anti-inflammatory activity of berenjenol and related compounds. Planta Med. 75: 18-23 (2009).

• Ara AI, Xia M, Ramani K, Mato JM, Lu SC. S-Adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology 47: 1655-1666 (2008). *

• Ara C, Kirimlioglu H, Karabulut AB, Coban S, Ay S, Harputluoglu M, Kirimlioglu V, Yilmaz S. Protective effect of resveratrol against oxidative stress in cholestasis. J. Surg. Res. 127: 112-117 (2005). *

• Arafa HM, Hemeida RA, El-Bahrawy AI, Hamada FM. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food Chem. Toxicol. 47: 1311-1317 (2009). *

• Arafat HA, Lada E, Katakam AK, Amin N. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes. Exp. Clin. Endocrinol. Diabetes 114: 555-562 (2006).

• Aram G, Potter JJ, Liu X, Torbenson MS, Mezey E. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration. Hepatology 47: 2051-2058 (2008). *

• Araujo Z, Acosta M, Escobar H, Banos R, Fernandez de Larrea C, Rivas-Santiago B. Immunitary response in tuberculosis and the role of Mycobacterium tuberculosis secretion antigens in its protection, pathology and diagnosis. Review. Invest. Clin. 49: 411-441 (2008).

• Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U.S.A. 102: 7671-7676 (2005). *

• Arko-Mensah J, Julian E, Singh M, Fernandez C. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages. Scand. J. Immunol. 65: 148-157 (2007). *

• Armstrong AM, Campbell GR, Gannon C, Kirk SJ, Gardiner KR. Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis. Scand. J. Gastroenterol. 35: 832-838 (2000). *

• Asanuma M, Miyazaki I. Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation. Expert Rev. Neurother. 6: 1313-1325 (2006).

• Asensi V, Montes AH, Valle E, Ocana MG, Astudillo A, Alvarez V, Lopez-Anglada E, Solis A, Coto E, Meana A, Gonzalez P, Carton JA, Paz J, Fierer J, Celada A. The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis. Nitric Oxide 16: 44-53 (2007). *

• Assassi S, Mayes MD, McNearney T, Fischbach M, Reveille JD, Arnett FC, Tan FK. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis. Am. J. Med. 118: 907-911 (2005). *

• Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Genetic susceptibility to Behcet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients. Rheumatol. Int. 29: 787-791 (2009). *

• Ates O, Musellim B, Ongen G, Topal-Sarikaya A. NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement. J. Clin. Immunol. 28: 73-77 (2008). *

• Augstein P, Heinke P, Salzsieder E, Grimm R, Giebel J, Salzsieder C, Harrison LC. Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (Deltapsim) in the pancreatic beta-cell line NIT-1. Diab. Vasc. Dis. Res. 5: 198-204 (2008).

• Auli M, Nasser Y, Ho W, Burgueno JF, Keenan CM, Romero C, Sharkey KA, Fernandez E. Neuromuscular changes in a rat model of colitis. Auton. Neurosci. 141: 10-21 (2008).

• Aversa A, Caprio M, Rosano GM, Spera G. Endothelial effects of drugs designed to treat erectile dysfunction. Curr. Pharm. Des. 14: 3768-3778 (2009).

• Awara WM, El-Sisi AE, El-Refaei M, El-Naa MM, El-Desoky K. Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes. Rev. Diabet. Stud. 2: 146-156 (2005). *

• Azarov I, He X, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, Kim-Shapiro DB. Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 18: 296-302 (2008).

• Badn W, Kalliomaki S, Widegren B, Sjogren HO. Low-dose combretastatin a4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma. Clin. Cancer Res. 12: 4714-4719 (2006). *

• Bae EH, Lee J, Ma SK, Kim IJ, Frokiaer J, Nielsen S, Kim SY, Kim SW. alpha-Lipoic acid prevents cisplatin-induced acute kidney injury in rats. Nephrol. Dial. Transplant. 24: 2692-2700 (2009).

• Baeten D, Peene I, Union A, Meheus L, Sebbag M, Serre G, Veys EM, De Keyser F. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum. 44: 2255-2262 (2001).

• Bagarolli RA, Saad MJ, Saad ST. Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes. J. Diabetes Complications Apr 21 [Epub ahead of print] (2009).

• Baggio B, Musacchio E, Priante G. Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications. J. Nephrol. 18: 362-367 (2005).

• Bai JP, Lesko LJ, Burckart GJ. Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors. Pharmacotherapy 30: 195-209 (2010).

• Bai Y, Onuma H, Bai X, Medvedev AV, Misukonis M, Weinberg JB, Cao W, Robidoux J, Floering LM, Daniel KW, Collins S. Persistent NF-kappa B activation in Ucp2-/-mice leads to enhanced nitric oxide and inflammatory cytokine production. J. Biol. Chem. 280: 19062-19069 (2005). *

• Baik JE, Ryu YH, Han JY, Im J, Kum KY, Yun CH, Lee K, Han SH. Lipoteichoic acid partially contributes to the inflammatory responses to Enterococcus faecalis. J. Endod. 34: 975-982 (2008).

• Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, Batthyany C, Sweeney S, Long MH, Iles KE, Baker LM, Branchaud BP, Chen YE, Freeman BA. Fatty acid transduction of nitric oxide signaling: identification of unsaturated fatty acid nitro derivatives and PPAR receptor-dependent signaling activity. J. Biol. Chem. 280: 42464-42475 (2005). *

• Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit. Rev. Immunol. 26: 407-442 (2006).

• Ballester I, Gonzalez R, Nieto A, Zarzuelo A, Sanchez de Medina F. Monochloramine induces acute and protracted colitis in the rat: response to pharmacological treatment. Life Sci. 76: 2965-2980 (2005). *

• Bansal V, Syres KM, Makarenkova V, Brannon R, Matta B, Harbrecht BG, Ochoa JB. Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets. JPEN J. Parenter. Enteral Nutr. 29: S75-S80 (2005). *

• Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am. J. Gastroenterol. 100: 2560-2568 (2005). *

• Barcellos LF, Ramsay PP, Caillier SJ, Sawcer S, Haines J, Schmidt S, Pericak-Vance M, Compston DA, Gabatto P, Hauser SL, Oksenberg JR. Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis. Genes Immun. 9: 493-500 (2008). *

• Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG. SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J. Autoimmun. 27: 166-173 (2006).

• Bartsch H, Ohshima H, Pignatelli B, Calmels S. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 2: 272-277 (1992).

• Basu S, Quilici C, Zhang HH, Grail D, Dunn AR. Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans. Growth Factors 26: 23-34 (2008).

• Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21: 437-451 (2001).

• Batuca JR, Ames PR, Amaral M, Favas C, Isenberg DA, Delgado Alves J. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus. Rheumatology (Oxford) 48: 26-31 (2009). *

• Beck PL, Li Y, Wong J, Chen CW, Keenan CM, Sharkey KA, McCafferty DM. Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation. Gastroenterology 132: 1778-1790 (2007). *

• Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, Mizoguchi E, Bhan AK, Podolsky DK. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G137-G147 (2004). *

• Beckett CG, Dell'Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ. Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies. Eur. J. Gastroenterol. Hepatol. 11: 529-535 (1999).

• Bellingham M, Evans TJ. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling. Cell. Signal. 19: 2183-2193 (2007). *

• Beltran B, Nos P, Dasi F, Iborra M, Bastida G, Martinez M, O'Connor JE, Saez G, Moret I, Ponce J. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naive and treated Crohn's disease. Inflamm. Bowel Dis. 16: 76-86 (2010).

• Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J. Parenter. Enteral Nutr. 30: 45-51 (2006). *

• Bengmark S. Bioecological control of inflammatory bowel disease. Clin. Nutr. 26: 169-181 (2007).

• Bentala H, Verweij WR, Huizinga-Van der Vlag A, van Loenen-Weemaes AM, Meijer DK, Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 18: 561-566 (2002). *

• Berdeli A, Gurkan A, Emingil G, Atilla G, Kose T. Endothelial nitric oxide synthase Glu298Asp gene polymorphism in periodontal diseases. J. Periodontol. 77: 1348-1354 (2006).

• Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *

• Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum. Genet. 121: 169-178 (2007). *

• Bertolini A, Ottani A, Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr. Med. Chem. 9: 1033-1043 (2002).

• Bertrand V, Quere S, Guimbaud R, Sogni P, Chauvelot-Moachon L, Tulliez M, Lamarque D, Charreire J, Giroud JP, Couturier D, Chaussade S, Breban M. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin. Eur. Cytokine Netw. 9: 161-170 (1998).

• Berzigotti A, Bellot P, De Gottardi A, Garcia-Pagan JC, Gagnon C, Spenard J, Bosch J. NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study. Am. J. Gastroenterol. Nov 17 [Epub ahead of print] (2009). *

• Besler C, Doerries C, Giannotti G, Luscher TF, Landmesse U. Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev. Cardiovasc. Ther. 6: 1071-1082 (2008).

• Bezerra MM, Brain SD, Girao VC, Greenacre S, Keeble J, Rocha FA. Neutrophils-derived peroxynitrite contributes to acute hyperalgesia and cell influx in zymosan arthritis. Naunyn. Schmiedebergs. Arch. Pharmacol. 374: 265-273 (2007).

• Bhattacharyya Majumdar S, Dey R, Majumder N, Bhattacharjee S, Majumdar S. A novel approach to regulate experimental visceral leishmaniasis in murine macrophages using CCR5 siRNA. Scand. J. Immunol. 67: 345-353 (2008). *

• Bi Y, Williams JA. Receptor biology and signal transduction in pancreatic acinar cells. Curr. Opin. Gastroenterol. 20: 427-434 (2004).

• Bica BE, Gomes NM, Fernandes PD, Luiz RR, Koatz VL. Nitric oxide levels and the severity of juvenile idiopathic arthritis. Rheumatol. Int. 27: 819-825 (2007). *

• Bickston SJ, Comerford LW, Cominelli F. Future therapies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 518-523 (2003).

• Biecker E, Neef M, Sagesser H, Shaw S, Koshy A, Reichen J. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int. 24: 345-353 (2004). *

• Biecker E, Trebicka J, Kang A, Hennenberg M, Sauerbruch T, Heller J. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension. Liver Int. 28: 331-338 (2008). *

• Billack B. Macrophage activation: role of Toll-like receptors, nitric oxide, and nuclear factor kappa B. Am. J. Pharm. Educ. 70: 102 (2006).

• Biller L, Schmidt H, Krause E, Gelhaus C, Matthiesen J, Handal G, Lotter H, Janssen O, Tannich E, Bruchhaus I. Comparison of two genetically related Entamoeba histolytica cell lines derived from the same isolate with different pathogenic properties. Proteomics 9: 4107-4120 (2009). *

• Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 26: 1175-1186 (2006). *

• Biondi ML, Marasini B, Leviti S, Turri O, Bernini M, Seminati R, Porreca W, Guagnellini E. Genotyping method for point mutation detection in the endothelial nitric oxide synthase exon 7 using fluorescent probes. Clinical validation in systemic sclerosis patients. Clin. Chem. Lab. Med. 39: 281-282 (2001).

• Bjelakovic G, Beninati S, Pavlovic D, Kocic G, Jevtovic T, Kamenov B, Saranac LJ, Bjelakovic B, Stojanovic I, Banic J. Glucocorticoids and oxidative stress. J. Basic Clin. Physiol. Pharmacol. 18: 115-127 (2007).

• Black JA, Waxman SG. Phenytoin protects central axons in experimental autoimmune encephalomyelitis. J. Neurol. Sci. 274: 57-63 (2008).

• Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov. Today. 10: 197-204 (2005).

• Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J. Clin. Invest. 103: 1431-1436 (1999). *

• Bobe P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK. Arsenic trioxide: a novel promising therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 108: 3967-3975 (2006). *

• Bobe P, Chelbi-Alix MK. New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases. Med. Sci. (Paris) 24: 967-971 (2008).

• Bonventre JV. Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation. Contrib. Nephrol. 156: 39-46 (2007).

• Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR, Wilkinson IB. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 50: 581-588 (2004). *

• Borniquel S, Jansson EA, Cole MP, Freeman BA, Lundberg JO. Nitrated oleic acid up-regulates PPAR-gamma and attenuates experimental inflammatory bowel disease. Free Radic. Biol. Med. Nov 19 [Epub ahead of print] (2009).

• Borrelli F, Aviello G, Romano B, Orlando P, Capasso R, Maiello F, Guadagno F, Petrosino S, Capasso F, Di Marzo V, Izzo AA. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J. Mol. Med. 87: 1111-1121 (2009). *

• Borysiewicz E, Fil D, Konat GW. Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes. J. Neurosci. Res. 87: 1565-1572 (2009).

• Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, Pohl LR. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298 (2002). *

• Boutlis CS, Yeo TW, Anstey NM. Malaria tolerance - for whom the cell tolls? Trends Parasitol. 22: 371-377 (2006). *

• Boyer L, Sidpra D, Jevon G, Buchan AM, Jacobson K. Differential responses of VIPergic and nitrergic neurons in paediatric patients with Crohn's disease. Auton. Neurosci. 134: 106-114 (2007).

• Brahmachari S, Pahan K. Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J. Immunol. 183: 2045-2058 (2009).

• Brandenburg LO, Kipp M, Lucius R, Pufe T, Wruck CJ. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm. Res. Nov 19 [Epub ahead of print] (2009). *

• Brenol CV, Chies JA, Brenol JC, Monticielo OA, Franciscatto P, Birriel F, Neves AG, Xavier RM. Endothelial nitric oxide synthase T-786C polymorphism in rheumatoid arthritis: association with extraarticular manifestations. Clin. Rheumatol. 28: 201-205 (2009).

• Brito MA, Lima S, Fernandes A, Falcao AS, Silva RF, Butterfield DA, Brites D. Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology 29: 259-269 (2008).

• Brunn A, Utermohlen O, Carstov M, Sanchez Ruiz M, Miletic H, Schluter D, Deckert M. CD4 T cells mediate axonal damage and spinal cord motor neuron apoptosis in murine P0106-125-induced experimental autoimmune neuritis. Am. J. Pathol. 173: 93-105 (2008). *

• Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther. 20: 813-819 (2004). *

• Budick-Harmelin N, Dudas J, Demuth J, Madar Z, Ramadori G, Tirosh O. Triglycerides potentiate the inflammatory response in rat Kupffer cells. Antioxid. Redox Signal. 10: 2009-2022 (2008).

• Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Burgner D, Stewart GJ. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. Eur. J. Hum. Genet. 13: 815-822 (2005). *

• Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, Garcia-Urkia N, Sarasqueta C, Cosme A, Irastorza B, Gonzalez A, Arenas J Jr. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol. 8: 40 (2008). *

• Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjoquist PO, Pernow J. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-kinase/Akt and NO pathway. Am. J. Physiol. Heart Circ. Physiol. 296: H719-H727 (2009). *

• Bulhak AA, Sjoquist PO, Xu CB, Edvinsson L, Pernow J. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Basic Res. Cardiol. 101: 244-252 (2006).

• Burgner D, Rockett K, Ackerman H, Hull J, Usen S, Pinder M, Kwiatkowski DP. Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations. Genes Immun. 4: 506-514 (2003). *

• Butterworth RF. Complications of cirrhosis III. Hepatic encephalopathy. J. Hepatol. 32: S171-S180 (2000).

• Buxbaum LU. Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection. Parasite Immunol. 32: 153-160 (2010). *

• Bzowska M, Stalinska K, Mezyk-Kopec R, Wawro K, Duda K, Das S, Bereta J. Exogenous nitric oxide inhibits shedding of ADAM17 substrates. Acta Biochim. Pol. 56: 325-335 (2009). *

• Caetano LC, do Prado Jr JC, Toldo MP, Abrahao AA. Trypanosoma cruzi: do different sylvatic strains trigger distinct immune responses? Exp. Parasitol. Sep 25 [Epub ahead of print] (2009).

• Cahill PA, Sitzmann JV. Nitric oxide and portal hypertension. J. Hepatol. 23: 355-356 (1995). *

• Calafat M, Larocca L, Roca V, Perez Leiros C. NOD mice exocrinopathy: towards a neuroimmune link. Neuroimmunomodulation 14: 175-181 (2007).

• Calatayud S, Ramirez MC, Sanz MJ, Moreno L, Hernandez C, Bosch J, Pique JM, Esplugues JV. Gastric mucosal resistance to acute injury in experimental portal hypertension. Br. J. Pharmacol. 132: 309-317 (2001). *

• Calder PC. Immunonutrition in surgical and critically ill patients. Br. J. Nutr. 98 Suppl. 1: S133-S139 (2007). *

• Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond.) 107: 1-11 (2004). *

• Cals-Grierson MM, Ormerod AD. Nitric oxide function in the skin. Nitric Oxide 10: 179-193 (2004). *

• Calvisi DF, Ladu S, Hironaka K, Factor VM, Thorgeirsson SS. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. J. Hepatol. 41: 815-822 (2004). *

• Camacho-Barquero L, Villegas I, Sanchez-Calvo JM, Talero E, Sanchez-Fidalgo S, Motilva V, Alarcon de la Lastra C. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int. Immunopharmacol. 7: 333-342 (2007).

• Camelo S, Lajavardi L, Bochot A, Goldenberg B, Naud MC, Brunel N, Lescure B, Klein C, Fattal E, Behar-Cohen F, de Kozak Y. Protective effect of intravitreal injection of vasoactive intestinal peptide (VIP)-loaded liposomes on experimental autoimmune uveoretinitis. J. Ocul. Pharmacol. Ther. 25: 9-21 (2009).

• Camuesco D, Comalada M, Concha A, Nieto A, Sierra S, Xaus J, Zarzuelo A, Galvez J. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin. Nutr. 25: 466-476 (2006).

• Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J. Nutr. 135: 687-694 (2005). *

• Camuesco D, Peran L, Comalada M, Nieto A, Di Stasi LC, Rodriguez-Cabezas ME, Concha A, Zarzuelo A, Galvez J. Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm. Bowel Dis. 11: 265-271 (2005). *

• Cano R, Llanos L, Zapater P, Pascual S, Bellot P, Barquero C, Perez-Mateo M, Such J, Frances R. Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites. J. Mol. Med. Jan 20 [Epub ahead of print] (2010). *

• Cao W, Fiocchi C, Pricolo VE. Production of interleukin-1beta, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis. Am. J. Physiol. Cell. Physiol. 289: C1408-C1416 (2005). *

• Cardoso L, Nascimento A, Royer C, Porto C, Lazari M. Locally produced relaxin may affect testis and vas deferens function in rats. Reproduction 139: 185-196 (2010).

• Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125: 1480-1491 (2003). *

• Carlsten C, de Roos AJ, Kaufman JD, Checkoway H, Wener M, Seixas N. Cell markers, cytokines, and immune parameters in cement mason apprentices. Arthritis Rheum. 57: 147-153 (2007). *

• Carrasco-Chaumel E, Rosello-Catafau J, Bartrons R, Franco-Gou R, Xaus C, Casillas A, Gelpi E, Rodes J, Peralta C. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J. Hepatol. 43: 997-1006 (2005). *

• Cartwright N, Murch O, McMaster SK, Paul-Clark MJ, van Heel DA, Ryffel B, Quesniaux VF, Evans TW, Thiemermann C, Mitchell JA. Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. Am. J. Respir. Crit. Care Med. 175: 595-603 (2007). *

• Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries S, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 164: 921-935 (2006). *

• Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115: 1599-1608 (2007). *

• Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol. 69: 479-491 (2009). *

• Caulfield VL, Balmer C, Dawson LJ, Smith PM. A role for nitric oxide-mediated glandular hypofunction in a non-apoptotic model for Sjogren's syndrome. Rheumatology (Oxford) 48: 727-733 (2009).

• Cauli O, Mansouri MT, Agusti A, Felipo V. Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 136: 1359-1367.e2 (2009). *

• Cauwels A, Brouckaert P. Survival of TNF toxicity: dependence on caspases and NO. Arch. Biochem. Biophys. 462: 132-139 (2007). *

• Cauwels A, Bultinck J, Brouckaert P. Dual role of endogenous nitric oxide in tumor necrosis factor shock: induced NO tempers oxidative stress. Cell. Mol. Life Sci. 62: 1632-1640 (2005). *

• Cejkova J, Ardan T, Simonova Z, Cejka C, Malec J, Jirsova K, Filipec M, Dotrelova D, Brunova B. Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjogren's syndrome). Nitric Oxide 17: 10-17 (2007).

• Celik U, Yildizdas D, Alhan E, Celik T, Attila G, Sertdemir Y, Tepe T. Genetic dilemma: eNOS gene intron 4a/b VNTR polymorphism in sepsis and its clinical features in Turkish children. Turk. J. Pediatr. 50: 114-119 (2008).

• Celio S, Troxler H, Durka SS, Chladek J, Wildhaber JH, Sennhauser FH, Heizmann CW, Moeller A. Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma. Nitric Oxide 15: 226-232 (2006).

• Cerinic Matucci M, Del Rosso A, Federico P, Livi R, Fiori G, Bartoli F, Blagojevic J, Tempestini A, Pignone A. Therapeutic challenges for systemic sclerosis: facts and future targets. Ann. N. Y. Acad. Sci. 1110: 448-454 (2007). *

• Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E(2) production in human chondrocytes. Osteoarthritis Cartilage 16: 1267-1274 (2008).

• Chabot F, Mestiri H, Sabry S, Dall'Ava-Santucci J, Lockhart A, Dinh-Xuan AT. Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis. Eur. Respir. J. 9: 560-564 (1996).

• Chan EP, Wells RG. Today's hepatic stellate cells: not your father's sternzellen. Hepatology 45: 1326-1327 (2007). *

• Chan PS, Kanwar M, Kowluru RA. Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory. J. Diabetes Complications 24: 55-63 (2010).

• Chandrasekharan B, Bala V, Kolachala VL, Vijay-Kumar M, Jones D, Gewirtz AT, Sitaraman SV, Srinivasan S. Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis. PLoS ONE 3: e3304 (2008). *

• Chang WW, Su IJ, Lai MD, Chang WT, Huang W, Lei HY. Toll-like receptor 4 plays an anti-HBV role in a murine model of acute hepatitis B virus expression. World J. Gastroenterol. 11: 6631-6637 (2005). *

• Chapidze G E, Kapanadze SD, Dolidze NK, Latsabidze NE, Bakhutashvili ZV. Combination treatment with coenzyme Q10 and simvastatin in patients with coronary atherosclerosis. Kardiologiia 46: 11-13 (2006).

• Chatterjee S, Lardinois O, Bonini MG, Bhattacharjee S, Stadler K, Corbett J, Deterding LJ, Tomer KB, Kadiiska M, Mason RP. Site-specific carboxypeptidase B1 tyrosine nitration and pathophysiological implications following its physical association with nitric oxide synthase-3 in experimental sepsis. J. Immunol. 183: 4055-4066 (2009).

• Chen C, Lee WH, Zhong L, Liu CP. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide. J. Immunol. 176: 3449-3460 (2006). *

• Chen C, Liu CP. Regulatory function of a novel population of mouse autoantigen-specific Foxp3 regulatory T cells depends on IFN-gamma, NO, and contact with target cells. PLoS One 4: e7863 (2009). *

• Chen C, Ran ZH, Xiao SD. Therapeutic effects of pravastatin on colitis induced by acetic acid and relevant mechanism: experiment with rats. Zhonghua Yi Xue Za Zhi 86: 1284-1288 (2006).

• Chen CT, Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC, Hou MC, Wu SL, Chan CC, Huang HC, Lee SD. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin. Hepatogastroenterology 56: 1261-1267 (2009).

• Chen TM, Subeq YM, Lee RP, Chiou TW, Hsu BG. Single dose intravenous thioacetamide administration as a model of acute liver damage in rats. Int. J. Exp. Pathol. 89: 223-231 (2008). *

• Chen Y, Chong MM, Darwiche R, Thomas HE, Kay TW. Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. Am. J. Pathol. 165: 913-921 (2004). *

• Chen Z, Suntres Z, Palmer J, Guzman J, Javed A, Xue J, Yu JG, Cooke H, Awad H, Hassanain HH, Cardounel AJ, Christofi FL. Cyclic AMP signaling contributes to neural plasticity and hyperexcitability in AH sensory neurons following intestinal Trichinella spiralis-induced inflammation. Int. J. Parasitol. 37: 743-761 (2007). *

• Cherrington NJ, Slitt AL, Li N, Klaassen CD. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab. Dispos. 32: 734-741 (2004). *

• Cheung KL, Khor TO, Kong AN. Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation. Pharm. Res. 26: 224-231 (2009). *

• Chikano S, Sawada K, Shimoyama T, Kashiwamura SI, Sugihara A, Sekikawa K, Terada N, Nakanishi K, Okamura H. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut 47: 779-786 (2000). *

• Chin MP, Schauer DB, Deen WM. Prediction of nitric oxide concentrations in colonic crypts during inflammation. Nitric Oxide 19: 266-275 (2008).

• Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashimoto M, Yagita H, Nawata H, Yoshimura A. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFN-gamma and IL-4 are involved. Gastroenterology 130: 373-388 (2006). *

• Chirino YI, Orozco-Lbarra M, Pedraza-Chaverri J. Role of peroxynitrite anion in different diseases. Rev. Invest. Clin. 58: 350-358 (2006).

• Chisaki K, Nakajima T, Iwasawa K, Iida H, Matsumoto A, Tada M, Komatsu Y, Hirose K, Miyamoto K, Okuda Y, Shiratori Y, Goto A, Hirata Y, Nagai R, Omata M. Enhancement of endothelial nitric oxide production by chenodeoxycholic acids in patients with hepatobiliary diseases. Jpn. Heart J. 42: 339-353 (2001). *

• Cho WS, Chae C. Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium. Vet. Pathol. 41: 419-423 (2004). *

• Choi EJ, Ko HH, Lee MW, Bang H, Lee CS. Inhibition of activated responses in dendritic cells exposed to lipopolysaccharide and lipoteichoic acid by diarylheptanoid oregonin. Int. Immunopharmacol. 8: 748-755 (2008).

• Choi KS, Song EK, Yim CY. Cytokines secreted by IL-2-activated lymphocytes induce endogenous nitric oxide synthesis and apoptosis in macrophages. J. Leukoc. Biol. 83: 1440-1450 (2008). *

• Chokshi NK, Guner YS, Hunter CJ, Upperman JS, Grishin A, Ford HR. The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin. Perinatol. 32: 92-99 (2008).

• Chon H, Choi B, Lee E, Lee S, Jeong G. Immunomodulatory effects of specific bacterial components of Lactobacillus plantarum KFCC11389P on the murine macrophage cell line RAW 264.7. J. Appl. Microbiol. 107: 1588-1597 (2009). *

• Chuman H. Nitric oxide in optic neuritis and multiple sclerosis. J. Neuroophthalmol. 26: 85-86 (2006).

• Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr. Vasc. Pharmacol. 7: 330-337 (2009).

• Cirillo C, Sarnelli G, Esposito G, Grosso M, Petruzzelli R, Izzo P, Calì G, d'armiento FP, Rocco A, Nardone G, Iuvone T, Steardo L, Cuomo R. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol. Motil. 21: 1209-e112 (2009).

• Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol. Sin. 28: 1450-1459 (2007).

• Clemens MG, Zhang JX. Regulation of sinusoidal perfusion: in vivo methodology and control by endothelins. Semin. Liver Dis. 19: 383-396 (1999).

• Coeffier M, Marion-Letellier R, Dechelotte P. Potential for amino acids supplementation during inflammatory bowel diseases. Inflamm. Bowel Dis. 16: 518-524 (2010).

• Colasurdo GN, Fullmer JJ, Elidemir O, Atkins C, Khan AM, Stark JM. Respiratory syncytial virus infection in a murine model of cystic fibrosis. J. Med. Virol. 78: 651-658 (2006). *

• Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Liver Int. 24: 63-68 (2004). *

• Colle I, Van Steenkiste C, Geerts A, Van Vlierberghe H. Hepatopulmonary syndrome and portopulmonary hypertension: what's new? Acta Gastroenterol. Belg. 70: 203-209 (2007).

• Collino M, Aragno M, Mastrocola R, Benetti E, Gallicchio M, Dianzani C, Danni O, Thiemermann C, Fantozzi R. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643. Free Radic. Biol. Med. 41: 579-589 (2006).

• Colon AL, Madrigal JL, Menchen LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig. Dis. Sci. 49: 1713-1721 (2004). *

• Colon AL, Menchen LA, Hurtado O, De Cristobal J, Lizasoain I, Leza JC, Lorenzo P, Moro MA. Implication of TNF-alpha convertase (TACE/ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis. Cytokine 16: 220-226 (2001).

• Coltri KC, Oliveira LL, Pinzan CF, Vendruscolo PE, Martinez R, Goldman MH, Panunto-Castelo A, Roque-Barreira MC. Therapeutic administration of KM+ lectin protects mice against Paracoccidioides brasiliensis infection via interleukin-12 production in a Toll-like receptor 2-dependent mechanism. Am. J. Pathol. 173: 423-432 (2008). *

• Combet E, Paterson S, Iijima K, Winter J, Mullen W, Crozier A, Preston T, McColl KE. Fat transforms ascorbic acid from inhibiting to promoting acid catalysed N-nitrosation. Gut 56: 1678-1684 (2007). *

• Conde CM, Cyrino FZ, Bottino DA, Gardette J, Bouskela E. Longchain n-3 polyunsaturated fatty acids and microvascular reactivity: observation in the hamster cheek pouch. Microvasc. Res. 73: 237-247 (2007).

• Cong Y, Oliver AO, Elson CO. Effects of cholera toxin on macrophage production of co-stimulatory cytokines. Eur. J. Immunol. 31: 64-71 (2001). *

• Cooke A. Th17 cells in inflammatory conditions. Rev. Diabet. Stud. 3: 72-75 (2006). *

• Copland DA, Calder CJ, Raveney BJ, Nicholson LB, Phillips J, Cherwinski H, Jenmalm M, Sedgwick JD, Dick AD. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171: 580-598 (2007). *

• Copland DA, Hussain K, Baalasubramanian S, Hughes TR, Morgan BP, Xu H, Dick AD, Nicholson LB. Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin. Exp. Immunol. Dec 14 [Epub ahead of print] (2009). *

• Corrales FJ, Ruiz F, Mato JM. In vivo regulation by glutathione of methionine adenosyltransferase S-nitrosylation in rat liver. J. Hepatol. 31: 887-894 (1999). *

• Cosen-Binker LI, Binker MG, Cosen R, Negri G, Tiscornia O. Relaxin prevents the development of severe acute pancreatitis. World J. Gastroenterol. 12: 1558-1568 (2006). *

• Crisafulli C, Bruscoli S, Esposito E, Mazzon E, Di Paola R, Genovese T, Bramanti P, Migliorati G, Cuzzocrea S. PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol. J. Pharmacol. Exp. Ther. 331: 796-807 (2009). *

• Cronauer MV, Ince Y, Engers R, Rinnab L, Weidemann W, Suschek CV, Burchardt M, Kleinert H, Wiedenmann J, Sies H, Ackermann R, Kroncke KD. Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression. Oncogene 26: 1875-1884 (2007). *

• Crosby MB, Svenson J, Gilkeson GS, Nowling TK. A novel PPAR response element in the murine iNOS promoter. Mol. Immunol. 42: 1303-1310 (2005). *

• Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 9: 179-189 (2003). *

• Cuenca J, Martin-Sanz P, Alvarez-Barrientos AM, Bosca L, Goren N. Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. Am. J. Pathol. 169: 1567-1576 (2006). *

• Cui T, Schopfer FJ, Zhang J, Chen K, Ichikawa T, Baker PR, Batthyany C, Chacko BK, Feng X, Patel RP, Agarwal A, Freeman BA, Chen YE. Nitrated fatty acids: endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 281: 35686-35698 (2006). *

• Curfs DM, Ghesquiere SA, Vergouwe MN, van der Made I, Gijbels MJ, Greaves DR, Verbeek JS, Hofker MH, de Winther MP. Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J. Biol. Chem. 283: 21640-21648 (2008). *

• Curgunlu A, Vural P, Canbaz M, Erten N, Karan MA, Tascioglu C. Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis. J. Clin. Lab. Anal. 19: 177-181 (2005).

• Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis. Curr. Pharm. Des. 12: 3551-3570 (2006).

• Cuzzocrea S, Bruscoli S, Mazzon E, Crisafulli C, Donato V, Di Paola R, Velardi E, Esposito E, Nocentini G, Riccardi C. Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids. Mol. Pharmacol. 73: 323-337 (2008). *

• Cuzzocrea S, McDonald MC, Mazzon E, Mota-Filipe H, Centorrino T, Terranova ML, Ciccolo A, Britti D, Caputi AP, Thiemermann C. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut 48: 478-488 (2001). *

• Cuzzocrea S, Saadat F, Di Paola R, Mirshafiey A. Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. Immunopharmacol. Immunotoxicol. 27: 615-630 (2005).

• Cvetkovic I, Al-Abed Y, Miljkovic D, Maksimovic-Ivanic D, Roth J, Bacher M, Lan HY, Nicoletti F, Stosic-Grujicic S. Critical role of macrophage migration inhibitory factor (MIF) activity in experimental autoimmune diabetes. Endocrinology 146: 2942-2951 (2005). *

• Cvjeticanin T, Stojanovic I, Timotijevic G, Stosic-Grujicic S, Miljkovic D. T cells cooperate with palmitic acid in induction of beta cell apoptosis. BMC Immunol. 10: 29 (2009). *

• Cynober L. Can arginine and ornithine support gut functions? Gut 35: S42-S45 (1994). *

• D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, Mattace Raso G, Cuzzocrea S, Loverme J, Piomelli D, Meli R, Calignano A. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. Eur. J. Pharmacol. 613: 54-59 (2009).

• da Silva Krause M, de Bittencourt PI Jr. Type 1 diabetes: can exercise impair the autoimmune event? The L-arginine/glutamine coupling hypothesis. Cell Biochem. Funct. 26: 406-433 (2008). *

• Daddaoua A, Puerta V, Requena P, Martinez-Ferez A, Guadix E, Sanchez de Medina F, Zarzuelo A, Suarez MD, Boza JJ, Martinez-Augustin O. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J. Nutr. 136: 672-676 (2006). *

• Daddaoua A, Puerta V, Zarzuelo A, Suarez MD, Sanchez de Medina F, Martinez-Augustin O. Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. J. Nutr. 135: 1164-1170 (2005). *

• Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced IFNgamma and nitric oxide in splenic lymphocytes by select estrogen-regulated miRNA: a novel mechanism of immune modulation. Blood 112: 4591-4597 (2008). *

• Dal-Ros S, Oswald-Mammosser M, Pestrikova T, Schott C, Boehm N, Bronner C, Chataigneau T, Geny B, Schini-Kerth VB. Losartan prevents portal hypertension induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats. Gastroenterology Oct 28 [Epub ahead of print] (2009). *

• Dallaire P, Bellmann K, Laplante M, Gelinas S, Centeno-Baez C, Penfornis P, Peyot ML, Latour MG, Lamontagne J, Trujillo ME, Scherer PE, Prentki M, Deshaies Y, Marette A. Obese mice lacking iNOS are sensitized to the metabolic actions of PPARgamma agonism. Diabetes 57: 1999-2011 (2008). *

• Daneshtalab N, Lewanczuk RZ, Russell AS, Jamali F. Drug-disease interactions: losartan effect is not downregulated by rheumatoid arthritis. J. Clin. Pharmacol. 46: 1344-1355 (2006). *

• Daniels I, Cavill D, Murray IA, Long RG. Elevated expression of iNOS mRNA and protein in coeliac disease. Clin. Chim. Acta 356: 134-142 (2005). *

• Das A, Banik NL, Ray SK. Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells. Neurochem. Res. 34: 87-101 (2009). *

• Das UN. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease - but how and why? Prostaglandins Leukot. Essent. Fatty Acids 78: 11-19 (2008). *

• Das UN. Insulin in the critically ill with focus on cytokines, reactive oxygen species, HLA-DR expression. J. Assoc. Physicians India 55: S56-S65 (2007).

• Das UN. Essential fatty acids - a review. Curr. Pharm. Biotechnol. 7: 467-482 (2006).

• Das UN. COX-2 inhibitors and metabolism of essential fatty acids. Med. Sci. Monit. 11: RA233-RA237 (2005). *

• Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol. J. 1: 420-439 (2006). *

• Das UN. Biological significance of essential fatty acids. J. Assoc. Physicians India 54: 309-319 (2006).

• Das UN. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 21: 762-773 (2005). *

• Das UN. Is angiotensin-II an endogenous pro-inflammatory molecule? Med. Sci. Monit. 11: RA155-RA162 (2005). *

• Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 7: 37 (2008). *

• Das UN. Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period? J. Nutr. Biochem. 18: 701-713 (2007). *

• Das UN. Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? Lipids Health Dis. 7: 19 (2008). *

• Das UN, Ramos EJ, Meguid MM. Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 6: 413-419 (2003).

• Datta PK, Lianos EA. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. Kidney Int. 56: 486-493 (1999). *

• Davis AS, Vergne I, Master SS, Kyei GB, Chua J, Deretic V. Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. PLoS Pathog. 3: e186 (2007). *

• Dayer JM. Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra. Clin. Exp. Rheumatol. 20 (5 Suppl. 27): S14-S20 (2002).

• De Backer O, Elinck E, Priem E, Leybaert L, Lefebvre RA. PPARgamma activation alleviates postoperative ileus in mice by inhibition of Egr-1 expression and its downstream target genes. J. Pharmacol. Exp. Ther. 331: 496-503 (2009). *

• de Jonge HR. Cystic fibrosis mice rehabilitated for studies of airway gland dysfunction. J. Physiol. 580: 7-8 (2007). *

• De La Hoz CL, Castro FR, Santos LM, Langone F. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis. Neuroimmunomodulation 17: 56-66 (2009).

• de Nigris F, Williams-Ignarro S, Lerman LO, Crimi E, Botti C, Mansueto G, D'Armiento FP, De Rosa G, Sica V, Ignarro LJ, Napoli C. Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc. Natl. Acad. Sci. U.S.A. 102: 4896-4901 (2005). *

• De Palma C, Falcone S, Panzeri C, Radice S, Bassi MT, Clementi E. Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection. J. Neurochem. 106: 193-204 (2008). *

• De Paula ML, Braga FG, Coimbra ES, Carmo AM, Teixeira HC, Da Silva AD, Souza MA, Ferreira AP. Modulatory effects of 6-carboxymethylthiopurine on activated murine macrophages. Chem. Biol. Drug Des. 71: 563-567 (2008). *

• De Rycke L, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekerckhove B, Veys EM, De Keyser F, Baeten D. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum. 52: 2323-2330 (2005). *

• De Stefano D, De Rosa G, Maiuri MC, Ungaro F, Quaglia F, Iuvone T, Cinelli MP, La Rotonda MI, Carnuccio R. Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat. Pharmacol. Res. 60: 33-40 (2009). *

• De Stefano D, Maiuri MC, Iovine B, Ialenti A, Bevilacqua MA, Carnuccio R. The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. J. Mol. Med. 84: 65-74 (2006). *

• De Stefano D, Maiuri MC, Simeon V, Grassia G, Soscia A, Cinelli MP, Carnuccio R. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur. J. Pharmacol. 566: 192-199 (2007). *

• de Winter-de Groot KM, van der Ent CK. Nitric oxide in cystic fibrosis. J. Cyst. Fibros. 4 Suppl. 2: S25-S29 (2005).

• Degenhardt T, Vaisanen S, Rakhshandehroo M, Kersten S, Carlberg C. Peroxisome proliferator-activated receptor alpha controls hepatic heme biosynthesis through ALAS1. J. Mol. Biol. 388: 225-238 (2009). *

• DeLeve LD, Wang X, Guo Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology 48: 920-930 (2008). *

• Delgado F, Estrada-Chavez C, Romano M, Paolicchi F, Blanco-Viera F, Capellino F, Chavez-Gris G, Pereira-Suarez AL. Expression of NRAMP1 and iNOS in Mycobacterium avium subsp. paratuberculosis naturally infected cattle. Comp. Immunol. Microbiol. Infect. Dis. Apr 3 [Epub ahead of print] (2009). *

• Deng GM. Tumor necrosis factor receptor pre-ligand assembly domain is an important therapeutic target in inflammatory arthritis. BioDrugs 21: 23-29 (2007).

• Desai A, Konda VR, Darland G, Austin M, Prabhu KS, Bland JS, Carroll BJ, Tripp ML. META060 inhibits multiple kinases in the NF-kB pathway and suppresses LPS-mediated inflammation in vitro and ex vivo. Inflamm. Res. 58: 229-234 (2009). *

• Devaux Y, Grosjean S, Seguin C, David C, Dousset B, Zannad F, Meistelman C, De Talance N, Mertes PM, Ungureanu-Longrois D. Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo. Am. J. Physiol. Endocrinol. Metab. 279: E1045-E1053 (2000). *

• Devaux Y, Seguin C, Grosjean S, de Talance N, Schwartz M, Burlet A, Zannad F, Meistelman C, Mertes PM, Ungureanu-Longrois D. Retinoic acid and lipopolysaccharide act synergistically to increase prostanoid concentrations in rats in vivo. J. Nutr. 131: 2628-2635 (2001). *

• Deykin A. Targeting biologic markers in asthma - is exhaled nitric oxide the bull's-eye? N. Engl. J. Med. 352: 2233-2235 (2005). *

• Dheen ST, Jun Y, Yan Z, Tay SS, Ling EA. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 50: 21-31 (2005). *

• Dhifallah IB, Houman H, Khanfir M, Hamzaoui K. Endothelial nitric oxide synthase gene polymorphism is associated with Behcet's disease in Tunisian population. Hum. Immunol. 69: 661-665 (2008).

• Di Paola R, Mazzon E, Patel NS, Genovese T, Muia C, Thiemermann C, De Sarro A, Cuzzocrea S. Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. Eur. J. Pharmacol. 507: 281-289 (2005). *

• Dias MA, Ceneviva R, Elias J Jr, Zucoloto S, Baldo CF, Evora PR. Liver histological, portal flow and plasmatic nitric oxide alterations caused by biliary obstruction and drainage in rats. Acta Cir. Bras. 23 Suppl. 1: 2-7 (2008). *

• Diaz-Lagares A, Alegre E, Gonzalez A. Detection of 3-nitrotyrosine-modified HLA-G in biological fluids. Hum. Immunol. 70: 976-980 (2009).

• Díaz-Lagares A, Alegre E, Lemaoult J, Carosella ED, Gonzalez A. Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu. Immunology 126: 436-445 (2009). *

• Diaz-Viciedo R, Hortelano S, Giron N, Masso JM, Rodriguez B, Villar A, de Las Heras B. Modulation of inflammatory responses by diterpene acids from Helianthus annuus L. Biochem. Biophys. Res. Commun. 369: 761-766 (2008). *

• Didilescu AC, Hanganu SC, Galie N, Greabu M, Totan A, Stratul SI, Puiu L. The role of smoking in changing essential parameters in body homeostasis. Pneumologia 58: 89-94 (2009).

• Diehl C, Lipozencic J, Ledic-Drvar D. The basis of topical superoxide dismutase antipruritic activity. Acta Dermatovenerol. Croat. 17: 25-39 (2009).

• Dietlin TA, Cua DJ, Burke KA, Lund BT, van der Veen RC. Role of IL-23 in mobilization of immunoregulatory nitric oxide or superoxide producing Gr-1(+) cells from bone marrow. Free Radic. Biol. Med. 47: 357-363 (2009).

• Digby JE, McNeill E, Dyar OJ, Lam V, Greaves DR, Choudhury RP. Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis Aug 31 [Epub ahead of print] (2009).

• Dijkstra G, Blokzijl H, Bok L, Homan M, van Goor H, Nico Faber K, Jansen PL, Moshage H. Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J. Pathol. 204: 296-303 (2004). *

• Dijkstra G, Moshage H, Jansen PL. Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease? Scand. J. Gastroenterol. Suppl. 236: 37-41 (2002). *

• Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, Jansen PL, van Goor H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J. Pathol. 186: 416-421 (1998). *

• Dijkstra G, van Goor H, Jansen PL, Moshage H. Targeting nitric oxide in the gastrointestinal tract. Curr. Opin. Investig. Drugs 5: 529-536 (2004).

• Dijkstra G, Yuvaraj S, Jiang HQ, Bun JC, Moshage H, Kushnir N, Peppelenbosch MP, Cebra JJ, Bos NA. Early bacterial dependent induction of inducible nitric oxide synthase (iNOS) in epithelial cells upon transfer of CD45RB(high) CD4(+) T cells in a model for experimental colitis. Inflamm. Bowel Dis. 13: 1467-1474 (2007). *

• Dijkstra G, Zandvoort AJ, Kobold AC, de Jager-Krikken A, Heeringa P, van Goor H, van Dullemen HM, Tervaert JW, van de Loosdrecht A, Moshage H, Jansen PL. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease. Scand. J. Gastroenterol. 37: 546-554 (2002). *

• Dimoulios P, Kolios G, Notas G, Matrella E, Xidakis C, Koulentaki M, Tsagarakis N, Kouroumalis A, Kouroumalis E. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis. Aliment. Pharmacol. Ther. 21: 227-234 (2005). *

• Dinarello CA. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20 (5 Suppl. 27): S1-S13 (2002).

• Dinarello CA. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr. Opin. Immunol. 3: 941-948 (1991).

• Dincer Y, Erzin Y, Himmetoglu S, Gunes KN, Bal K, Akcay T. Oxidative DNA damage and antioxidant activity in patients with inflammatory bowel disease. Dig. Dis. Sci. 52: 1636-1641 (2007). *

• Ding JW, Wang K, Brems JJ, Gamelli RL. Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent. J. Am. Coll. Surg. 198: 67-77 (2004). *

• Ding LA, Li JS, Li YS, Zhu NT, Liu FN, Tan L. Intestinal barrier damage caused by trauma and lipopolysaccharide. World J. Gastroenterol. 10: 2373-2378 (2004). *

• Ding X, Hiraku Y, Ma N, Kato T, Saito K, Nagahama M, Semba R, Kuribayashi K, Kawanishi S. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci. 96: 157-163 (2005). *

• Ding Y, Zhao L, Mei H, Zhang SL, Huang ZH, Duan YY, Ye P. Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur. J. Pharmacol. 590: 377-386 (2008).

• DiScipio RG, Schraufstatter IU. The role of the complement anaphylatoxins in the recruitment of eosinophils. Int. Immunopharmacol. 7: 1909-1923 (2007).

• Distrutti E, Mencarelli A, Santucci L, Renga B, Orlandi S, Donini A, Shah V, Fiorucci S. The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology 47: 659-667 (2008). *

• Dixit SG, Zingarelli B, Buckley DJ, Buckley AR, Pauletti GM. Nitric oxide mediates increased P-glycoprotein activity in interferon-gamma-stimulated human intestinal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G533-G540 (2005). *

• Dombrecht EJ, Van Offel JF, Bridts CH, Ebo DG, Seynhaeve V, Schuerwegh AJ, Stevens WJ, De Clerck LS. Influence of simvastatin on the production of pro-inflammatory cytokines and nitric oxide by activated human chondrocytes. Clin. Exp. Rheumatol. 25: 534-539 (2007).

• Domenicali M, Ros J, Fernandez-Varo G, Cejudo-Martin P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, Rodes J, Jimenez W. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut 54: 522-527 (2005). *

• Dong JJ, Zhao JJ, Lee KO, Lir MC, Chan SW, Liao L. Distribution of polymorphism in endothelial nitric oxide synthase gene in Singapore Chinese and its association with diabetic nephropathy. Zhonghua Yi Xue Za Zhi 87: 3415-3417 (2007).

• Dong WG, Liu SP, Yu BP, Wu DF, Luo HS, Yu JP. Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J. Gastroenterol. 9: 2533-2538 (2003). *

• Donnelly S, O'Neill SM, Stack CM, Robinson MW, Turnbull L, Whitchurch C, Dalton JP. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J. Biol. Chem. Nov 18 [Epub ahead of print] (2009). *

• Dost T, Ozkayran H, Gokalp F, Yenisey C, Birincioglu M. The effect of Hypericum perforatum (St. John's wort) on experimental colitis in rat. Dig. Dis. Sci. 54: 1214-1221 (2009). *

• Dotsch J, Puls J, Klimek T, Rascher W. Reduction of neuronal and inducible nitric oxide synthase gene expression in patients with cystic fibrosis. Eur. Arch. Otorhinolaryngol. 259: 222-226 (2002).

• Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J. Rheumatol. 31: 1756-1762 (2004).

• Duan J, Avci FY, Kasper DL. Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc. Natl. Acad. Sci. U.S.A. 105: 5183-5188 (2008). *

• Dubois RN. Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and colorectal cancer prevention. Curr. Opin. Gastroenterol. 17: 65-71 (2001).

• Dudhgaonkar SP, Tandan SK, Kumar D, Raviprakash V, Kataria M. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats. Inflammopharmacology 15: 188-195 (2007).

• Dunne JB, Alexander B, Williams R, Tredger JM. Evidence that S-adenosyl-L-methionine diastereoisomers may reduce ischaemia-reperfusion injury by interacting with purinoceptors in isolated rat liver. Br. J. Pharmacol. 125: 225-233 (1998). *

• Dursun A, Durakbasi-Dursun HG, Dursun R, Baris S, Akduman L. Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behcet's disease with or without ocular involvement. Inflamm. Res. Mar 3 [Epub ahead of print] (2009). *

• Duru M, Nacar A, Yonden Z, Kuvandik G, Helvaci MR, Koc A, Akaydin Y, Oksuz H, Sogut S. Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity. Ren. Fail. 30: 453-459 (2008).

• Duthie MS, Kahn M, White M, Kapur RP, Kahn SJ. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect. Immun. 73: 181-192 (2005). *

• Ebrahimi F, Tavakoli S, Hajrasouliha AR, Shafaroodi H, Sadeghipour H, Riazi K, Borhani AA, Houshmand G, Ahmadi SH, Dehpour AR. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats. Eur. J. Pharmacol. 523: 93-100 (2005). *

• Ebrahimkhani MR, Mani AR, Moore K. Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis. Gut 54: 1668-1671 (2005). *

• Ebrahimkhani MR, Moezi L, Kiani S, Merat S, Dehpour AR. Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis. Dig. Dis. Sci. 53: 3007-3011 (2008). *

• Ebrahimkhani MR, Sadeghipour H, Dehghani M, Kiani S, Payabvash S, Riazi K, Honar H, Pasalar P, Mirazi N, Amanlou M, Farsam H, Dehpour AR. Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis. Life Sci. 76: 2497-2512 (2005). *

• Efrati S, Berman S, Chachashvili A, Cohen N, Siman-Tov Y, Averbukh Z, Weissgarten J. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction. Nephrology (Carlton) 14: 189-197 (2009).

• Egan LJ. Mechanism of action of established drugs: cyclosporine, methotrexate and others. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 63-64. May 7-8 (2004). *

• Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I. Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine. A randomized controlled trial. Nutr. Metab. (Lond.) 3: 4 (2006). *

• Eisenhut M. Changes in ion transport in inflammatory disease. J. Inflamm. (Lond.) 3: 5 (2006). *

• Ekmekci H, Ekmekci OB, Erdine S, Sonmez H, Ataev Y, Ozturk Z, Butun II, Gurel C, Kucur M, Turfaner N, Ulutin T, Purisa S, Vural VA. Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension. J. Thromb. Thrombolysis 28: 418-424 (2009).

• El Eter E, Al Tuwaijiri A, Hagar H, Arafa M. In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat. J. Gastroenterol. Hepatol. 22: 1791-1799 (2007). *

• El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, Konig T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9: 1399-1406 (2008). *

• El-Medany A, Mahgoub A, Mustafa A, Arafa M, Morsi M. The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats. Eur. J. Pharmacol. 507: 291-299 (2005).

• El-Remessy AB, Tang Y, Zhu G, Matragoon S, Khalifa Y, Liu EK, Liu JY, Hanson E, Mian S, Fatteh N, Liou GI. Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. Mol. Vis. 14: 2190-2203 (2008). *

• Eley HL, Russell ST, Tisdale MJ. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am. J. Physiol. Endocrinol. Metab. 295: E1417-E1426 (2008). *

• Eliakim R, Karmeli F, Cohen P, Rachmilewitz D, Shao JS, Alpers DH. Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle. Inflamm. Bowel Dis. 5: 16-23 (1999). *

• Elseweidy MM, Younis NN, Amin RS, Abdallah FR, Fathy AM, Yousif ZA. Effect of some natural products either alone or in combination on gastritis induced in experimental rats. Dig. Dis. Sci. 53: 1774-1784 (2008). *

• Elson CO. Genes, microbes, and T cells - new therapeutic targets in Crohn's disease. N. Engl. J. Med. 346: 614-616 (2002). *

• Emre Y, Hurtaud C, Karaca M, Nubel T, Zavala F, Ricquier D. Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 104: 19085-19090 (2007). *

• Endres M. Statins: potential new indications in inflammatory conditions. Atheroscler. Suppl. 7: 31-35 (2006).

• Enrico V, Ivano B, Gregoriana Z, Silvia F, Claudia F, Riccardo R, Livio DC. Homocysteine and heart failure: an overview. Recent Patents Cardiovasc. Drug Discov. 4: 15-21 (2009).

• Er H, Evereklioglu C, Cumurcu T, Turkoz Y, Ozerol E, Sahin K, Doganay S. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease. Br. J. Ophthalmol. 86: 653-657 (2002). *

• Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA, Ge Z, Lee CW, Schauer DB, Wogan GN, Tannenbaum SR, Fox JG. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 106: 1027-1032 (2009). *

• Erdogan M, Karadeniz M, Berdeli A, Alper G, Caglayan O, Yilmaz C. The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients. J. Endocrinol. Invest. 31: 624-629 (2008).

• Ertekin V, Selimoglu MA, Turkan Y, Akcay F. Serum nitric oxide levels in children with celiac disease. J. Clin. Gastroenterol. 39: 782-785 (2005).

• Espinosa A, Oke V, Elfving A, Nyberg F, Covacu R, Wahren-Herlenius M. The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters the nucleus upon cellular exposure to nitric oxide. Exp. Cell Res. 314: 3605-3613 (2008). *

• Esposito G, Cirillo C, Sarnelli G, De Filippis D, D'armiento FP, Rocco A, Nardone G, Petruzzelli R, Grosso M, Izzo P, Iuvone T, Cuomo R. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology 133: 918-925 (2007). *

• Esrefoglu M, Gul M, Emre MH, Polat A, Selimoglu MA. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats. World J. Gastroenterol. 11: 1951-1956 (2005). *

• Eum HA, Park SW, Lee SM. Role of nitric oxide in the expression of hepatic vascular stress genes in response to sepsis. Nitric Oxide 17: 126-133 (2007).

• Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease. Surv. Ophthalmol. 50: 297-350 (2005).

• Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy. Clin. Endocrinol. (Oxf.) 68: 542-546 (2008). *

• Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J. Diabetes Complications 22: 331-338 (2008).

• Fabis MJ, Scott GS, Kean RB, Koprowski H, Hooper DC. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc. Natl. Acad. Sci. U.S.A. 104: 5656-5661 (2007). *

• Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J. Clin. Gastroenterol. 39: S138-S142 (2005).

• Fang SH, Hou YC, Chao PD. Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin. Toxicol. Appl. Pharmacol. 205: 65-70 (2005). *

• Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition 18: 872-879 (2002). *

• Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F, Chiarugi A. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J. Neurochem. 103: 590-603 (2007).

• Farazi PA, Zeisberg M, Glickman J, Zhang Y, Kalluri R, DePinho RA. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res. 66: 6622-6627 (2006). *

• Farias AS, de la Hoz C, Castro FR, Oliveira EC, Ribeiro Dos Reis JR, Silva JS, Langone F, Santos LM. Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination. Neuroimmunomodulation 14: 32-38 (2007).

• Fatini C, Gensini F, Sticchi E, Battaglini B, Angotti C, Conforti ML, Generini S, Pignone A, Abbate R, Matucci-Cerinic M. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am. J. Med. 112: 540-544 (2002). *

• Fayon M, Chiron R, Abely M; pour le Groupe "Inflammation" de la Societe Francaise de la Mucoviscidose*. Measurement of pulmonary inflammation in cystic fibrosis. Rev. Mal. Respir. 25: 705-724 (2008).

• Feng G, Gao W, Strom TB, Oukka M, Francis RS, Wood KJ, Bushell A. Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3(+) regulatory T cells. Eur. J. Immunol. 38: 2512-2527 (2008). *

• Ferguson JW, Dover AR, Chia S, Cruden NL, Hayes PC, Newby DE. Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites. Gut 55: 542-546 (2006). *

• Fermor B, Christensen SE, Youn I, Cernanec JM, Davies CM, Weinberg JB. Oxygen, nitric oxide and articular cartilage. Eur. Cell Mater. 13: 56-65 (2007). *

• Fernandez D, Bonilla E, Phillips P, Perl A. Signaling abnormalities in systemic lupus erythematosus as potential drug targets. Endocr. Metab. Immune Disord. Drug Targets 6: 305-311 (2006).

• Fernandez J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jimenez W, Bosch J, Arroyo V. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J. Hepatol. 41: 384-390 (2004). *

• Fernandez-Martinez A, Callejas NA, Casado M, Bosca L, Martin-Sanz P. Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes. J. Hepatol. 40: 963-970 (2004). *

• Fernell E, Fagerberg UL, Hellstrom PM. No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide. Acta Paediatr. 96: 1076-1079 (2007). *

• Ferran M, Gimenez-Arnau AM, Bellosillo B, Pujol RM, Santamaria-Babi LF. Effector function of CLA(+) T lymphocytes on autologous keratinocytes in psoriasis. Actas Dermosifiliogr. 99: 701-707 (2008).

• Figiel I. Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol. Exp. (Wars.) 68: 526-534 (2008).

• Fink MP. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr. Opin. Crit. Care 9: 143-151 (2003).

• Fiorucci S, Antonelli E, Brancaleone V, Sanpaolo L, Orlandi S, Distrutti E, Acuto G, Clerici C, Baldoni M, Del Soldato P, Morelli A. NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver. J. Hepatol. 39: 932-939 (2003). *

• Fiorucci S, Antonelli E, Distrutti E, Mencarelli A, Farneti S, Soldato PD, Morelli A. Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. Br. J. Pharmacol. 143: 33-42 (2004). *

• Fiorucci S, Antonelli E, Morelli A. Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver. Dig. Liver Dis. 35 Suppl. 2: S61-S69 (2003).

• Fiorucci S, Antonelli E, Tocchetti P, Morelli A. Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status. Cardiovasc. Drug Rev. 22: 135-146 (2004). *

• Fiorucci S, Distrutti E, Cirino G, Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131: 259-271 (2006). *

• Fiorucci S, Mencarelli A, Palazzetti B, Del Soldato P, Morelli A, Ignarro LJ. An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc. Natl. Acad. Sci. U.S.A. 98: 2652-2657 (2001). *

• Folador A, Hirabara SM, Bonatto SJ, Aikawa J, Yamazaki RK, Curi R, Fernandes LC. Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats. Int. J. Cancer 120: 344-350 (2007). *

• Foley KF, Pantano C, Ciolino A, Mawe GM. IFN-gamma and TNF-alpha decrease serotonin transporter function and expression in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G779-G784 (2007). *

• Fondevila C, Shen XD, Tsuchiyashi S, Yamashita K, Csizmadia E, Lassman C, Busuttil RW, Kupiec-Weglinski JW, Bach FH. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40: 1333-1341 (2004). *

• Fouad D, Siendones E, Costan G, Muntane J. Role of NF-kappaB activation and nitric oxide expression during PGE protection against D-galactosamine-induced cell death in cultured rat hepatocytes. Liver Int. 24: 227-236 (2004). *

• Frances R, Munoz C, Zapater P, Uceda F, Gascon I, Pascual S, Perez-Mateo M, Such J. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 53: 860-864 (2004). *

• Franco L, Talamini G. Cross-talk between inducible nitric oxide synthase and cyclooxygenase in Helicobacter-pylori-induced gastritis. Med. Princ. Pract. 18: 477-481 (2009).

• Freeman SL, MacNaughton WK. Nitric oxide inhibitable isoforms of adenylate cyclase mediate epithelial secretory dysfunction following exposure to ionising radiation. Gut 53: 214-221 (2004). *

• Frost RA, Lang CH. Regulation of muscle growth by pathogen associated molecules. J. Anim. Sci. 86: E84-E93 (2008).

• Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in mouse skeletal muscle and C2C12 myoblasts via Toll-like receptor-4 and c-Jun NH2-terminal kinase pathways. Am. J. Physiol. Cell Physiol. 287: C1605-C1615 (2004). *

• Frumento G, Piazza T, Di Carlo E, Ferrini S. Targeting tumor-related immunosuppression for cancer immunotherapy. Endocr. Metab. Immune Disord. Drug Targets 6: 233-237 (2006).

• Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect. Immun. 70: 779-786 (2002). *

• Fujiyama N, Shitara Y, Ito K, Masubuchi Y, Horie T. Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury. Biol. Pharm. Bull. 30: 556-561 (2007). *

• Fung E, Tang SM, Canner JP, Morishige K, Arboleda-Velasquez JF, Cardoso AA, Carlesso N, Aster JC, Aikawa M. Delta-like 4 induces Notch signaling in macrophages: implications for inflammation. Circulation 115: 2948-2956 (2007). *

• Gabriele C, de Benedictis FM, de Jongste JC. Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications. Ital. J. Pediatr. 35: 21 (2009).

• Gadano AC, Sogni P, Heller J, Moreau R, Bories PN, Lebrec D. Vascular nitric oxide production during the development of two experimental models of portal hypertension. J. Hepatol. 30: 896-903 (1999). *

• Gaines DI, Fallon MB. Hepatopulmonary syndrome. Liver Int. 24: 397-401 (2004). *

• Galanakis E, Kofteridis D, Stratigi K, Petraki E, Vazgiourakis V, Fragouli E, Mamoulakis D, Boumpas DT, Goulielmos GN. Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population. Hum. Immunol. 69: 279-283 (2008).

• Galle PR, Schuchmann M, Strand D, Strand S. Fas (CD95) mediated apoptosis in liver disease. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 18. October 20 - 21 (2003). *

• Galvao Da Silva AP, Jacysyn JF, De Almeida Abrahamsohn I. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response. Immunology 108: 230-237 (2003). *

• Gan SI, Beck PL. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am. J. Gastroenterol. 98: 2363-2371 (2003). *

• Gandotra S, Jang S, Murray PJ, Salgame P, Ehrt S. NOD2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 75: 5127-5134 (2007). *

• Ganea D, Gonzalez-Rey E, Delgado M. A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells. J. Neuroimmune Pharmacol. 1: 400-409 (2006).

• Ganzinelli S, Borda E, Sterin-Borda L. Autoantibodies from schizophrenia patients induce cerebral cox-1/iNOS mRNA expression with NO/PGE2/MMP-3 production. Int. J. Neuropsychopharmacol. Oct 19 [Epub ahead of print] (2009).

• Gao H, Gao Y, Li X, Shen A, Yan M. Spatiotemporal patterns of dexamethasone-induced Ras protein 1 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis. J. Mol. Neurosci. Jan 19 [Epub ahead of print] (2010).

• Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ. Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation 31: 121-132 (2008). *

• Garcia YR, Krolick KA. Short-circuiting autoimmune disease by target-tissue-derived nitric oxide. Clin. Immunol. 113: 74-80 (2004). *

• Garcia-Gonzalez MA, Pena AS. Nitric oxide and inflammatory bowel disease. Rev. Esp. Enferm. Dig. 90: 870-876 (1998).

• Garcia-Ruiz I, Rodriguez-Juan C, Diaz-Sanjuan T, Del Hoyo P, Colina F, Munoz-Yague T, Solis-Herruzo JA. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44: 581-591 (2006). *

• Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang XJ, DeGeorge GL, Laskin JD, Laskin DL. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 27: 748-754 (1998). *

• Gassull MA. The role of nutrition in the treatment of inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 79-83 (2004). *

• Gatta A, Sacerdoti D, Bolognesi M, Merkel C. Portal hypertension: state of the art. Ital. J. Gastroenterol. Hepatol. 31: 326-345 (1999).

• Gatti G, Rivero V, Motrich RD, Maccioni M. Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation. J. Leukoc. Biol. 79: 989-998 (2006). *

• Gattoni A, Marotta F, Vangieri B, Pisani G, Cristiano F. Hepatorenal syndrome. Clin. Ter. 155: 375-389 (2004).

• Gaultier A, Arandjelovic S, Niessen S, Overton CD, Linton MF, Fazio S, Campana WM, Cravatt BF 3rd, Gonias SL. Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the anti-inflammatory activity of this receptor. Blood 111: 5316-5325 (2008). *

• Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 574-585 (2006). *

• Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, Liu GY, Sitthimonchai S, Frank N. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res. 523-524: 163-172 (2003).

• Gerritsen ME. Genetic variations in vascular endothelial growth factor and endothelial nitric oxide synthase and their contributions to human disease. Microcirculation 12: 129-140 (2005).

• Gharavi N, El-Kadi AO. Role of nitric oxide in downregulation of cytochrome P450 1a1 and NADPH: quinone oxidoreductase 1 by tumor necrosis factor-alpha and lipopolysaccharide. J. Pharm. Sci. 96: 2795-2807 (2007). *

• Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH, Wesselborg S, Halayko AJ, Klonisch T, Los M. Role of BNIP3 in TNF-induced cell death - TNF upregulates BNIP3 expression. Biochim. Biophys. Acta 1793: 546-560 (2009). *

• Ghazavi A, Mosayebi G, Salehi H, Abtahi H. Effect of ethanol extract of saffron (Crocus sativus L.) on the inhibition of experimental autoimmune encephalomyelitis in C57bl/6 mice. Pak. J. Biol. Sci. 12: 690-695 (2009).

• Gholipour T, Riazi K, Noorian AR, Jannati A, Honar H, Doratotaj B, Nik HH, Shariftabrizi A, Dehpour AR. Seizure susceptibility alteration following reversible cholestasis in mice: modulation by opioids and nitric oxide. Eur. J. Pharmacol. 580: 322-328 (2008). *

• Ghosn EE, Almeida SR. Nitric oxide-dependent killing of Cryptococcus neoformans by B-1-derived mononuclear phagocyte. J. Leukoc. Biol. 80: 36-44 (2006). *

• Gingras S, Parganas E, de Pauw A, Ihle JN, Murray PJ. Re-examination of the role of SOCS1 in the regulation of Toll-like receptor signaling. J. Biol. Chem. 279: 54702-54707 (2004). *

• Giovannoni L. TNFA locus is associated with beta degrees 39 thalassemia in Corsica and Sardinia. Eur. Cytokine Netw. 19: 196-203 (2008).

• Glueck CJ, Freiberg RA, Boppana S, Wang P. Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis. J. Bone Joint Surg. Am. 90: 2220-2229 (2008).

• Go EK, Jung KJ, Kim JY, Yu BP, Chung HY. Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinases. J. Gerontol. A. Biol. Sci. Med. Sci. 60: 1252-1264 (2005).

• Gockel I, Bohl JR, Eckardt VF, Junginger T. Reduction of interstitial cells of Cajal (ICC) associated with neuronal nitric oxide synthase (n-NOS) in patients with achalasia. Am. J. Gastroenterol. 103: 856-864 (2008). *

• Godinez I, Haneda T, Raffatellu M, George MD, Paixao TA, Rolan HG, Santos RL, Dandekar S, Tsolis RM, Baumler AJ. T cells help to amplify inflammatory responses induced by Salmonella enterica serotype typhimurium in the intestinal mucosa. Infect. Immun. 76: 2008-2017 (2008). *

• Goggins MG, Shah SA, Goh J, Cherukuri A, Weir DG, Kelleher D, Mahmud N. Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease. Mediators Inflamm. 10: 69-73 (2001). *

• Goh BJ, Tan BT, Hon WM, Lee KH, Khoo HE. Nitric oxide synthase and heme oxygenase expressions in human liver cirrhosis. World J. Gastroenterol. 12: 588-594 (2006). *

• Gokhale NR, Belgaumkar VA, Pandit DP, Deshpande S, Damle DK. A study of serum nitric oxide levels in psoriasis. Indian J. Dermatol. Venereol. Leprol. 71: 175-178 (2005). *

• Gomez MA, Li S, Tremblay ML, Olivier M. NRAMP-1 expression modulates protein tyrosine phosphatase activity in macrophages: impact on host cell signaling and functions. J. Biol. Chem. 282: 36190-36198 (2007). *

• Gomez-Nicola D, Doncel-Perez E, Nieto-Sampedro M. Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin-15. J. Neurosci. Res. 83: 754-762 (2006). *

• Gomma AH, Elrayess MA, Knight CJ, Hawe E, Fox KM, Humphries SE. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur. Heart J. 23: 1955-1962 (2002). *

• Gonzalez FJ. Role of HNF4alpha in the superinduction of the IL-1beta-activated iNOS gene by oxidative stress. Biochem. J. 394: e3-e5 (2006). *

• Gonzalez R, Collado JA, Nell S, Briceno J, Tamayo MJ, Fraga E, Bernardos A, Lopez-Cillero P, Pascussi JM, Rufian S, Vilarem MJ, Mata Mde L, Brigelius-Flohe R, Maurel P, Muntane J. Cytoprotective properties of alpha-tocopherol are related to gene regulation in cultured D-galactosamine-treated human hepatocytes. Free Radic. Biol. Med. 43: 1439-1452 (2007).

• Gonzalez-Abraldes J, Garcia-Pagan JC, Bosch J. Nitric oxide and portal hypertension. Metab. Brain Dis. 17: 311-324 (2002).

• Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gonzalez-Juanatey C, de Matias JM, Martin J, Dessein PH, Llorca J. Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. Clin. Exp. Rheumatol. 27: 452-458 (2009).

• Goodman JE, Hofseth LJ, Hussain SP, Harris CC. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ. Mol. Mutagen. 44: 3-9 (2004). *

• Goos M, Lange P, Hanisch UK, Prinz M, Scheffel J, Bergmann R, Ebert S, Nau R. Fibronectin is elevated in the cerebrospinal fluid of patients suffering from bacterial meningitis and enhances inflammation caused by bacterial products in primary mouse microglial cell cultures. J. Neurochem. 102: 2049-2060 (2007).

• Gorg B, Wettstein M, Metzger S, Schliess F, Haussinger D. Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology 41: 1065-1073 (2005). *

• Grange PA, Chereau C, Raingeaud J, Nicco C, Weill B, Dupin N, Batteux F. Production of superoxide anions by keratinocytes initiates P. acnes-induced inflammation of the skin. PLoS Pathog. 5: e1000527 (2009). *

• Grasemann C, Ratjen F, Schnabel D, Reutershahn E, Vester U, Grasemann H. Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients. Eur. Respir. J. 31: 815-821 (2008). *

• Grasemann H, Knauer N, Buscher R, Hubner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am. J. Respir. Crit. Care Med. 162: 2172-2176 (2000). *

• Green JT, Richardson C, Marshall RW, Rhodes J, McKirdy HC, Thomas GA, Williams GT. Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment. Pharmacol. Ther. 14: 1429-1434 (2000). *

• Greenough A. Emerging drugs for the prevention of bronchopulmonary dysplasia. Expert Opin. Emerg. Drugs 13: 537-546 (2008).

• Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun. Rev. 7: 544-549 (2008).

• Grimble RF. Immunonutrition. Curr. Opin. Gastroenterol. 21: 216-222 (2005).

• Groeneveld AB, Beishuizen A, Appelmelk BJ, Girbes AR. Adjuvant therapies for sepsis and shock: which are more effective? Ned. Tijdschr. Geneeskd. 145: 1718-1722 (2001).

• Grumbach IM, Chen W, Mertens SA, Harrison DG. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J. Mol. Cell. Cardiol. 39: 595-603 (2005). *

• Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell DL, Nichols BL, Burrin DG. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130: 150-164 (2006). *

• Guarner C, Gonzalez-Navajas JM, Sanchez E, Soriando G, Frances R, Chiva M, Zapater P, Benlloch S, Munoz C, Pascual S, Balanzo J, Perez-Mateo M, Such J. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 44: 633-639 (2006). *

• Guilliams M, Movahedi K, Bosschaerts T, VandenDriessche T, Chuah MK, Herin M, Acosta-Sanchez A, Ma L, Moser M, Van Ginderachter JA, Brys L, De Baetselier P, Beschin A. IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J. Immunol. 182: 1107-1118 (2009).

• Guinazu N, Pellegrini A, Carrera-Silva EA, Aoki MP, Cabanillas AM, Girones N, Fresno M, Cano R, Gea S. Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression. Int. J. Parasitol. 37: 1243-1254 (2007). *

• Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, Kantengwa S, Rubbia-Brandt L, Mensi N, Angelillo-Scherrer A, Martinez-Soria E, Tacchini-Cottier F, Garcia I. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41: 773-781 (2004). *

• Gultekin FA, Kerem M, Tatlicioglu E, Aricioglu A, Unsal C, Bukan N. Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis. World J. Gastroenterol. 13: 2932-2938 (2007). *

• Guo H, Gao C, Mi Z, Wai PY, Kuo PC. Phosphorylation of Ser158 regulates inflammatory redox-dependent hepatocyte nuclear factor-4alpha transcriptional activity. Biochem. J. 394: 379-387 (2006). *

• Guo H, Gao C, Mi Z, Zhang J, Kuo PC. Characterization of the PC4 binding domain and its interactions with HNF4alpha. J. Biochem. 141: 635-640 (2007). *

• Guo LH, Guo KT, Wendel HP, Schluesener HJ. Combinations of TLR and NOD2 ligands stimulate rat microglial P2X4R expression. Biochem. Biophys. Res. Commun. 349: 1156-1162 (2006). *

• Gupta N, Martin PM, Miyauchi S, Ananth S, Herdman AV, Martindale RG, Podolsky R, Ganapathy V. Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem. Biophys. Res. Commun. 343: 571-577 (2006). *

• Gupta R, Dixon KM, Deo SS, Holliday CJ, Slater M, Halliday GM, Reeve VE, Mason RS. Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J. Invest. Dermatol. 127: 707-715 (2007). *

• Gustafsson SB, Lindgren T, Jonsson M, Jacobsson SO. Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil. Cancer Chemother. Pharmacol. 63: 691-701 (2009). *

• Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Whynot J, Novitskaya I, Cardinale I, Haider A, Khatcherian A, Carucci JA, Bergman R, Krueger JG. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J. Allergy Clin. Immunol. 119: 1210-1217 (2007). *

• Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R. Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J. Physiol. Pharmacol. 58: 591-610 (2007). *

• Habib S, Moinuddin, Ali R. Peroxynitrite modified DNA: a better antigen for systemic lupus erythematosus anti-DNA autoantibodies. Biotechnol. Appl. Biochem. 43: 65-70 (2006). *

• Habib SS. Exhaled nitric oxide. An emerging marker of inflammation in respiratory diseases. Saudi Med. J. 29: 1697-1702 (2008).

• Haddad G, Belosevic M. Transferrin-derived synthetic peptide induces highly conserved pro-inflammatory responses of macrophages. Mol. Immunol. 46: 576-586 (2009). *

• Hagar HH, El Etter E, Arafa M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin. Exp. Pharmacol. Physiol. 33: 189-196 (2006).

• Hagar HH, El Medany A, El Eter E, Arafa M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur. J. Pharmacol. 554: 69-77 (2007).

• Hagge DA, Saunders BM, Ebenezer GJ, Ray NA, Marks VT, Britton WJ, Krahenbuhl JL, Adams LB. Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy. Am. J. Pathol. 174: 1379-1389 (2009).

• Hagiwara S, Iwasaka H, Hidaka S, Hasegawa A, Noguchi T. Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB. Inflamm. Res. 58: 198-203 (2009). *

• Haider AS, Lowes MA, Suarez-Farinas M, Zaba LC, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM, Krueger JG. Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine a in psoriasis. J. Immunol. 180: 1913-1920 (2008). *

• Haile LA, Wasielewski RV, Gamrekelashvili J, Kruger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881.e5 (2008). *

• Halliwell B. Free radicals and other reactive species in disease. ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *

• Hamilton SJ, Chew GT, Watts GF. Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diab. Vasc. Dis. Res. 4: 89-102 (2007). *

• Hammadi A, Billard C, Faussat AM, Kolb JP. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. Nitric Oxide 19: 138-145 (2008).

• Han S, Kim K, Kim H, Kwon J, Lee YH, Lee CK, Song Y, Lee SJ, Ha N, Kim K. Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages. Arch. Pharm. Res. 31: 67-74 (2008).

• Han SH, Quon MJ, Koh KK. Beneficial vascular and mtabolic effects of peroxisome proliferator-activated receptor-alpha activators. Hypertension 46: 1086-1092 (2005).

• Hanai H, Sugimoto K. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr. Pharm. Des. 15: 2087-2094 (2009).

• Hao JS, Shan BE. Immune enhancement and anti-tumour activity of IL-23. Cancer Immunol. Immunother. 55: 1426-1431 (2006). *

• Haq E, Rohrer B, Nath N, Crosson CE, Singh I. S-Nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161180))-induced experimental autoimmune uveitis. J. Ocul. Pharmacol. Ther. 23: 221-231 (2007).

• Hara DB, Leite DF, Fernandes ES, Passos GF, Guimaraes AO, Pesquero JB, Campos MM, Calixto JB. The relevance of kinin B(1) receptor upregulation in a mouse model of colitis. Br. J. Pharmacol. 154: 1276-1286 (2008). *

• Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL Jr. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am. J. Pathol. Jan 7 [Epub ahead of print] (2010). *

• Harisa GE, Abo-Salem OM, El-Sayed el-SM, Taha EI, El-Halawany N. L-arginine augments the antioxidant effect of garlic against acetic acid-induced ulcerative colitis in rats. Pak. J. Pharm. Sci. 22: 373-380 (2009).

• Harris VK, Sadiq SA. Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making. Mol. Diagn. Ther. 13: 225-244 (2009).

• Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab. Vasc. Dis. Res. 4: 84-88 (2007).

• Haruna Y, Morita Y, Komai N, Yada T, Sakuta T, Tomita N, Fox DA, Kashihara N. Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase. Arthritis Rheum. 54: 1847-1855 (2006). *

• Hasko G, Deitch EA, Nemeth ZH, Kuhel DG, Szabo C. Inhibitors of ATP-binding cassette transporters suppress interleukin-12 p40 production and major histocompatibility complex II up-regulation in macrophages. J. Pharmacol. Exp. Ther. 301: 103-110 (2002). *

• Hasko G, Pacher P, Deitch EA, Vizi ES. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol. Ther. 113: 264-275 (2007). *

• Hasko G, Szabo C, Nemeth ZH, Deitch EA. Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression. Immunology 103: 473-478 (2001). *

• Hasselblatt P, Rath M, Komnenovic V, Zatloukal K, Wagner EF. Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 104: 17105-17110 (2007). *

• Hatano E. Tumor necrosis factor signaling in hepatocyte apoptosis. J. Gastroenterol. Hepatol. 22 Suppl. 1: S43-S44 (2007). *

• Hatoum OA, Gauthier KM, Binion DG, Miura H, Telford G, Otterson MF, Campbell WB, Gutterman DD. Novel mechanism of vasodilation in inflammatory bowel disease. Arterioscler. Thromb. Vasc. Biol. 25: 2355-2361 (2005). *

• Hattori Y, Murakami Y, Hattori S, Kuroda H, Kasai K, Shimoda S. Ursodeoxycholic acid inhibits the induction of nitric oxide synthase. Eur. J. Pharmacol. 300: 147-150 (1996).

• Haubitz M, Busch T, Gerlach M, Schafer S, Brunkhorst R, Falke K, Koch KM, Gerlach H. Exhaled nitric oxide in patients with Wegener's granulomatosis. Eur. Respir. J. 14: 113-117 (1999). *

• Hayashi D, Takii T, Fujiwara N, Fujita Y, Yano I, Yamamoto S, Kondo M, Yasuda E, Inagaki E, Kanai K, Fujiwara A, Kawarazaki A, Chiba T, Onozaki K. Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains. FEMS Immunol. Med. Microbiol. 56: 116-128 (2009). *

• Hayashi H, Shimizu K, Tani T, Takamura H, Takeshita M, Nakamura K, Ninomiya I, Fushida S, Harada SI, Kayahara M. Effect of porto-systemic shunting on NOS expression after extended hepatectomy in rats. Hepatol. Res. 39: 78-85 (2009).

• Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc. Soc. Exp. Biol. Med. 222: 99-112 (1999). *

• Heale CE, Fahraeus-Van Ree GE, Rahman P, Richardson VJ. Progressive and concordant expression of PKC-{eta} and iNOS phenotypes in monocytes from patients with rheumatoid arthritis: association with disease severity. J. Histochem. Cytochem. 55: 495-503 (2007). *

• Heemskerk S, Masereeuw R, Moesker O, Bouw MP, van der Hoeven JG, Peters WH, Russel FG, Pickkers P; On behalf of the APSEP Study Group. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit. Care Med. 37: 417-423, e1 (2009).

• Heemskerk S, van Koppen A, van den Broek L, Poelen GJ, Wouterse AC, Dijkman HB, Russel FG, Masereeuw R. Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia. Pflugers Arch. 454: 321-334 (2007). *

• Heeringa P, Bijl M, de Jager-Krikken A, Zandvoort A, Dijkstra G, Moshage H, Tervaert JW, Tiebosch AT, Kallenberg CG, van Goor H. Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis. J. Pathol. 193: 224-232 (2001). *

• Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, Liesenfeld O, Schumann RR, Gobel UB, Bereswill S. Exacerbation of murine ileitis by Toll-like receptor 4 meditated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56: 941-948 (2007). *

• Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, Lapp WS. T cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103: 3457-3464 (2004). *

• Heitmeier MR, Kelly CB, Ensor NJ, Gibson KA, Mullis KG, Corbett JA, Maziasz TJ. Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets. J. Biol. Chem. 279: 53145-53151 (2004). *

• Heller J, Kristeleit H, Brensing KA, Woitas RP, Spengler U, Sauerbruch T. Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state. Scand. J. Gastroenterol. 34: 297-302 (1999). *

• Hendriks HJ, van Kreel B, Forget PP. Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients. J. Pediatr. Gastroenterol. Nutr. 33: 260-265 (2001). *

• Hennenberg M, Trebicka J, Buecher D, Heller J, Sauerbruch T. Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase? Liver Int. 29: 933-941 (2009). *

• Hermann M. Cyclooxygenase-2 and nitric oxide. J. Cardiovasc. Pharmacol. 47 Suppl. 1: S21-S25 (2006).

• Herrick A. Raynaud's phenomenon. Curr. Treat. Options Cardiovasc. Med. 10: 146-155 (2008).

• Herulf M, Ljung T, Hellstrom PM, Weitzberg E, Lundberg JO. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand. J. Gastroenterol. 33: 164-169 (1998). *

• Heslan JM, Renaudin K, Thebault P, Josien R, Cuturi MC, Chiffoleau E. New evidence for a role of allograft accommodation in long-term tolerance. Transplantation 82: 1185-1193 (2006).

• Hinson JA, Reid AB, McCullough SS, James LP. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab. Rev. 36: 805-822 (2004).

• Hirai S, Kim YI, Goto T, Kang MS, Yoshimura M, Obata A, Yu R, Kawada T. Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci. 81: 1272-1279 (2007). *

• Hiremath MM, Chen VS, Suzuki K, Ting JP, Matsushima GK. MHC class II exacerbates demyelination in vivo independently of T cells. J. Neuroimmunol. 203: 23-32 (2008).

• Hofer M, Mueller L, Rechsteiner T, Benden C, Boehler A. Extended nitric oxide measurements in exhaled air of cystic fibrosis and healthy adults. Lung 187: 307-313 (2009).

• Hoffjan S, Ostrovnaja I, Nicolae D, Newman DL, Nicolae R, Gangnon R, Steiner L, Walker K, Reynolds R, Greene D, Mirel D, Gern JE, Lemanske RF Jr, Ober C. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J. Allergy Clin. Immunol. 113: 511-518 (2004). *

• Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP, Quezado MM, Zurer I, Rotter V, Wink DA, Appella E, Harris CC. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl. Acad. Sci. U.S.A. 100: 143-148 (2003). *

• Hogaboam CM, Vallance BA, Kumar A, Addison CL, Graham FL, Gauldie J, Collins SM. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J. Clin. Invest. 100: 2766-2776 (1997). *

• Hogman M, Lafih J, Merilainen P, Broms K, Malinovschi A, Janson C. Extended NO analysis in a healthy subgroup in of a random sample from a Swedish population. Clin. Physiol. Funct. Imaging 29: 18-23 (2009).

• Hokari A, Zeniya M, Esumi H, Kawabe T, Gershwin ME, Toda G. Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury. J. Gastroenterol. Hepatol. 17: 308-315 (2002). *

• Hollen E, Forslund T, Hogberg L, Laurin P, Stenhammar L, Falth-Magnusson K, Magnusson KE, Sundqvist T. Urinary nitric oxide during one year of gluten-free diet with or without oats in children with coeliac disease. Scand. J. Gastroenterol. 41: 1272-1278 (2006). *

• Hollen E, Holmgren Peterson K, Sundqvist T, Grodzinsky E, Hogberg L, Laurin P, Stenhammar L, Falth-Magnusson K, Magnusson KE. Coeliac children on a gluten-free diet with or without oats display equal anti-avenin antibody titres. Scand. J. Gastroenterol. 41: 42-47 (2006). *

• Holma R, Salmenpera P, Virtanen I, Vapaatalo H, Korpela R. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats. J. Physiol. Pharmacol. 58: 455-467 (2007). *

• Holmqvist B, Olsson CF, Svensson ML, Svanborg C, Forsell J, Alm P. Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4. J. Mol. Histol. 36: 499-516 (2005). *

• Holzknecht C, Rohl C. Effects of methylprednisolone and glatiramer acetate on nitric oxide formation of cytokine-stimulated cells from the rat oligodendroglial cell line OLN-93. Neuroimmunomodulation 17: 23-30 (2009).

• Hong I, Lee MH, Na TY, Zouboulis CC, Lee MO. LXRalpha enhances lipid synthesis in SZ95 sebocytes. J. Invest. Dermatol. 128: 1266-1272 (2008). *

• Hong JH, Lee GT, Lee JH, Kwon SJ, Park SH, Kim SJ, Kim IY. Effect of bone morphogenetic protein-6 on macrophages. Immunology 128: e442-e450 (2009). *

• Hong L, Fast W. Inhibition of human dimethylarginine dimethylamionhydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide: analysis, quantification, and implications for hyperhomocysteinemia. J. Biol. Chem. 282: 34684-34692 (2007). *

• Hong SK, Maltz BE, Coburn LA, Slaughter JC, Chaturvedi R, Schwartz DA, Wilson KT. Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity. Inflamm. Bowel Dis. 16: 105-111 (2010).

• Horowitz S, Binion DG, Nelson V, Kanaa Y, Javadi P, Lazarova Z, Andrekopoulos C, Kalyanaraman B, Otterson MF, Rafiee P. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1323-G1336 (2007). *

• Hosseini-Tabatabaei A, Abdollahi M. Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease? Inflamm. Allergy Drug Targets 7: 129-135 (2008).

• Houslay MD. Disrupting specific PDZ domain-mediated interactions for therapeutic benefit. Br. J. Pharmacol. 158: 483-485 (2009). *

• Howes LG. The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients. Diabetes Obes. Metab. 8: 8-14 (2006).

• Hoyos S, Granell S, Heredia N, Bulbena O, Closa D, Fernandez-Cruz L. Influence of portal blood on the development of systemic inflammation associated with experimental acute pancreatitis. Surgery 137: 186-191 (2005). *

• Hsieh MC, Hsiao JY, Tien KJ, Chang SJ, Lin PC, Hsu SC, Liang HT, Chen HC, Lin SR. The association of endothelial nitric oxide synthase G894T polymorphism with C-reactive protein level and metabolic syndrome in a Chinese study group. Metabolism 57: 1125-1129 (2008). *

• Hu RG, Sheng J, Qi X, Xu Z, Takahashi TT, Varshavsky A. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 437: 981-986 (2005). *

• Hu T, Chouinard M, Cox AL, Sipes P, Marcelo M, Ficorilli J, Li S, Gao H, Ryan TP, Michael MD, Michael LF. Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation. J. Biol. Chem. 281: 39831-39838 (2006). *

• Huang B, Zhao J, Shen S, Li H, He KL, Shen GX, Mayer L, Unkeless J, Li D, Yuan Y, Zhang GM, Xiong H, Feng ZH. Listeria monocytogenes promotes tumor growth via tumor cell Toll-like receptor 2 signaling. Cancer Res. 67: 4346-4352 (2007). *

• Huang HC, Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC, Hou MC, Chan CC, Wu SL, Chen CT, Lee SD. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension. Scand. J. Gastroenterol. 35: 1308-1313 (2000). *

• Huang LT, Chen CC, Sheen JM, Chen YJ, Hsieh CS, Tain YL. The interaction between high ammonia diet and bile duct ligation in developing rats: assessment by spatial memory and asymmetric dimethylarginine. Int. J. Dev. Neurosci. Nov 23 [Epub ahead of print] (2009).

• Huang TY, Chu HC, Lin YL, Lin CK, Hsieh TY, Chang WK, Chao YC, Liao CL. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Toxicol. Appl. Pharmacol. 237: 69-82 (2009). *

• Huang WC, Lin YS, Wang CY, Tsai CC, Tseng HC, Chen CL, Lu PJ, Chen PS, Qian L, Hong JS, Lin CF. Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 128: e275-e286 (2009).

• Hung LF, Lai JH, Lin LC, Wang SJ, Hou TY, Chang DM, Liang CC, Ho LJ. Retinoid acid inhibits IL-1-induced iNOS, COX-2 and chemokine production in human chondrocytes. Immunol. Invest. 37: 675-693 (2008). *

• Hussain S. Role of surfactant protein A in the innate host defense and autoimmunity. Autoimmunity 37: 125-130 (2004).

• Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 60: 3333-3337 (2000). *

• Hutchins H. Omega-3 fatty acids: recommendations for therapeutics and prevention. MedGenMed. 7: 18 (2005). *

• Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc. Res. 73: 326-340 (2007). *

• Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y. A novel cyclohexene derivative, TAK-242, selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol. 69: 1288-1295 (2006). *

• Iida A, Inagaki K, Miyazaki A, Yonemori F, Ito E, Igarashi K. Bach1 deficiency ameliorates hepatic injury in a mouse model. Tohoku J. Exp. Med. 217: 223-229 (2009). *

• Ikeda Y, Akbar F, Matsui H, Onji M. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 13: 841-850 (2001).

• Ilic V, Krstic A, Katic-Radivojevic S, Jovcic G, Milenkovic P, Bugarski D. Syphacia obvelata modifies mitogen-activated protein kinases and nitric oxide synthases expression in murine bone marrow cells. Parasitol. Int. Nov 7 [Epub ahead of print] (2009).

• Imamura A, Takahashi R, Murakami R, Kataoka H, Cheng XW, Numaguchi Y, Murohara T, Okumura K. The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels. Eur. J. Endocrinol. 158: 189-195 (2008). *

• Immervoll T, Loesgen S, Dutsch G, Gohlke H, Herbon N, Klugbauer S, Dempfle A, Bickeboller H, Becker-Follmann J, Ruschendorf F, Saar K, Reis A, Wichmann HE, Wjst M. Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum. Mutat. 18: 327-336 (2001). *

• Ina K, Itoh J, Fukushima K, Kusugami K, Yamaguchi T, Kyokane K, Imada A, Binion DG, Musso A, West GA, Dobrea GM, McCormick TS, Lapetina EG, Levine AD, Ottaway CA, Fiocchi C. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol. 163: 1081-1090 (1999). *

• Inan S, Cowan A. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacol. Biochem. Behav. 85: 39-43 (2006). *

• Ingbir M, Schwartz IF, Shtabsky A, Filip I, Reshef R, Chernichovski T, Iaina NL, Rozovski U, Levo Y, Schwartz D. Rosiglitazone improves aortic arginine transport, through inhibition of PKCalpha, in uremic rats. Am. J. Physiol. Renal Physiol. 295: F471-F477 (2008). *

• Into T, Inomata M, Nakashima M, Shibata KI, Hacker H, Matsushita K. Regulation of MyD88-dependent signaling events by S-nitrosylation retards Toll-like receptor signal transduction and initiation of acute-phase immune responses. Mol. Cell. Biol. 28: 1338-1347 (2008). *

• Invernizzi P, Salzman AL, Szabo C, Ueta I, O'Connor M, Setchell KD. Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo. Am. J. Physiol. 273: G131-G138 (1997). *

• Iseri SO, Ersoy Y, Ercan F, Yuksel M, Atukeren P, Gumustas K, Alican I. The effect of sildenafil, a phosphodiesterase-5 inhibitor, on acetic acid-induced colonic inflammation in the rat. J. Gastroenterol. Hepatol. 24: 1142-1148 (2009). *

• Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 16: 1227-1236 (2002). *

• Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G88-G95 (2004). *

• Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Gastroenterology 128: 1354-1368 (2005). *

• Ishizaki M, Kaibori M, Uchida Y, Hijikawa T, Tanaka H, Ozaki T, Tokuhara K, Matsui K, Kwon AH, Kamiyama Y, Nishizawa M, Okumura T. Protective effect of FR183998, a Na+/H+ exchanger inhibitor, and its inhibition of iNOS induction in hepatic ischemia-reperfusion injury in rats. Shock 30: 311-317 (2008). *

• Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43: S121-S131 (2006). *

• Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J. Hepatol. 46: 927-934 (2007). *

• Iwashita E. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective microelectrode. J. Gastroenterol. Hepatol. 13: 391-395 (1998). *

• Izmailova ES, Paz N, Alencar H, Chun M, Schopf L, Hepperle M, Lane JH, Harriman G, Xu Y, Ocain T, Weissleder R, Mahmood U, Healy AM, Jaffee B. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum. 56: 117-128 (2007). *

• Jabs DA, Gerard HC, Wei Y, Campbell AL, Hudson AP, Akpek EK, Lee B, Prendergast RA, Whittum-Hudson JA. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest. Ophthalmol. Vis. Sci. 45: 2293-2298 (2004). *

• Jacques C, Gosset M, Berenbaum F, Gabay C. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam. Horm. 74C: 371-403 (2006).

• Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol. Sci. 65: 166-176 (2002). *

• Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig. Dis. Sci. 49: 1752-1757 (2004). *

• Jahnel J, Fickert P, Langner C, Hogenauer C, Silbert D, Gumhold J, Fuchsbichler A, Trauner M. Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice. Liver Int. 29: 1316-1325 (2009). *

• Jahnke VE, Sabido O, Freyssenet DG. Control of mitochondrial biogenesis, ROS level and cytosolic Ca2+ concentration during the cell cycle and the onset of differentiation in L6E9 myoblasts. Am. J. Physiol. Cell Physiol. 296: C1185-C1194 (2009). *

• Jain R, DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin. Proc. 81: 205-212 (2006). *

• Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 120: 190-199 (2001). *

• James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 31: 1499-1506 (2003). *

• Jancar S, Sanchez Crespo M. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol. 26: 48-55 (2005). *

• Jarrar D, Chaudry IH, Wang P. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (review). Int. J. Mol. Med. 4: 575-583 (1999).

• Jasinska M, Owczarek J, Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol. Rep. 59: 483-99 (2007). *

• Jeong GS, Lee SH, Jeong SN, Kim YC, Kim EC. Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1. Int. Immunopharmacol. 9: 1374-1380 (2009).

• Jeyabalan G, Tsung A, Billiar TR. Linking proximal and downstream signalling events in hepatic ischaemia/reperfusion injury. Biochem. Soc. Trans. 34: 957-959 (2006). *

• Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J. Gastroenterol. 10: 1699-1708 (2004). *

• Jia Y, Turek JJ. Altered NF-kappaB gene expression and collagen formation induced by polyunsaturated fatty acids. J. Nutr. Biochem. 16: 500-506 (2005). *

• Jia Y, Turek JJ. Inducible nitric oxide synthase links NF-kappaB to PGE2 in polyunsaturated fatty acid altered fibroblast in-vitro wound healing. Lipids Health Dis. 4: 14 (2005). *

• Jiang LH, Shi Y, Wang LS, Yang ZR. The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice. J. Nutr. Biochem. 20: 735-741 (2009). *

• Jiang W, Pisetsky DS. The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J. Immunol. 177: 3337-3343 (2006). *

• Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J. Gastroenterol. 8: 158-161 (2002). *

• Jiang Y, Zhang J, Xiong J, Cao J, Li G, Wang S. Ligands of peroxisome proliferator-activated receptor inhibit homocysteine-induced DNA methylation of inducible nitric oxide synthase gene. Acta Biochim. Biophys. Sin. (Shanghai) 39: 366-376 (2007).

• Johannesen J, Pociot F, Kristiansen OP, Karlsen AE, Nerup J; DIEGG and DSGD Danish IDDM Epidemiology and Genetics Group, Danish Study Group of Diabetis in Childhood. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population. Genes Immun. 1: 362-366 (2000). *

• Joo SS, Kang HC, Won TJ, Lee DI. Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1beta and nitric oxide in rat microglia. Arch. Pharm. Res. 26: 1067-1073 (2003).

• Joo SS, Won TJ, Lee do I. Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch. Pharm. Res. 27: 954-960 (2004).

• Joo Y, Kim HS, Woo RS, Park CH, Shin KY, Lee JP, Chang KA, Kim S, Suh YH. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models. Mol. Pharmacol. 69: 76-84 (2006). *

• Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9: 213-219 (2003). *

• Joung CI, Park YW, Kim SK, Uhm WS, Kim TH, Yoo DH. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Korean patients with systemic sclerosis. J. Korean Med. Sci. 21: 329-332 (2006). *

• Jozefowicz E, Brisson H, Rozenberg S, Mebazaa A, Gele P, Callebert J, Lebuffe G, Vallet B, Bordet R, Tavernier B. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats. Crit. Care Med. 35: 856-863 (2007).

• Jørgensen VL, Ibsen M, Andresen L, Schulzke JD, Perner A. Effects of endotoxaemia on markers of permeability, metabolism and inflammation in the large bowel of healthy subjects. Acta Anaesthesiol. Scand. 51: 1085-1092 (2007).

• Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Christos P, Paraskevi K, Konstantinos P, Katsaraki A, Tsianos EV. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Dig. Dis. Sci. 50: 1771-1777 (2005). *

• Kalayarasan S, Sriram N, Sudhandiran G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta. Life Sci. 82: 1142-1153 (2008). *

• Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J. Gastroenterol. 43: 811-822 (2008). *

• Kamoun WS, Karaa A, Kresge N, Merkel SM, Korneszczuk K, Clemens MG. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1. Hepatology 43: 182-190 (2006). *

• Kanazawa H, Yoshikawa J. A case-control study of bronchial asthma associated with ulcerative colitis: role of airway microvascular permeability. Clin. Exp. Allergy 35: 1432-1436 (2005).

• Kang BY, Kim E, Kim TS. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell. Signal. 17: 665-673 (2005). *

• Kang K, Zhao M, Jiang H, Tan G, Pan S, Sun X. Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl. 15: 1306-1314 (2009).

• Kang YH, Berthiaume F, Yarmush ML. Long-term stable cultures of rat hepatocytes: an in vitro model to study acute and chronic hepatic inflammation. Tissue Eng. 8: 681-693 (2002).

• Kania G, Blyszczuk P, Valaperti A, Dieterle T, Leimenstoll B, Dirnhofer S, Zulewski H, Eriksson U. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis. Cardiovasc. Res. 80: 236-245 (2008).

• Kanjwani DG, Marathe TP, Chiplunkar SV, Sathaye SS. Evaluation of immunomodulatory activity of methanolic extract of Piper betel. Scand. J. Immunol. 67: 589-593 (2008). *

• Kankuri E, Hamalainen M, Hukkanen M, Salmenpera P, Kivilaakso E, Vapaatalo H, Moilanen E. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scand. J. Gastroenterol. 38: 186-192 (2003). *

• Kanwar JR. Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease. Curr. Med. Chem. 12: 2947-2962 (2005).

• Kanwar JR, Kanwar RK, Burrow H, Baratchi S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr. Med. Chem. 16: 2373-2394 (2009).

• Kanwar JR, Kanwar RK, Krissansen GW. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127: 1313-1331 (2004).

• Kanwar JR, Palmano KP, Sun X, Kanwar RK, Gupta R, Haggarty N, Rowan A, Ram S, Krissansen GW. 'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol. Cell Biol. 86: 277-288 (2008). *

• Kapoor N, Narayana Y, Patil SA, Balaji KN. Nitric oxide is involved in Mycobacterium bovis Bacillus Calmette-Guerin-activated Jagged1 and Notch1 signaling. J. Immunol. Feb 10 [Epub ahead of print] (2010).

• Kapralov AA, Vlasova II, Feng W, Maeda A, Walson K, Tyurin VA, Huang Z, Aneja RK, Carcillo J, Bayir H, Kagan VE. Peroxidase activity of hemoglobin/haptoglobin complexes: covalent aggregation and oxidative stress in plasma and macrophages. J. Biol. Chem. 284: 30395-30407 (2009). *

• Kara N, Senturk N, Gunes SO, Bagci H, Yigit S, Turanli AY. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphism (glu298asp) with Behcet's disease in the Turkish population. Arch. Dermatol. Res. 297: 468-471 (2006). *

• Karabulut AB, Ara C. Melatonin ameliorates tacrolimus (FK-506)'s induced immunosupressive effect in rat liver. Transplant. Proc. 41: 1875-1877 (2009). *

• Karaman A, Iraz M, Kirimlioglu H, Karadag N, Tas E, Fadillioglu E. Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment. Pediatr. Surg. Int. 22: 701-708 (2006). *

• Karaman A, Kirimlioglu H, Tas E, Karadag N, Gulsul C, Fadillioglu E, Demircan M. Effect of leflunomide on liver regeneration after partial hepatectomy in rats. Pediatr. Surg. Int. 26: 219-226 (2010).

• Karaman A, Kirimlioglu H, Tas E, Karadag N, Gulsul C, Fadillioglu E, Demircan M. Effect of leflunomide on liver regeneration after partial hepatectomy in rats. Pediatr. Surg. Int. Nov 18 [Epub ahead of print] (2009). *

• Karasneh JA, Hajeer AH, Silman A, Worthington J, Ollier WE, Gul A. Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behcet's disease. Rheumatology (Oxford) 44: 614-617 (2005). *

• Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F. Hepatic recruitment of the inflammatory Gr1(+) monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50: 261-274 (2009).

• Karpuzoglu E, Ahmed SA. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide 15: 177-186 (2006). *

• Karpuzoglu E, Fenaux JB, Phillips RA, Lengi AJ, Elvinger F, Ansar Ahmed S. Estrogen up-regulates inducible nitric oxide synthase (iNOS), nitric oxide, and cyclooxygenase-2 (COX-2) in splenocytes activated with T cell stimulants: role of interferon-gamma (IFN-gamma). Endocrinology 147: 662-671 (2006). *

• Karpuzoglu E, Phillips RA, Gogal RM Jr, Ansar Ahmed S. IFN-gamma-inducing transcription factor, T-bet is upregulated by estrogen in murine splenocytes: role of IL-27 but not IL-12. Mol. Immunol. 44: 1819-1825 (2007). *

• Katayama Y, Takahashi M, Kuwayama H. Helicobacter pylori causes Runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochem. Biophys. Res. Commun. 388: 496-500 (2009). *

• Katiyar SK. Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin. Int. J. Oncol. 21: 1213-1222 (2002).

• Katsuki H, Kurimoto E, Takemori S, Kurauchi Y, Hisatsune A, Isohama Y, Izumi Y, Kume T, Shudo K, Akaike A. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling. J. Neurochem. 110: 707-718 (2009).

• Katsuta Y, Zhang XJ, Aramaki T. Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension. Nippon Rinsho 59: 1186-1192 (2001).

• Kaunitz JD, Akiba Y. Gastroduodenal mucosal defense: role of endogenous mediators. Curr. Opin. Gastroenterol. 20: 526-532 (2004).

• Kaur G, Athar M, Alam MS. Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response. Invest. New Drugs Jul 10 [Epub ahead of print] (2009).

• Kawachi H, Moriya NH, Korai T, Tanaka SY, Watanabe M, Matsui T, Kawada T, Yano H. Nitric oxide suppresses preadipocyte differentiation in 3T3-L1 culture. Mol. Cell. Biochem. 300: 61-67 (2007). *

• Kawanishi N, Tanaka Y, Kato Y, Shiva D, Yano H. Lipopolysaccharide-induced monocyte chemotactic protein-1 is enhanced by suppression of nitric oxide production, which depends on poor CD14 expression on the surface of skeletal muscle. Cell. Biochem. Funct. 26: 486-492 (2008). *

• Kawanishi S, Hiraku Y, Pinlaor S, Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 387: 365-372 (2006).

• Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, Suzumura A. Production and functions of IL-17 in microglia. J. Neuroimmunol. 194: 54-61 (2008).

• Kazi HA, Qian Z. Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of NFkB. Saudi J. Gastroenterol. 15: 181-187 (2009). *

• Keen C, Gustafsson P, Lindblad A, Wennergren G, Olin AC. Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis. Pediatr. Pulmonol. Feb 9 [Epub ahead of print] (2010). *

• Keen C, Olin AC, Edentoft A, Gronowitz E, Strandvik B. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, pseudomonas infection, and polyunsaturated fatty acids. Chest 131: 1857-1864 (2007). *

• Kelleher ZT, Matsumoto A, Stamler JS, Marshall HE. NOS2 regulation of NF-kappa B by S-nitrosylation of p65. J. Biol. Chem. 282: 30667-30672 (2007). *

• Kershenobich Stalnikowitz D, Weissbrod AB. Liver fibrosis and inflammation. A review. Ann. Hepatol. 2: 159-163 (2003). *

• Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52: 720-728 (2003). *

• Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats? J. Hepatol. 50: 538-547 (2009).

• Khair-El-Din T, Sicher SC, Vazquez MA, Chung GW, Stallworth KA, Kitamura K, Miller RT, Lu CY. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J. Exp. Med. 183: 1241-1246 (1996). *

• Khalifeh MS, Al-Rukibat R, Hananeh W, Boumezrag A, Okour O. Investigation of the role of tumour necrosis factor-alpha, interleukin-1beta, interleukin-10, nitric oxide and rheumatoid factor-immunoglobulin M in a rat model of arthritis. Lab. Anim. Oct 26 [Epub ahead of print] (2009).

• Kheradmand T, Wolf NA, Swanborg RH. Myelin basic protein-reactive T cells persist in an inactive state in the bone marrow of Lewis rats that have recovered from autoimmune encephalomyelitis. J. Neuroimmunol. 209: 26-32 (2009).

• Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 66: 11580-11584 (2006). *

• Kiani S, Valizadeh B, Hormazdi B, Samadi H, Najafi T, Samini M, Dehpour AR. Alteration in male reproductive system in experimental cholestasis: roles for opioids and nitric oxide overproduction. Eur. J. Pharmacol. 615: 246-251 (2009).

• Kida T, Murata T, Hori M, Ozaki H. Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 296: H195-H201 (2009). *

• Kielar ML, Jeyarajah DR, Penfield JG, Lu CY. Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NFkappa d response elements of the iNOS promoter. Transplantation 69: 2131-2137 (2000).

• Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J. Am. Soc. Nephrol. 14: 389-396 (2003). *

• Kikuchi H, Katsuramaki T, Kukita K, Taketani S, Meguro M, Nagayama M, Isobe M, Mizuguchi T, Hirata K. New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis. Wound Repair Regen. 15: 881-888 (2007). *

• Killeen ME, Englert JA, Stolz DB, Song M, Han Y, Delude RL, Kellum JA, Fink MP. The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J. Pharmacol. Exp. Ther. 316: 1070-1079 (2006). *

• Kim EK, Kwon KB, Koo BS, Han MJ, Song MY, Song EK, Han MK, Park JW, Ryu DG, Park BH. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NFkappaB pathway. Int. J. Biochem. Cell Biol. 39: 1260-1275 (2007). *

• Kim J, Cha YN, Surh YJ. A protective role of nuclear erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat. Res. Sep 29 [Epub ahead of print] (2009).

• Kim JH, Studer RK, Sowa GA, Vo NV, Kang JD. Activated macrophage-like THP-1 cells modulate annulus fibrosus cell production of inflammatory mediators in response to cytokines. Spine 33: 2253-2259 (2008).

• Kim JU, Chang HK, Lee SS, Kim JW, Kim KT, Lee SW, Chung WT. Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis. Ann. Rheum. Dis. 62: 1083-1087 (2003). *

• Kim KA, Lee MS. Recent progress in research on beta-cell apoptosis by cytokines. Front. Biosci. 14: 657-664 (2009).

• Kim SF, Huri DA, Snyder SH. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310: 1966-1970 (2005). *

• Kim SH, Cheon HJ, Yun N, Oh ST, Shin E, Shim KS, Lee SM. Protective effect of a mixture of Aloe vera and Silybum marianum against carbon tetrachloride-induced acute hepatotoxicity and liver fibrosis. J. Pharmacol. Sci. 109: 119-127 (2009). *

• Kim YH, Kwon HS, Kim DH, Cho HJ, Lee HS, Jun JG, Park JH, Kim JK. Piceatannol, a stilbene present in grapes, attenuates DSS-induced colitis. Int. Immunopharmacol. 8: 1695-1702 (2008).

• Kim YH, Kwon HS, Kim DH, Shin EK, Kang YH, Park JH, Shin HK, Kim JK. 3,3'-Diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm. Bowel Dis. 15: 1164-1173 (2009).

• Kim YJ, Kim HJ, No JK, Chung HY, Fernandes G. Anti-inflammatory action of dietary fish oil and calorie restriction. Life Sci. 78: 2523-2532 (2006). *

• Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, Higuchi H, Akiba Y, Hokari R, Hirokawa M, Serizawa H, Ishii H. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig. Dis. Sci. 42: 1047-1054 (1997). *

• Kinsner A, Boveri M, Hareng L, Brown GC, Coecke S, Hartung T, Bal-Price A. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide. J. Neurochem. 99: 596-607 (2006). *

• Kirchmeyer M, Deffaud J, Sebillaud S, Moulin D, Koufany M, Netter P, Bianchi A, Jouzeau JY. Evidence for species differences in the regulation of MMPs by all-trans retinoic acid in cytokine-stimulated chondrocytes. Biorheology 45: 415-432 (2008).

• Kirimlioglu V, Kirimlioglu H, Yilmaz S, Ozgor D, Coban S, Karadag N, Yologlu S. Effect of fish oil, olive oil, and vitamin E on liver pathology, cell proliferation, and antioxidant defense system in rats subjected to partial hepatectomy. Transplant. Proc. 38: 564-567 (2006). *

• Kirsten H, Petit-Teixeira E, Hantmann H, Reichardt J, Burkhardt J, Emmrich F, Cornelis F, Ahnert P. A family-based study does not support the association of a functional polymorphism in the gene for endothelial nitric oxide synthase with risk for rheumatoid arthritis. Scand. J. Rheumatol. Mar 2 [Epub ahead of print] (2009). *

• Kizaki T, Izawa T, Sakurai T, Haga S, Taniguchi N, Tajiri H, Watanabe K, Day NK, Toba K, Ohno H. beta2-Adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2. Immunology 124: 348-356 (2008). *

• Klicek R, Sever M, Radic B, Drmic D, Kocman I, Zoricic I, Vuksic T, Ivica M, Barisic I, Ilic S, Berkopic L, Vrcic H, Brcic L, Blagaic AB, Coric M, Brcic I, Rokotov DS, Anic T, Seiwerth S, Sikiric P. Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. J. Pharmacol. Sci. 108: 7-17 (2008). *

• Kmiec Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell. Biol. 161: III-XIII, 1-151 (2001).

• Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, Rudiger M, Boehm O, Fink K, Dreiner U, Grohe C, Hoeft A, Baumgarten G, Koch A, Zacharowski K, Meyer R. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9. Cardiovasc. Res. 78: 26-35 (2008). *

• Koca R, Armutcu F, Altinyazar C, Gurel A. Evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata. Med. Sci. Monit. 11: CR296-CR299 (2005). *

• Koch M, De Keyser J. Uric acid in multiple sclerosis. Neurol. Res. 28: 316-319 (2006).

• Koek GH, Verleden GM, Evenepoel P, Rutgeerts P. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement? Respir. Med. 96: 530-535 (2002).

• Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Kolls JK, Joosten LA, van den Berg WB. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 52: 975-983 (2005). *

• Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin. Sci. (Lond.) 108: 205-213 (2005). *

• Koh KK, Ahn JY, Jin DK, Han SH, Kim HS, Choi IS, Ahn TH, Shin EK, Jeong EM. Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia. Int. J. Cardiol. 97: 239-244 (2004).

• Kohn FR, Kung AH. Role of endotoxin in acute inflammation induced by Gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Infect. Immun. 63: 333-339 (1995). *

• Kohno H, Suzuki R, Sugie S, Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 5: 46 (2005). *

• Kohno H, Suzuki R, Yasui Y, Miyamoto S, Wakabayashi K, Tanaka T. Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice. Clin. Cancer Res. 13: 2519-2525 (2007). *

• Kohno K, Miyake M, Sano O, Tanaka-Kataoka M, Yamamoto S, Koya-Miyata S, Arai N, Fujii M, Watanabe H, Ushio S, Iwaki K, Fukuda S. Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3-one. Biol. Pharm. Bull. 31: 1938-1945 (2008). *

• Kolaczkowska E, Koziol A, Plytycz B, Arnold B. Inflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis. Immunobiology Aug 3 [Epub ahead of print] (2009).

• Kolios G, Manousou P, Bourikas L, Notas G, Tsagarakis N, Mouzas I, Kouroumalis E. Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium. Eur. J. Clin. Invest. 36: 720-729 (2006). *

• Kolios G, Rooney N, Murphy CT, Robertson DA, Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 43: 56-63 (1998). *

• Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 113: 427-437 (2004). *

• Kolios G, Wright KL, Linehan JD, Robertson DA, Westwick J. Interleukin-13 inhibits nitric oxide production in human colonic mucosa. Hepatogastroenterology 47: 714-717 (2000).

• Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic. Biol. Med. 34: 1006-1016 (2003).

• Konda VR, Desai A, Darland G, Bland JS, Tripp ML. Rho iso-alpha acids from hops inhibit the GSK-3/NF-kappaB pathway and reduce inflammatory markers associated with bone and cartilage degradation. J. Inflamm. (Lond.) 6: 26 (2009). *

• Konturek PC, Brzozowski T, Engel M, Burnat G, Gaca P, Kwiecien S, Pajdo R, Konturek SJ. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J. Physiol. Pharmacol. 60: 41-47 (2009). *

• Konturek PC, Konturek SJ, Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis. J. Physiol. Pharmacol. 60: 3-21 (2009). *

• Koppal T, Drake J, Yatin S, Jordan B, Varadarajan S, Bettenhausen L, Butterfield DA. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem. 72: 310-317 (1999).

• Korshunova TIu, Akhmetova VL, Kutuev IA, Khusainova RI, Guseinov GG, Khusnutdinova EK. VNTR-polymorphism of the PAH, e-NOS genes and deletion of the CCR5 gene in populations in the northern Caucasus. Genetika 40: 409-414 (2004).

• Koshy A, De Gottardi A, Ledermann M, Saegesser H, Shaw SG, Zimmermann A, Reichen J. Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice. Liver Int. 25: 1044-1052 (2005). *

• Kozlov AV, van Griensven M, Haindl S, Kehrer I, Duvigneau JC, Hartl RT, Ebel T, Jafarmadar M, Calzia E, Gnaiger E, Redl H, Radermacher P, Bahrami S. Peritoneal inflammation in pigs is sssociated with early mitochondrial dysfunction in liver and kidney. Inflammation Feb 24 [Epub ahead of print] (2010).

• Krasowska-Zoladek A, Banaszewska M, Kraszpulski M, Konat GW. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation. J. Neurosci. Res. 85: 205-212 (2007).

• Krause I, Weinberger A. Behcet's disease. Curr. Opin. Rheumatol. 20: 82-87 (2008).

• Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, Gonzalez-Gallego J, Tunon MJ. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm. Bowel Dis. 14: 1504-1513 (2008). *

• Kristjansson G, Hogman M, Venge P, Hallgren R. Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn. Gut 54: 769-774 (2005). *

• Kristjansson G, Venge P, Hallgren R. Mucosal reactivity to cow's milk protein in coeliac disease. Clin. Exp. Immunol. 147: 449-455 (2007). *

• Krstic A, Ilic V, Mojsilovic S, Jovcic G, Milenkovic P, Bugarski D. p38 MAPK signaling mediates IL-17-induced nitric oxide synthase expression in bone marrow cells. Growth Factors 27: 79-90 (2009).

• Krstic A, Santibanez JF, Okic I, Mojsilovic S, Kocic J, Jovcic G, Milenkovic P, Bugarski D. Combined effect of IL-17 and blockade of nitric oxide biosynthesis on haematopoiesis in mice. Acta Physiol. (Oxf.) Jan 22 [Epub ahead of print] (2010). *

• Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J. Pathol. 201: 28-36 (2003). *

• Krzystyniak KL. Current strategies for anticancer chemoprevention and chemoprotection. Acta Pol. Pharm. 59: 473-478 (2002).

• Kuhad A, Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci. 84: 296-301 (2009). *

• Kuhn A, Beissert S. Photosensitivity in lupus erythematosus. Autoimmunity 38: 519-529 (2005).

• Kuhn A, Sontheimer RD. Cutaneous lupus erythematosus: molecular and cellular basis of clinical findings. Curr. Dir. Autoimmun. 10: 119-140 (2008).

• Kullberg MC, Rothfuchs AG, Jankovic D, Caspar P, Wynn TA, Gorelick PL, Cheever AW, Sher A. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect. Immun. 69: 4232-4241 (2001). *

• Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66: 5157-5166 (1998). *

• Kumar R, Bumb RA, Salotra P. Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors. Immunology Jan 22 [Epub ahead of print] (2010). *

• Kumazawa Y, Kawaguchi K, Takimoto H. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr. Pharm. Des. 12: 4271-4279 (2006).

• Kundu S, Kumar M, Sen U, Mishra PK, Tyagi N, Metreveli N, Lominadze D, Rodriguez W, Tyagi SC. Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice. J. Cell. Biochem. 106: 119-126 (2008). *

• Kunig AM, Parker TA, Nogee LM, Abman SH, Kinsella JP. ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. J. Pediatr. 151: 322-324 (2007). *

• Kuniyasu H, Luo Y, Fujii K, Sasahira T, Moriwaka Y, Tatsumoto N, Sasaki T, Yamashita Y, Ohmori H. CD10 enhances metastasis of colorectal cancer by abrogating the antitumoral effect of methionine-enkephalin in the liver. Gut Oct 13 [Epub ahead of print] (2009).

• Kurtz TW, Klein U. Next generation multifunctional angiotensin receptor blockers. Hypertens. Res. 32: 826-834 (2009).

• Kwon HS, Oh SM, Kim JK. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin. Exp. Immunol. 151: 165-173 (2008). *

• Kwon KH, Murakami A, Hayashi R, Ohigashi H. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. Biochem. Biophys. Res. Commun. 337: 647-654 (2005). *

• Kwon KH, Murakami A, Tanaka T, Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem. Pharmacol. 69: 395-406 (2005). *

• Kwon SJ, Lee GT, Lee JH, Kim WJ, Kim IY. Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages. Immunology 128: e758-e765 (2009).

• Kyokane T, Norimizu S, Taniai H, Yamaguchi T, Takeoka S, Tsuchida E, Naito M, Nimura Y, Ishimura Y, Suematsu M. Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology 120: 1227-1240 (2001). *

• La Flamme AC, Harvie M, McNeill A, Goldsack L, Tierney JB, Backstrom BT. Fcgamma receptor-ligating complexes improve the course of experimental autoimmune encephalomyelitis by enhancing basal Th2 responses. Immunol. Cell. Biol. 84: 522-529 (2006). *

• Lagerstedt-Robinson K, Svenningsson A, Nordenskjold A. No association between a promoter NOS1 polymorphism (rs41279104) and infantile hypertrophic pyloric stenosis. J. Hum. Genet. 54: 706-708 (2009).

• Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135: 41-60 (2008). *

• Laleman W, Omasta A, Van de Casteele M, Zeegers M, Vander Elst I, Van Landeghem L, Severi T, van Pelt J, Roskams T, Fevery J, Nevens F. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis. Hepatology 42: 1382-1390 (2005). *

• Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Gastroenterology 132: 709-719 (2007). *

• Lamarque D. Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs. Gastroenterol. Clin. Biol. 28 Spec. No 3: C18-C26 (2004).

• Lamarque D, Nhieu JT, Breban M, Bernardeau C, Martin-Garcia N, Szepes Z, Delchier JC, Whittle B, Claudepierre P. Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitis. J. Rheumatol. 30: 2428-2436 (2003).

• Lanas A, Ferrandez A. NSAIDs and the colon. Curr. Opin. Gastroenterol. 25: 44-49 (2009).

• Landar A, Darley-Usmar VM. Nitric oxide signaling gone awry: nitration of glutamine synthetase and hyperammonemia in sepsis. Hepatology 41: 980-982 (2005). *

• Landoni VI, de Campos-Nebel M, Schierloh P, Calatayud C, Fernandez GC, Ramos MV, Rearte B, Palermo MS, Isturiz MA. Shiga toxin 1-induced inflammatory response in LPS-sensitized astrocytes is mediated by endogenous TNF-alpha. Infect. Immun. Dec 15 [Epub ahead of print] (2009). *

• Langer DA, Das A, Semela D, Kang-Decker N, Hendrickson H, Bronk SF, Katusic ZS, Gores GJ, Shah VH. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology 47: 1983-1993 (2008). *

• Langer DA, Shah VH. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis. J. Hepatol. 44: 209-216 (2006). *

• Langer DA, Shah VH. A gas, an amino acid, and an imposter: the story of nitric oxide, L-arginine, and ADMA in portal hypertension. Hepatology 42: 1255-1257 (2005). *

• Lara A, Khatri SB, Wang Z, Comhair SA, Xu W, Dweik RA, Bodine M, Levison BS, Hammel J, Bleecker E, Busse W, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, Gaston B, Israel E, Jarjour N, Moore W, Erzurum SC. Alterations of the arginine metabolome in asthma. Am. J. Respir. Crit. Care Med. 178: 673-681 (2008). *

• Laragione T, Yarlett NC, Brenner M, Mello A, Sherry B, Miller EJ, Metz CN, Gulko PS. The arthritis severity quantitative trait loci Cia4 and Cia6 regulate neutrophil migration into inflammatory sites and levels of TNF-alpha and nitric oxide. J. Immunol. 178: 2344-2351 (2007). *

• Larocca L, Calafat M, Roca V, Franchi AM, Leiros CP. VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages. Int. Immunopharmacol. 7: 1343-1349 (2007).

• Larrosa M, Gonzalez-Sarrias A, Yanez-Gascon MJ, Selma MV, Azorin-Ortuno M, Toti S, Tomas-Barberan F, Dolara P, Espín JC. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem. Jul 17 [Epub ahead of print] (2009). *

• Lasagna N, Fantappie O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, Ziche M, Mazzanti R. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res. 66: 2673-2682 (2006). *

• Lazebnik LB, Baryshnikov EN, Drozdov VN, Rumiantsev VG, Nilova TV. Nitric oxide as an inflammation marker at non-specific ulcerous colitis and Crohn's disease. Eksp. Klin. Gastroenterol. 3: 4-8 (2006).

• Leandro AC, Rocha MA, Cardoso CS, Bonecini-Almeida MG. Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Braz. J. Med. Biol. Res. 42: 312-322 (2009). *

• Lecleire S, Hassan A, Marion-Letellier R, Antonietti M, Savoye G, Bole-Feysot C, Lerebours E, Ducrotte P, Dechelotte P, Coeffier M. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways. J. Nutr. 138: 2481-2486 (2008). *

• Lee C, An HJ, Kim JL, Lee H, Paik SG. Inhibitory effect of a phosphatidyl ethanolamine derivative on LPS-induced sepsis. Mol. Cells 27: 251-255 (2009). *

• Lee DK, Jang S, Kim MJ, Kim JH, Chung MJ, Kim KJ, Ha NJ. Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer 8: 310 (2008). *

• Lee H, Park C, Cho IH, Kim HY, Jo EK, Lee S, Kho HS, Choi SY, Bae Oh S, Park K, Kim JS, Lee SJ. Double-stranded RNA induces iNOS gene expression in Schwann cells, sensory neuronal death, and peripheral nerve demyelination. Glia 55: 712-722 (2007).

• Lee HJ, Dang HT, Kang GJ, Yang EJ, Park SS, Yoon WJ, Jung JH, Kang HK, Yoo ES. Two enone fatty acids isolated from Gracilaria verrucosa suppress the production of inflammatory mediators by down-regulating NF-kappaB and STAT1 activity in lipopolysaccharide-stimulated RAW 264.7 cells. Arch. Pharm. Res. 32: 453-462 (2009). *

• Lee JH, Rhee CS, Kim DW, Lee CH. Modulators of ion transport in nasal polyps: an in situ measurement of short-circuit current. Clin. Exp. Otorhinolaryngol. 1: 75-97 (2008). *

• Lee JY, Kim JY, Lee YG, Shin WC, Chun T, Rhee MH, Cho JY. Hydroquinone, a reactive metabolite of benzene, reduces macrophage-mediated immune responses. Mol. Cells 23: 198-206 (2007). *

• Lee KC, Yang YY, Huang YT, Lee FY, Hou MC, Lin HC, Lee SD. Administration of a low dose of sildenafil for one week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability. Clin. Sci. (Lond.) Feb 5 [Epub ahead of print] (2010). *

• Lee KM, Seong SY. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern. Immunol. Lett. 125: 31-39 (2009).

• Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 102: 1906-1910 (2005). *

• Lee PY, Tsai PS, Huang YH, Huang CJ. Inhibition of Toll-like receptor-4, nuclear factor-kappaB and mitogen-activated protein kinase by lignocaine may involve voltage-sensitive sodium channels. Clin. Exp. Pharmacol. Physiol. 35: 1052-1058 (2008). *

• Lee S, Son SC, Han MJ, Kim WJ, Kim SH, Kim HR, Jeon WK, Park KH, Shin MG. Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites. World J. Gastroenterol. 14: 3884-3890 (2008). *

• Lee SJ, Lim KT. Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A/J mice. J. Biomed. Sci. 15: 111-121 (2008). *

• Lee SJ, Lim KT. ZPDC glycoprotein inhibits inflammation-related cytokine and protein via nuclear factor-kappa B in dextran sulfate sodium-stimulated ICR mouse. Biomed. Pharmacother. 63: 528-536 (2009).

• Lee SM, Yune TY, Kim SJ, Kim YC, Oh YJ, Markelonis GJ, Oh TH. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J. Neurochem. 91: 568-578 (2004).

• Lee SW, Kim JH, Park YB, Lee SK. Bortezomib attenuates murine collagen-induced arthritis. Ann. Rheum. Dis. 68: 1761-1767 (2009).

• Lee YG, Kim JY, Lee JY, Byeon SE, Hong EK, Lee J, Rhee MH, Park HJ, Cho JY. Regulatory effects of Codonopsis lanceolata on macrophage-mediated immune responses. J. Ethnopharmacol. 112: 180-188 (2007). *

• Lee YM, Seon MR, Cho HJ, Kim JS, Park JH. Benzyl isothiocyanate exhibits anti-inflammatory effects in murine macrophages and in mouse skin. J. Mol. Med. Sep 17 [Epub ahead of print] (2009). *

• LeGrand A, Fermor B, Fink C, Pisetsky DS, Weinberg JB, Vail TP, Guilak F. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum. 44: 2078-2083 (2001). *

• Lelievre V, Favrais G, Abad C, Adle-Biassette H, Lu Y, Germano PM, Cheung-Lau G, Pisegna JR, Gressens P, Lawson G, Waschek JA. Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease. Peptides 28: 1688-1699 (2007). *

• Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem. Res. 32: 1749-1756 (2007). *

• Leung CH, Grill SP, Lam W, Gao W, Sun HD, Cheng YC. Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a non-competitive manner. Mol. Pharmacol. 70: 1946-1955 (2006). *

• Leung TF, Liu EK, Li CY, Chan IH, Yung E, Lam CW, Wong GW. Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration. Pediatr. Pulmonol. 41: 649-655 (2006).

• Leung TF, Liu EK, Tang NL, Ko FW, Li CY, Lam CW, Wong GW. Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children. Clin. Exp. Allergy 35: 1288-1294 (2005). *

• Levine AD, Fiocchi C. Immunology of inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 306-309 (2000).

• Levy O. Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J. Leukoc. Biol. 76: 909-925 (2004). *

• Lew W, Lee E, Krueger JG. Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris. Br. J. Dermatol. 150: 668-676 (2004). *

• Lewis EC, Dinarello CA. Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc. Natl. Acad. Sci. U.S.A. 103: 16852-16857 (2006). *

• Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. alpha1-Antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. U.S.A. 102: 12153-12158 (2005). *

• Lewis ND, Asim M, Barry DP, Singh K, de Sablet T, Boucher JL, Gobert AP, Chaturvedi R, Wilson KT. Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J. Immunol. Jan 22 [Epub ahead of print] (2010).

• Li C, Lim SW, Sun BK, Yang CW. Chronic cyclosporine nephrotoxicity: new insights and preventive strategies. Yonsei Med. J. 45: 1004-1016 (2004). *

• Li CQ, Kim MY, Godoy LC, Thiantanawat A, Trudel LJ, Wogan GN. Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 106: 14547-14551 (2009). *

• Li FQ, Sempowski GD, McKenna SE, Laskowitz DT, Colton CA, Vitek MP. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J. Pharmacol. Exp. Ther. 318: 956-965 (2006). *

• Li H, Cui H, Kundu TK, Alzawahra W, Zweier JL. Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J. Biol. Chem. 283: 17855-17863 (2008). *

• Li J, Wilson A, Gao X, Kuruba R, Liu Y, Poloyac S, Pitt B, Xie W, Li S. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. J. Pharmacol. Exp. Ther. 331: 234-243 (2009). *

• Li J, Wilson A, Kuruba R, Zhang Q, Gao X, He F, Zhang LM, Pitt BR, Xie W, Li S. FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc. Res. 77: 169-177 (2008). *

• Li N, Klaassen CD. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, or inducible nitric oxide synthase. Toxicol. Sci. 83: 197-203 (2005). *

• Li N, Shigihara T, Tzioufas AG, Notkins AL, Yoon JW, Jun HS. Human chorionic gonadotropin prevents Sjogren's syndrome-like exocrinopathy in mice. Arthritis Rheum. 56: 2211-2215 (2007). *

• Li Q, Zhang Q, Wang M, Zhao S, Ma J, Luo N, Li N, Li Y, Xu G, Li J. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 89: 169-177 (2007).

• Li QF, Zhu YS, Jiang H, Xu H, Sun Y. Heme oxygenase-1 mediates the anti-inflammatory effect of isoflurane preconditioning in LPS-stimulated macrophages. Acta Pharmacol. Sin. 30: 228-234 (2009).

• Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Arterioscler. Thromb. Vasc. Biol. 27: 2606-2611 (2007).

• Liang C, Ren Y, Tan H, He Z, Jiang Q, Wu J, Zhen Y, Fan M, Wu Z. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Br. J. Pharmacol. 158: 1865-1873 (2009). *

• Liao YF, Zeng TS, Chen LL, Li YM, Yu F, Hu LJ, Yue L. Association of a functional polymorphism (C59038T) in GTP cyclohydrolase 1 gene and type 2 diabetic macrovascular disease in the Chinese population. J. Diabetes Complications Jun 8 [Epub ahead of print] (2009).

• Liden M, Kristjansson G, Valtysdottir S, Hallgren R. Gluten sensitivity in patients with primary Sjogren's syndrome. Scand. J. Gastroenterol. 42: 962-967 (2007). *

• Liden M, Kristjansson G, Valtysdottir S, Venge P, Hallgren R. Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjogren's syndrome. Clin. Exp. Allergy 38: 929-935 (2008). *

• Liew CY, Tham CL, Lam KW, Mohamad AS, Kim MK, Cheah YK, Zakaria ZA, Sulaiman MR, Lajis MN, Israf DA. A synthetic hydroxypropenone inhibits nitric oxide, prostaglandin E2, and proinflammatory cytokine synthesis. Immunopharmacol. Immunotoxicol. Jan 28 [Epub ahead of print] (2010).

• Lim SC, Liu JJ, Low HQ, Morgenthaler NG, Li Y, Yeoh LY, Wu YS, Goh SK, Chionh CY, Tan SH, Kon YC, Soon PC, Bee YM, Subramaniam T, Sum CF, Chia KS. Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals. Diabetologia 52: 1343-1351 (2009). *

• Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, Lin CJ, Tseng SC, Lin WP, Chen WT, Sheen IS. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J. Hepatol. 46: 816-826 (2007). *

• Lin MW, Tsao LT, Chang LC, Chen YL, Huang LJ, Kuo SC, Tzeng CC, Lee MR, Wang JP. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway. Biochem. Pharmacol. 73: 1796-1806 (2007). *

• Lin R, Liu J, Peng N, Gan W, Wang W, Han C, Ding C. Lovastatin reduces apoptosis and downregulates the CD40 expression induced by TNF-alpha in cerebral vascular endothelial cells. Curr. Neurovasc. Res. 3: 41-47 (2006).

• Lin ST, Wang Y, Xue Y, Feng DC, Xu Y, Xu LY. Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway. Mol. Cell. Biochem. 315: 41-49 (2008). *

• Linehan JD, Kolios G, Valatas V, Robertson DA, Westwick J. Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cells. Free Radic. Biol. Med. 39: 1560-1569 (2005).

• Linehan JD, Kolios G, Valatas V, Robertson DA, Westwick J. The effect of corticosteroids on nitric oxide production in inflammatory bowel disease: are leukocytes the site of action? Am. J. Physiol. Gastrointest. Liver Physiol. 288: G261-G267 (2005). *

• Ling S, Lai A, Borschukova O, Pumpens P, Holoshitz J. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum. 54: 3423-3432 (2006). *

• Ling S, Li Z, Borschukova O, Xiao L, Pumpens P, Holoshitz J. The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway. Arthritis Res. Ther. 9: R5 (2007). *

• Linz W, Wohlfart P, Baader M, Breitschopf K, Falk E, Schafer HL, Gerl M, Kramer W, Rutten H. The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats. Acta Pharmacol. Sin. 30: 935-946 (2009).

• Liscovsky MV, Ranocchia RP, Gorlino CV, Alignani DO, Morón G, Maletto BA, Pistoresi-Palencia MC. Interferon-gamma priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages. Immunology 128: e159-e169 (2009).

• Liu BG, Jia XM, Cao YY, Chen SH, Gao PH, Wang Y, Jiang YY, Cao YB. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions. J. Ethnopharmacol. 115: 1-8 (2008). *

• Liu CF, Chen YL, Chang WT, Shieh CC, Yu CK, Reid KB, Wang JY. Mite allergen induces nitric oxide production in alveolar macrophage cell lines via CD14/Toll-like receptor 4, and is inhibited by surfactant protein D. Clin. Exp. Allergy 35: 1615-1624 (2005). *

• Liu GH, Qu J, Shen X. Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor alpha transcriptional activity. Mol. Biol. Cell. 17: 1822-1833 (2006). *

• Liu H, Gaskari SA, Lee SS. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J. Gastroenterol. 12: 837-842 (2006). *

• Liu J, He YY, Chignell CF, Clark J, Myers P, Saavedra JE, Waalkes MP. Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice. Biochem. Pharmacol. 70: 144-151 (2005). *

• Liu LL, Gong LK, Wang H, Xiao Y, Wu XF, Zhang YH, Xue X, Qi XM, Ren J. Baicalin inhibits macrophage activation by lipopolysaccharide and protects mice from endotoxin shock. Biochem. Pharmacol. 75: 914-922 (2008). *

• Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773 (2006). *

• Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat. Med. 11: 952-958 (2005). *

• Liu SZ, Yan H, Hou WK, Xu P, Tian J, Tian LF, Zhu BF, Ma J, Lu SM. Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women. J. Zhejiang Univ. Sci. B. 10: 609-618 (2009).

• Liu Y, Bando Y, Vargas-Lowy D, Elyaman W, Khoury SJ, Huang T, Reif K, Chitnis T. CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. J. Neurosci. 30: 2025-2038 (2010).

• Liz R, Vigil SV, Goulart S, Moritz MI, Schenkel EP, Frode TS. The anti-inflammatory modulatory role of Solidago chilensis Meyen in the murine model of the air pouch. J. Pharm. Pharmacol. 60: 515-521 (2008).

• Ljubuncic P, Fuhrman B, Oiknine J, Aviram M, Bomzon A. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut 39: 475-478 (1996). *

• Ljung T, Axelsson LG, Herulf M, Lundberg JO, Hellstrom PM. Early changes in rectal nitric oxide and mucosal inflammatory mediators in Crohn's colitis in response to infliximab treatment. Aliment. Pharmacol. Ther. 25: 925-932 (2007). *

• Ljung T, Beijer E, Herulf M, Weitzberg E, Lundberg JO, Finkel Y, Hellstrom PM. Increased rectal nitric oxide in children with active inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 34: 302-306 (2002). *

• Ljung T, Herulf M, Beijer E, Jacobsson H, Lundberg J, Finkel Y, Hellstrom PM. Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection. Scand. J. Gastroenterol. 36: 1073-1076 (2001). *

• Ljung T, Lundberg S, Varsanyi M, Johansson C, Schmidt PT, Herulf M, Lundberg JO, Hellstrom PM. Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders. World J. Gastroenterol. 12: 3386-3392 (2006). *

• Lluis JM, Morales A, Blasco C, Colell A, Mari M, Garcia-Ruiz C, Fernandez-Checa JC. Critical role of mitochondrial glutathione in the survival of hepatocytes during hypoxia. J. Biol. Chem. 280: 3224-3232 (2005). *

• Lopez-Collazo E, Fuentes-Prior P, Arnalich F, Del Fresno C. Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state. Curr. Opin. Infect. Dis. 19: 237-244 (2006).

• Lopez-Fontal R, Zeini M, Traves PG, Gomez-Ferreria M, Aranda A, Saez GT, Cerda C, Martin-Sanz P, Hortelano S, Bosca L. Mice lacking thyroid hormone receptor beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy. PLoS One 5: e8710 (2010). *

• Lopez-Nevot MA, Ramal L, Jimenez-Alonso J, Martin J. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 42: 113-116 (2003). *

• Lopez-Sanchez LM, Corrales FJ, Barcos M, Espejo I, Munoz-Castaneda JR, Rodriguez-Ariza A. Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis. Lab. Invest. Oct 5 [Epub ahead of print] (2009). *

• Lotz M, Konig T, Menard S, Gutle D, Bogdan C, Hornef MW. Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells. Immunology 122: 306-315 (2007). *

• Loureiro-Silva MR, Cadelina GW, Iwakiri Y, Groszmann RJ. A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats. J. Hepatol. 39: 940-946 (2003). *

• Loures FV, Pina A, Felonato M, Araujo EF, Leite KR, Calich VL. TLR4 signaling leads to a more severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect. Immun. Dec 14 [Epub ahead of print] (2009). *

• Louw JA, Marks IN. The management of peptic ulcer disease. Curr. Opin. Gastroenterol. 19: 533-539 (2003).

• Lu J, Wu DM, Zheng YL, Sun DX, Hu B, Shan Q, Zhang ZF, Fan SH. Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway. Brain Behav. Immun. 23: 193-203 (2009).

• Lu JW, Wang H, Yan-Li J, Zhang C, Ning H, Li XY, Zhang H, Duan ZH, Zhao L, Wei W, Xu DX. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis. J. Hepatol. 48: 442-452 (2008). *

• Lu P, Mamiya T, Lu L, Mouri A, Niwa M, Hiramatsu M, Zou LB, Ikejima T, Nagai T, Nabeshima T. Silibinin attenuates amyloid beta25-35 peptide-induced memory impairments: implication of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha in mice. J. Pharmacol. Exp. Ther. 331: 319-326 (2009). *

• Lundberg JO. Nitric oxide and the paranasal sinuses. Anat. Rec. (Hoboken) 291: 1479-1484 (2008).

• Lundberg JO, Hellstrom PM, Fagerhol MK, Weitzberg E, Roseth AG. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 96-102 (2005). *

• Lundberg S, Holst M, Hellstrom PM. Expression of iNOS mRNA associated with suppression of colonic contraction in rat colitis. Acta Physiol. (Oxf.) 187: 489-494 (2006). *

• Luo L, Wang Y, Feng Q, Zhang H, Xue B, Shen J, Ye Y, Han X, Ma H, Xu J, Chen D, Yin Z. Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice. Mol. Immunol. 46: 848-857 (2009). *

• Luo Y, Han R, Evanoff DP, Chen X. Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guerin (BCG)-induced macrophage cytotoxicity against bladder cancer cells. Clin. Exp. Immunol. Feb 10 [Epub ahead of print] (2010). *

• Lupusoru CE, Tartau L, Ghiciuc C. New inflammation modulator interleukins. Therapeutic implications. Rev. Med. Chir. Soc. Med. Nat. Iasi. 106: 24-29 (2002).

• Lytle C, Tod TJ, Vo KT, Lee JW, Atkinson RD, Straus DS. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm. Bowel Dis. 11: 231-243 (2005). *

• Ma J, Nakajima T, Iida H, Iwasawa K, Terasawa K, Oonuma H, Jo T, Morita T, Imuta H, Suzuki J, Hirose K, Okuda Y, Yamada N, Nagai R, Omata M. Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. Eur. J. Pharmacol. 464: 79-86 (2003). *

• Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn. Schmiedebergs. Arch. Pharmacol. 378: 171-184 (2008). *

• Machado MC, Coelho AM, Martins JO, Sampietre SN, Molan NA, Patzina RA, Machado MA, Jancar S. CO2 abdominal insufflation decreases local and systemic inflammatory response in experimental acute pancreatitis. Pancreas Nov 16 [Epub ahead of print] (2009).

• Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J. Virol. 80: 7199-7207 (2006). *

• Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, Carlson D, Munch G. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv. Drug Deliv. Rev. 60: 1463-1470 (2008).

• Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm. Bowel Dis. 5: 262-270 (1999). *

• Maeda H. Carcinogenesis via microbial infection. Gan To Kagaku Ryoho 25: 1474-1485 (1998).

• Magez S, Radwanska M, Drennan M, Fick L, Baral TN, Brombacher F, Baetselier PD. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 infections. J. Infect. Dis. 193: 1575-1583 (2006). *

• Maggi LB Jr, Sadeghi H, Weigand C, Scarim AL, Heitmeier MR, Corbett JA. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49: 346-355 (2000). *

• Maher JJ. Interactions between hepatic stellate cells and the immune system. Semin. Liver Dis. 21: 417-426 (2001).

• Mahgoub A, El-Medany A, Mustafa A, Arafah M, Moursi M. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. Toxicol. Appl. Pharmacol. 205: 43-52 (2005).

• Majewska M, Szczepanik M. The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation. Postepy. Hig. Med. Dosw. (Online) 60: 52-63 (2006).

• Makimura Y, Asai Y, Sugiyama A, Ogawa T. Chemical structure and immunobiological activity of lipid A from Serratia marcescens LPS. J. Med. Microbiol. 56: 1440-1446 (2007). *

• Makino N, Maeda T, Oyama JI, Higuchi Y, Mimori K. Improving insulin sensitivity via activation of PPAR-gamma increases telomerase activity in the heart of OLETF rats. Am. J. Physiol. Heart Circ. Physiol. 297: H2188-H2195 (2009). *

• Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J. Hepatol. 45: 856-867 (2006). *

• Mamani-Matsuda M, Kauss T, Al-Kharrat A, Rambert J, Fawaz F, Thiolat D, Moynet D, Coves S, Malvy D, Mossalayi MD. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem. Pharmacol. 72: 1304-1310 (2006). *

• Mamoulakis D, Bitsori M, Galanakis E, Vazgiourakis V, Panierakis C, Goulielmos GN. Intron 4 polymorphism of the endothelial nitric oxide synthase eNOS gene and early microangiopathy in type 1 diabetes. Int. J. Immunogenet. 36: 153-157 (2009). *

• Manguso F, Sanges M, Staiano T, Gargiulo S, Nastro P, Gargano D, Somma P, Mansueto G, Peluso R, Scarpa R, D'Armiento FP, Astarita C, Ayala F, Renda A, Mazzacca G, D'Arienzo A. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am. J. Gastroenterol. 99: 327-334 (2004). *

• Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways inflammatory diseases. Inflamm. Res. 56: 58-69 (2007). *

• Manna I, Liguori M, Valentino P, Condino F, La Russa A, Clodomiro A, Nistico R, Di Palma G, Quattrone A. Preliminary evidences of a NOS2A protective effect from relapsing-remitting multiple sclerosis. J. Neurol. Sci. 264: 112-117 (2008). *

• Mao XJ, Zhang XM, Zhang HL, Quezada HC, Mix E, Yang X, Winblad B, Adem A, Zhu J. TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice. Neurosci. Lett. Dec 23 [Epub ahead of print] (2009).

• Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, Tontonoz P, Castrillo A. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J. Biol. Chem. 281: 32197-32206 (2006). *

• Marcato LG, Ferlini AP, Bonfim RC, Ramos-Jorge ML, Ropert C, Afonso LF, Vieira LQ, Sobrinho AP. The role of Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide production by macrophage cells stimulated with root canal pathogens. Oral Microbiol. Immunol. 23: 353-359 (2008). *

• Marcinkiewicz J, Ciszek M, Bobek M, Strus M, Heczko PB, Kurnyta M, Biedron R, Chmielarczyk A. Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int. J. Exp. Pathol. 88: 155-164 (2007). *

• Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130: 2800-2815 (2007). *

• Marion-Letellier R, Butler M, Dechelotte P, Playford RJ, Ghosh S. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells. Am. J. Clin. Nutr. 87: 939-948 (2008). *

• Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, Lees W, Novelli M, Bloom S, Segal AW. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 367: 668-678 (2006). *

• Marley R, Holt S, Fernando B, Harry D, Anand R, Goodier D, Davies S, Moore K. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology 29: 1358-1363 (1999). *

• Marquina M, Espana A, Fernandez-Galar M, Lopez-Zabalza MJ. The role of nitric oxide synthases in pemphigus vulgaris in a mouse model. Br. J. Dermatol. 159: 68-76 (2008). *

• Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated … Arthritis Rheum. 42: 2399-2409 (1999). *

• Martin AI, Lopez-Menduina M, Castillero E, Granado M, Villanua M, Lopez-Calderon A. Ptgs2 activation by endotoxin mediates the decrease in Igf1, but not in Igfbp3, gene expression in the liver. J. Endocrinol. 198: 385-394 (2008). *

• Martin MC, Martinez A, Mendoza JL, Taxonera C, Diaz-Rubio M, Fernandez-Arquero M, de la Concha EG, Urcelay E. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics 59: 833-837 (2007). *

• Martínez B, Barrios K, Vergara C, Mercado D, Jimenez S, Gusmao L, Caraballo L. A NOS1 gene polymorphism associated with asthma and specific immunoglobulin E response to mite allergens in a Colombian population. Int. Arch. Allergy Immunol. 144: 105-113 (2007).

• Martínez-Augustin O, Romero-Calvo I, Suarez MD, Zarzuelo A, de Medina FS. Molecular bases of impaired water and ion movements in inflammatory bowel diseases. Inflamm. Bowel Dis. 15: 114-127 (2009). *

• Martino A, Badell E, Abadie V, Balloy V, Chignard M, Mistou MY, Combadiere B, Combadiere C, Winter N. Mycobacterium bovis Bacillus Calmette-Guerin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production. J. Immunol. Jan 18 [Epub ahead of print] (2010).

• Masamune A, Kikuta K, Watanabe T, Satoh K, Satoh A, Shimosegawa T. Pancreatic stellate cells express Toll-like receptors. J. Gastroenterol. 43: 352-362 (2008). *

• Massacand JC, Kaiser P, Ernst B, Tardivel A, Burki K, Schneider P, Harris NL. Intestinal bacteria condition dendritic cells to promote IgA production. PLoS ONE 3: e2588 (2008). *

• Masubuchi Y, Enoki K, Horie T. Down-regulation of hepatic cytochrome P450 enzymes in rats with trinitrobenzene sulfonic acid-induced colitis. Drug Metab. Dispos. 36: 597-603 (2008). *

• Matei V, Rodriguez-Vilarrupla A, Deulofeu R, Colomer D, Fernandez M, Bosch J, Garcia-Pagan JC. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis. Hepatology 44: 44-52 (2006). *

• Mathew JS, Sharma RP. Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int. J. Immunopharmacol. 22: 693-706 (2000).

• Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J. Pharmacol. Exp. Ther. 329: 324-334 (2009). *

• Matuszek MA, Boutcher SH. Elevated levels of circulating cortisol in young normotensive adult men with a family history of hypertension. Clin. Exp. Pharmacol. Physiol. 35: 280-286 (2008).

• Mazzon E, Cuzzocrea S. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis. Cell. Mol. Biol. (Noisy-le-grand) 49: 45-57 (2003).

• Mazzon E, Esposito E, Di Paola R, Muia C, Crisafulli C, Genovese T, Caminiti R, Meli R, Bramanti P, Cuzzocrea S. Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept. Clin. Exp. Immunol. 153: 136-149 (2008). *

• Mazzon E, Esposito E, Di Paola R, Riccardi L, Caminiti R, Dal Toso R, Pressi G, Cuzzocrea S. Effects of verbascoside biotechnologically produced by Syringa vulgaris plant cell cultures in a rodent model of colitis. Naunyn. Schmiedebergs. Arch. Pharmacol. 380: 79-94 (2009).

• McCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 45: 864-873 (1999). *

• McCarty MF. High-dose folate may improve platelet function in acute coronary syndrome and other pathologies associated with increased platelet oxidative stress. Med. Hypotheses 69: 12-19 (2007).

• McConell GK, Ng GP, Phillips M, Ruan Z, Macaulay SL, Wadley GD. Central role of nitric oxide synthase in AICAR and caffeine induced mitochondrial biogenesis in L6 myocytes. J. Appl. Physiol. Dec 31 [Epub ahead of print] (2009). *

• McLaughlan JM, Seth R, Vautier G, Robins RA, Scott BB, Hawkey CJ, Jenkins D. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J. Pathol. 181: 87-92 (1997).

• McMaster SK, Paul-Clark MJ, Walters M, Fleet M, Anandarajah J, Sriskandan S, Mitchell JA. Cigarette smoke inhibits macrophage sensing of Gram-negative bacteria and lipopolysaccharide: relative roles of nicotine and oxidant stress. Br. J. Pharmacol. 153: 536-543 (2008). *

• Meares GP, Hughes KJ, Jaimes KF, Salvatori AS, Rhodes CJ, Corbett JA. AMP-activated protein kinase attenuates nitric oxide induced beta-cell death. J. Biol. Chem. Nov 20 [Epub ahead of print] (2009). *

• Mearin F, Garcia-Gonzalez MA, Strunk M, Zarate N, Malagelada JR, Lanas A. Association between achalasia and nitric oxide synthase gene polymorphisms. Am. J. Gastroenterol. 101: 1979-1984 (2006). *

• Melchers I, Blaschke S, Hecker M, Cattaruzza M. The (-786)C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis. Arthritis Rheum. 54: 3144-3151 (2006). *

• Menard G, Turmel V, Bissonnette EY. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E(2). Clin. Exp. Immunol. 150: 340-348 (2007). *

• Menchen L, Colon AL, Madrigal JL, Beltran L, Botella S, Lizasoain I, Leza JC, Moro MA, Menchen P, Cos E, Lorenzo P. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis. Am. J. Gastroenterol. 99: 1756-1764 (2004). *

• Meng QH, Springall DR, Bishop AE, Morgan K, Evans TJ, Habib S, Gruenert DC, Gyi KM, Hodson ME, Yacoub MH, Polak JM. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J. Pathol. 184: 323-331 (1998). *

• Metzger BT, Barnes DM, Reed JD. Purple carrot (Daucus carota L.) polyacetylenes decrease lipopolysaccharide-induced expression of inflammatory proteins in macrophage and endothelial cells. J. Agric. Food Chem. 56: 3554-3560 (2008). *

• Meyer M, Huaux F, Gavilanes X, van den Brule S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Am. J. Respir. Cell. Mol. Biol. 41: 590-602 (2009). *

• Micci MA, Kahrig KM, Simmons RS, Sarna SK, Espejo-Navarro MR, Pasricha PJ. Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice. Gastroenterology 129: 1817-1824 (2005). *

• Middleton SJ, Reynolds PD, Shorthouse M, Hunter JO, Moss S. Nitric oxide synthase in gastric mucosa. Gut 36: 942 (1995). *

• Miguel Gomez L, Anaya JM, Ramon Vilchez J, Cadena J, Hinojosa R, Velez L, Angel Lopez-Nevot M, Martin J. A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis (Edinb.) 87: 288-294 (2007).

• Miki K, Kumar A, Yang R, Killeen ME, Delude RL. Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. Aug 27 [Epub ahead of print] (2009). *

• Miletic T, Kovacevic-Jovanovic V, Vujic V, Stanojevic S, Mitic K, Lazarevic-Macanovic M, Dimitrijevic M. Reactive oxygen species (ROS), but not nitric oxide (NO), contribute to strain differences in the susceptibility to experimental arthritis in rats. Immunobiology 212: 95-105 (2007).

• Miljkovic D, Trajkovic V. Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev. 15: 21-32 (2004).

• Miller C, McMullin B, Ghaffari A, Stenzler A, Pick N, Roscoe D, Ghahary A, Road J, Av-Gay Y. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric Oxide 20: 16-23 (2009).

• Miller SS, Li R, Maminishkis A, Banzon T, Wan Q, Jalickee S, Chen S. IFNgamma regulates retinal pigment epithelial fluid transport. Am. J. Physiol. Cell Physiol. 297: C1452-C1465 (2009). *

• Ming XF, Rajapakse AG, Carvas JM, Ruffieux J, Yang Z. Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline. BMC Cardiovasc. Disord. 9: 12 (2009). *

• Minns LA, Buzoni-Gatel D, Ely KH, Rachinel N, Luangsay S, Kasper LH. A novel triterpenoid induces transforming growth factor beta production by intraepithelial lymphocytes to prevent ileitis. Gastroenterology 127: 119-126 (2004). *

• Mishra KP, Chauhan UK, Naik S. Effect of lead exposure on serum immunoglobulins and reactive nitrogen and oxygen intermediate. Hum. Exp. Toxicol. 25: 661-665 (2006). *

• Misirkic MS, Todorovic-Markovic BM, Vucicevic LM, Janjetovic KD, Jokanovic VR, Dramicanin MD, Markovic ZM, Trajkovic VS. The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene (C(60)) nanoparticles. Biomaterials 30: 2319-2328 (2009). *

• Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp. Physiol. 93: 141-147 (2008).

• Miyakawa H, Mason RP, Jiang J, Kadiiska MB. Lipid-derived free radical production in superantigen-induced interstitial pneumonia. Free Radic. Biol. Med. 47: 241-249 (2009).

• Miyatake K, Inoue H, Hashimoto K, Takaku H, Takata Y, Nakano S, Yasui N, Itakura M. PKC412 (CGP41251) modulates the proliferation and lipopolysaccharide-induced inflammatory responses of RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 360: 115-121 (2007). *

• Mizuhara H, Kuno M, Seki N, Yu WG, Yamaoka M, Yamashita M, Ogawa T, Kaneda K, Fujii T, Senoh H, Fujiwara H. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Hepatology 27: 513-519 (1998). *

• Moezi L, Shafaroodi H, Sarkar S, Emami-Razavi SH, Sanatkar M, Mirazi N, Dehpour AR. Involvement of nitrergic and opioidergic systems in the hypothermia induced by cholestasis in rats. Pathophysiology 13: 227-232 (2006).

• Mohamadin AM, Ashour OM, El-Sherbeny NA, Alahdal AM, Morsy GM, Abdel-Naim AB. Melatonin protects against hydrogen peroxide-Iinduced gastric injury in rats. Clin. Exp. Pharmacol. Physiol. 36: 367-372 (2009).

• Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun Y, von Grafenstein H, Hong SC, McInerney MF. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int. Immunol. 18: 1101-1113 (2006). *

• Molina-Holgado E, Guaza C, Borrell J, Molina-Holgado F. Effects of cannabinoids on the immune system and central nervous system: therapeutic implications. BioDrugs 12: 317-326 (1999).

• Moller S, Bendtsen F, Henriksen JH. Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. Can. J. Gastroenterol. 15: 94-106 (2001). *

• Mollsten A, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann. Med. 38: 522-528 (2006).

• Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C, Sen S, Williams R, Leiper J, Vallance P, Jalan R. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis. Hepatology 45: 62-71 (2007). *

• Moon KH, Hood BL, Kim BJ, Hardwick JP, Conrads TP, Veenstra TD, Song BJ. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 44: 1218-1230 (2006). *

• Moore PK, Marshall M. Nitric oxide releasing acetaminophen (nitroacetaminophen). Dig. Liver Dis. 35 Suppl. 2: S49-S60 (2003).

• Moreau R. Are nitric oxide synthases new players in the pathophysiology of fulminant hepatic failure? J. Hepatol. 37: 678-680 (2002). *

• Moreau R, Barriere E, Tazi KA, Lardeux B, Dargere D, Urbanowicz W, Poirel O, Chauvelot-Moachon L, Guimont MC, Bernuau D, Lebrec D. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Hepatology 36: 1070-1078 (2002). *

• Moreno B, Hevia H, Santamaria M, Sepulcre J, Munoz J, Garcia-Trevijano ER, Berasain C, Corrales FJ, Avila MA, Villoslada P. Methylthioadenosine reverses brain autoimmune disease. Ann. Neurol. 60: 323-334 (2006).

• Moreno MG, Muriel P. Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl(4) in mice. J. Appl. Toxicol. 26: 326-332 (2006). *

• Morsy MM, Abdelaziz NA, Boghdady AM, Ahmed H, Abul Fadl EM, Ismail MA. Lack of association between endothelial constitutive nitric oxide synthase (ecNOS 4 b/a) gene polymorphism and rheumatic heart disease. Mod. Rheumatol. Sep 25 [Epub ahead of print] (2009). *

• Mosa A, Trumstedt C, Eriksson E, Soehnlein O, Heuts F, Janik K, Klos A, Dittrich-Breiholz O, Kracht M, Hidmark A, Wigzell H, Rottenberg ME. Non-hematopoietic cells control the outcome of infection with Listeria monocytogenes in a NOD1-dependent manner. Infect. Immun. 77: 2908-2918 (2009). *

• Mosca M, Virdis A, Tani C, Ghiadoni L, Versari D, Duranti E, d'Ascanio A, Salvetti A, Taddei S, Bombardieri S. Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis 203: 185-191 (2009).

• Mossalayi MD, Vouldoukis I, Mamani-Matsuda M, Kauss T, Guillon J, Maugein J, Moynet D, Rambert J, Desplat V, Mazier D, Vincendeau P, Malvy D. CD23 mediates anti-mycobacterial activity of human macrophages. Infect. Immun. 77: 5537-5542 (2009). *

• Motilva V, Talero E, Calvo JR, Villegas I, Alarcon-de-la-Lastra C, Sanchez-Fidalgo S. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities. Curr. Pharm. Des. 14: 71-95 (2008).

• Motomura K, Ohata M, Satre M, Tsukamoto H. Destabilization of TNF-alpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease. Am. J. Physiol. Endocrinol. Metab. 281: E420-E429 (2001). *

• Motomura K, Sakai H, Isobe H, Nawata H. Effects of retinoids on the production of tumour necrosis factor-alpha and nitric oxide by lipopolysaccharide-stimulated rat Kupffer cells in vitro: evidence for participation of retinoid X receptor signalling pathway. Cell. Biochem. Funct. 15: 95-101 (1997). *

• Motomura Y, Wang H, Deng Y, El-Sharkawy RT, Verdu EF, Khan WI. Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin. Exp. Immunol. 155: 88-95 (2009). *

• Mourad FH, Barada KA, Bou Rached NA, Khoury CI, Saade NE, Nassar CF. Inhibitory effect of experimental colitis on fluid absorption in rat jejunum: role of the enteric nervous system, VIP and nitric oxide. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G262-G268 (2006). *

• Mucenic T, Brenol J, Bredemeier M, Paiva Dos Santos B, Chies J, Monticielo O, Xavier R. Glu298Asp eNOS polymorphism is not associated with SLE. Lupus 18: 448-451 (2009). *

• Mueller M, Lukas B, Novak J, Simoncini T, Genazzani AR, Jungbauer A. Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J. Agric. Food Chem. 56: 11621-11630 (2008). *

• Munhoz CD, Garcia-Bueno B, Madrigal JL, Lepsch LB, Scavone C, Leza JC. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz. J. Med. Biol. Res. 41: 1037-1046 (2008). *

• Muniappan L, Ozcan S. Induction of insulin secretion in engineered liver cells by nitric oxide. BMC Physiol. 7: 11 (2007). *

• Murakami I, Hamada Y, Yamane S, Fujino H, Horie S, Murayama T. Nicotine-induced neurogenic relaxation in the mouse colon: changes with dextran sodium sulfate-induced colitis. J. Pharmacol. Sci. 109: 128-138 (2009). *

• Murawska-Cialowicz E, Januszewska L, Zuwala-Jagiello J, Milczarska J, Zawadzki M, Paprocka-Borowicz M, Wierzbicka-Damska I. Melatonin decreases homocysteine level in blood of rats. J. Physiol. Pharmacol. 59: 717-729 (2008). *

• Muriel P, Rivera-Espinoza Y. Beneficial drugs for liver diseases. J. Appl. Toxicol. 28: 93-103 (2008). *

• Murphy BA, Fakira KA, Song Z, Beuve A, Routh VH. AMP-activated protein kinase (AMPK) and nitric oxide (NO) regulate the glucose sensitivity of ventromedial hypothalamic (VMH) glucose-inhibited (GI) neurons. Am. J. Physiol. Cell Physiol. 297: C750-C758 (2009). *

• Murphy E, Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 75: 478-486 (2007). *

• Murr C, Meinitzer A, Grammer T, Schroecksnadel K, Bohm BO, Marz W, Fuchs D. Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease. Scand. J. Immunol. 70: 63-67 (2009). *

• Musiek ES, Gao L, Milne GL, Han W, Everhart MB, Wang D, Backlund MG, Dubois RN, Zanoni G, Vidari G, Blackwell TS, Morrow JD. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J. Biol. Chem. 280: 35562-35570 (2005). *

• Nagasaka H, Okano Y, Tsukahara H, Shigematsu Y, Momoi T, Yorifuji J, Miida T, Ohura T, Kobayashi K, Saheki T, Hirano K, Takayanagi M, Yorifuji T. Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent period. Mol. Genet. Metab. 97: 21-26 (2009). *

• Nagassaki S, Herculano RD, Graeff CF, Tanus-Santos JE. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. Eur. J. Clin. Pharmacol. 65: 385-392 (2009).

• Nagesh Babu G, Kumar A, Kalita J, Misra UK. Proinflammatory cytokine levels in the serum and cerebrospinal fluid of tuberculous meningitis patients. Neurosci. Lett. 436: 48-51 (2008).

• Nagl F, Schonhofer K, Seidler B, Mages J, Allescher HD, Schmid RM, Schneider G, Saur D. Retinoic acid induced nNOS expression depends on a novel PI3K/AKT/DAX1 pathway in human TGW-nu-I neuroblastoma cells. Am. J. Physiol. Cell Physiol. 297: C1146-C1156 (2009). *

• Nagy G, Clark JM, Buzas E, Gorman C, Pasztoi M, Koncz A, Falus A, Cope AP. Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunol. Lett. 118: 55-58 (2008).

• Nagy G, Geher P, Koncz A, Perl A. Signal transduction abnormalities in systemic lupus erythematosus. Orv. Hetil. 146: 1625-1630 (2005).

• Nagy G, Perl A. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus. Clin. Immunol. 118: 145-151 (2006). *

• Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, Imanishi J, Yoshikawa T. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J. Gastroenterol. Hepatol. 18: 560-569 (2003). *

• Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Yanagisawa R, Inoue K, Takano H, Satoh M, Yoshida N, Okanoue T, Yoshikawa T. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int. J. Mol. Med. 14: 191-196 (2004).

• Naito Y, Takagi T, Yoshikawa T. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J. Gastroenterol. 42: 787-798 (2007). *

• Nakai K, Kadiiska MB, Jiang JJ, Stadler K, Mason RP. Free radical production requires both inducible nitric oxide synthase and xanthine oxidase in LPS-treated skin. Proc. Natl. Acad. Sci. U.S.A. 103: 4616-4621 (2006). *

• Nakamura H, Masuko K, Yudoh K, Kato T, Nishioka K. Effects of celecoxib on human chondrocytes - enhanced production of chemokines. Clin. Exp. Rheumatol. 25: 11-16 (2007).

• Nakanishi H, Kaibori M, Teshima S, Yoshida H, Kwon AH, Kamiyama Y, Nishizawa M, Ito S, Okumura T. Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1beta at a step of NF-kappaB DNA binding in hepatocytes. J. Hepatol. 41: 730-736 (2004). *

• Nakao A, Schmidt J, Harada T, Tsung A, Stoffels B, Cruz Jr RJ, Kohmoto J, Peng X, Tomiyama K, Murase N, Bauer AJ, Fink MP. A single intraperitoneal dose of carbon monoxide-saturated Ringer's lactate solution ameliorates post-operative ileus in mice. J. Pharmacol. Exp. Ther. 319: 1265-1275 (2006). *

• Nakao K, Isashiki Y, Sonoda S, Uchino E, Shimonagano Y, Sakamoto T. Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behcet disease. Arch. Ophthalmol. 125: 246-251 (2007). *

• Nakase H, Okazaki K, Tabata Y, Chiba T. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease. J. Gastroenterol. 38 Suppl. 15: 59-62 (2003).

• Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, Matsushima Y, Kawanami C, Oshima C, Ikada Y, Chiba T. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. J. Pharmacol. Exp. Ther. 292: 15-21 (2000). *

• Namazi MR. Nicotinamide: a potential addition to the anti-psoriatic weaponry. FASEB J. 17: 1377-1379 (2003). *

• Nan YH, Jeon YJ, Park IS, Shin SY. Antimicrobial peptide P18 inhibits inflammatory responses by LPS- but not by IFN-gamma-stimulated macrophages. Biotechnol. Lett. 30: 1183-1187 (2008). *

• Nandi J, Saud B, Zinkievich JM, Palma DT, Levine RA. 5-Aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats. Dig. Dis. Sci. 53: 123-132 (2008). *

• Nandi J, Saud B, Zinkievich JM, Yang ZJ, Levine RA. TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. Mol. Cell. Biochem. Oct 3 [Epub ahead of print] (2009). *

• Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G321-G327 (2003). *

• Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri Jr WA, Cunha FQ, Ferreira SH. 15d-Prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. J. Pharmacol. Exp. Ther. 324: 313-321 (2007). *

• Napimoga MH, Vieira SM, Dal-Secco D, Freitas A, Souto FO, Mestriner FL, Alves-Filho JC, Grespan R, Kawai T, Ferreira SH, Cunha FQ. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. J. Immunol. 180: 609-617 (2008). *

• Narayanan BA, Narayanan NK, Simi B, Reddy BS. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res. 63: 972-979 (2003). *

• Natarajan SK, Basivireddy J, Ramachandran A, Thomas S, Ramamoorthy P, Pulimood AB, Jacob M, Balasubramanian KA. Renal damage in experimentally-induced cirrhosis in rats: role of oxygen free radicals. Hepatology 43: 1248-1256 (2006). *

• Nath N, Morinaga O, Singh I. S-Nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. Jan 21 [Epub ahead of print] (2010).

• Nathan JD, Liddle RA. Neurohormonal control of pancreatic exocrine secretion. Curr. Opin. Gastroenterol. 18: 536-544 (2002).

• Navarro-Lerida I, Martinez-Moreno M, Ventoso I, Alvarez-Barrientos A, Rodriguez-Crespo I. Binding of CAP70 to inducible nitric oxide synthase and implications for the vectorial release of nitric oxide in polarized cells. Mol. Biol. Cell 18: 2768-2777 (2007). *

• Net M, Valero R, Almenara R, Barros P, Capdevila L, Lopez-Boado MA, Ruiz A, Sanchez-Crivaro F, Miquel R, Deulofeu R, Taura P, Manyalich M, Garcia-Valdecasas JC. The effect of normothermic recirculation is mediated by ischemic preconditioning in NHBD liver transplantation. Am. J. Transplant. 5: 2385-2392 (2005). *

• Neve BP, Fruchart JC, Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem. Pharmacol. 60: 1245-1250 (2000). *

• Newaz M, Blanton A, Fidelis P, Oyekan A. NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Mutat. Res. 579: 163-171 (2005).

• Newaz M, Ranganna K, Truong LD, Oyekan A. Effect of peroxisome proliferator-activated receptor-alpha siRNA on hypertension and renal injury in the rat following nitric oxide withdrawal and high salt diet. J. Hypertens. Oct 14 [Epub ahead of print] (2009).

• Nicolas A, Cathelin D, Larmonier N, Fraszczak J, Puig PE, Bouchot A, Bateman A, Solary E, Bonnotte B. Dendritic cells trigger tumor cell death by a nitric oxide-dependent mechanism. J. Immunol. 179: 812-818 (2007). *

• Nicoletti F, Conrad D, Wang A, Pieters R, Mangano K, van Heeckeren A, White SK, Frincke J, Reading CL, Auci DL, Stickney D. 16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs. Clin. Exp. Immunol. 158: 308-316 (2009). *

• Niedbala W, Cai B, Liu H, Pitman N, Chang L, Liew FY. Nitric oxide induces CD4+CD25+ Foxp3- regulatory T cells from CD4+CD25- T cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. U.S.A. 104: 15478-15483 (2007). *

• Nijveldt RJ, Siroen MP, Teerlink T, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int. 24: 510-518 (2004). *

• Nishio K, Shigemitsu M, Kodama Y, Itoh S, Konno N, Satoh R, Katagiri T, Kobayashi Y. The effect of pioglitazone on nitric oxide synthase in patients with type 2 diabetes mellitus. J. Cardiometab. Syndr. 3: 200-204 (2008).

• Niveloni S, Weksler-Zangen S, Pedreira S, Dezi R, Granot E, Doldan I, Wengrower D, Vazquez H, Smecuol E, Valero J, Kogan Z, Maurino E, Bai JC, Goldin E. Time course of nitric oxide synthase generation after gluten exposure in the rectal mucosa of gluten-sensitive patients. Scand. J. Gastroenterol. 35: 1150-1156 (2000). *

• Njoku CJ, Patrick KS, Ruiz P Jr, Oates JC. Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis. J. Investig. Med. 53: 347-352 (2005).

• Nohara H, Saito Y, Higaki S, Okayama N, Hamanaka Y, Okita K, Hinoda Y. Polymorphisms of the IL-1beta and IL-1beta-inducible genes in ulcerative colitis. J. Gastroenterol. 37 Suppl. 14: 107-110 (2002).

• Nomura H, Yamawaki H, Mukohda M, Okada M, Hara Y. Mechanisms underlying pioglitazone-mediated relaxation in isolated blood vessel. J. Pharmacol. Sci. 108: 258-265 (2008). *

• Norman MU, Zbytnuik L, Kubes P. Interferon-gamma limits Th1 lymphocyte adhesion to inflamed endothelium: a nitric oxide regulatory feedback mechanism. Eur. J. Immunol. 38: 1368-1380 (2008). *

• Novitskiy G, Potter JJ, Wang L, Mezey E. Influences of reactive oxygen species and nitric oxide on hepatic fibrogenesis. Liver Int. 26: 1248-1257 (2006). *

• Nowak J, Weylandt KH, Habbel P, Wang J, Dignass A, Glickman JN, Kang JX. Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids. Carcinogenesis 28: 1991-1995 (2007). *

• Nozaki Y, Yamagata T, Sugiyama M, Ikoma S, Kinoshita K, Funauchi M. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin. Immunol. 119: 272-279 (2006). *

• O'Dwyer MJ, Dempsey F, Crowley V, Kelleher D, McManus R, Ryan T. Septic shock correlates with ADMA levels which may be influenced by a polymorphism in DDAH II: a prospective observational study. Crit. Care 10: R139 (2006). *

• O’Keefe SJ, Hegazi RA. Nutritional support in acute pancreatitis. Gastroenterology & Hepatology Annual Review Vol. 1, June 2006, p. 72-76 (2006). *

• O'Shaughnessy MC, Vetsika EK, Inglis JJ, Carleson J, Haigh R, Kidd BL, Winyard PG. The effect of substance P on nitric oxide release in a rheumatoid arthritis model. Inflamm. Res. 55: 236-240 (2006). *

• Oates JC. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity Dec 14 [Epub ahead of print] (2009).

• Oates JC, Gilkeson GS. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin. Immunol. 121: 243-250 (2006). *

• Oates JC, Levesque MC, Hobbs MR, Smith EG, Molano ID, Page GP, Hill BS, Weinberg JB, Cooper GS, Gilkeson GS. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in African-Americans. J. Rheumatol. 30: 60-67 (2003).

• Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol. 116: 238-245 (1999). *

• Ock J, Kim S, Suk K. Anti-inflammatory effects of a fluorovinyloxyacetamide compound KT-15087 in microglia cells. Pharmacol. Res. 59: 414-422 (2009). *

• Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr. Mol. Med. 8: 437-445 (2008).

• Oh PS, Lim KT. Plant originated glycoprotein has anti-oxidative and anti-inflammatory effects on dextran sulfate sodium-induced colitis in mouse. J. Biomed. Sci. 13: 549-560 (2006). *

• Oh YI, Kim JH, Kang CW. Oxidative stress in MCF-7 cells is involved in the effects of retinoic acid-induced activation of protein kinase C-delta on insulin-like growth factor-I secretion and synthesis. Growth Horm. IGF Res. Nov 20 [Epub ahead of print] (2009).

• Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305: 253-264 (1994).

• Okabe TA, Hattori M, Yuan Z, Kishimoto C. L-Arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes. Int. J. Exp. Pathol. 89: 382-388 (2008).

• Okaya T, Lentsch AB. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G606-G612 (2004). *

• Okiyama W, Tanaka N, Nakajima T, Tanaka E, Kiyosawa K, Gonzalez FJ, Aoyama T. Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. J. Hepatol. 50: 1236-1246 (2009).

• Okoko T, Oruambo IF. Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells. Food Chem. Toxicol. 47: 809-812 (2009).

• Oksel F, Keser G, Ozmen M, Aksu K, Kitapcioglu G, Berdeli A, Doganavsargil E. Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with Behcet's disease. Clin. Exp. Rheumatol. 24: S079-S082 (2006).

• Olesen M, Middelveld R, Bohr J, Tysk C, Lundberg JO, Eriksson S, Alving K, Jarnerot G. Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis. Scand. J. Gastroenterol. 38: 66-72 (2003). *

• Olinga P, van der Hoeven JA, Merema MT, Freund RL, Ploeg RJ, Groothuis GM. The influence of brain death on liver function. Liver Int. 25: 109-116 (2005). *

• Oliver J, Gomez-Garcia M, Vilchez JR, Lopez-Nevot MA, Pinero A, Correro F, Nieto A, Martin J. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease. Tissue Antigens 67: 326-330 (2006). *

• Olleros ML, Vesin D, Martinez-Soria E, Allenbach C, Tacchini-Cottier F, Pache JC, Marchal G, Rahman J, Fernandez C, Izui S, Garcia I. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guerin and Mycobacterium tuberculosis clearance. Immunology 122: 350-361 (2007). *

• Orellana RA, Suryawan A, Kimball SR, Wu G, Nguyen HV, Jefferson LS, Davis TA. Insulin signaling in skeletal muscle and liver of neonatal pigs during endotoxemia. Pediatr. Res. 64: 505-510 (2008). *

• Ortega-Gutierrez S, Molina-Holgado E, Arevalo-Martin A, Correa F, Viso A, Lopez-Rodriguez ML, Di Marzo V, Guaza C. Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis. FASEB J. 19: 1338-1340 (2005). *

• Osiecki H. The role of chronic inflammation in cardiovascular disease and its regulation by nutrients. Altern. Med. Rev. 9: 32-53 (2004). *

• Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gomez-Reino J, Gualillo O. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45: 944-950 (2006). *

• Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gomez-Reino JJ, Gualillo O. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 579: 295-301 (2005). *

• Oudkerk Pool M, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SG, Pena AS. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand. J. Gastroenterol. 30: 784-788 (1995).

• Oxenkrug GF. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann. N. Y. Acad. Sci. 1122: 35-49 (2007). *

• Ozbek E, Ilbey YO, Simsek A, Cekmen M, Mete F, Somay A. Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats. Int. Urol. Nephrol. Sep 25 [Epub ahead of print] (2009).

• Ozyilmaz E, Yildirim B, Erbas G, Akten S, Oguzulgen IK, Tunc B, Tuncer C, Turktas H. Value of fractional exhaled nitric oxide (FE(NO)) for the diagnosis of pulmonary involvement due to inflammatory bowel disease. Inflamm. Bowel Dis. Aug 24 [Epub ahead of print] (2009).

• Pacquelet S, Presle N, Boileau C, Dumond H, Netter P, Martel-Pelletier J, Pelletier JP, Terlain B, Jouzeau JY. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis. J. Rheumatol. 29: 2602-2610 (2002). *

• Pahan K, Sheikh FG, Liu X, Hilger S, McKinney M, Petro TM. Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J. Biol. Chem. 276: 7899-7905 (2001). *

• Pais TF, Figueiredo C, Peixoto R, Braz MH, Chatterjee S. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J. Neuroinflammation 5: 43 (2008).

• Palaga T, Buranaruk C, Rengpipat S, Fauq AH, Golde TE, Kaufmann SH, Osborne BA. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur. J. Immunol. 38: 174-183 (2008). *

• Palatka K, Serfozo Z, Vereb Z, Batori R, Lontay B, Hargitay Z, Nemes Z, Udvardy M, Erdodi F, Altorjay I. Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. World J. Gastroenterol. 12: 1730-1738 (2006). *

• Palma C, Iona E, Ebensen T, Guzman CA, Cassone A. The Toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophages. Open Microbiol. J. 3: 47-52 (2009). *

• Palop-Cervera M, de Diego Damia A, Martinez-Moragon E, Cortijo J, Fullana J, Leon M. Inflammation markers in the exhaled air of patients with bronchiectasis unassociated with cystic fibrosis. Arch. Bronconeumol. 45: 597-602 (2009).

• Pan X, Wang X, Lei W, Min L, Yang Y, Wang X, Song J. Nitric oxide suppresses transforming growth factor-beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology 50: 1577-1587 (2009).

• Pan Y, Chen C, Shen Y, Zhu CH, Wang G, Wang XC, Chen HQ, Zhu MS. Curcumin alleviates dystrophic muscle pathology in mdx mice. Mol. Cells 25: 531-537 (2008).

• Panaro MA, Cianciulli A, Gagliardi N, Mitolo CI, Acquafredda A, Cavallo P, Mitolo V. CD14 major role during lipopolysaccharide-induced inflammation in chick embryo cardiomyocytes. FEMS Immunol. Med. Microbiol. 53: 35-45 (2008). *

• Panchal PC, Forman JS, Blumberg DR, Wilson KT. Helicobacter pylori infection: pathogenesis. Curr. Opin. Gastroenterol. 19: 4-10 (2003).

• Papadopoulos D, Rundle J, Patel R, Marshall I, Stretton J, Eaton R, Richardson JC, Gonzalez MI, Philpott KL, Reynolds R. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses. J. Neurosci. Res. 88: 346-359 (2009).

• Park EJ, Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 184: 18-25 (2009). *

• Park HJ, Son DJ, Lee CW, Choi MS, Lee US, Song HS, Lee JM, Hong JT. Melittin inhibits inflammatory target gene expression and mediator generation via interaction with IkappaB kinase. Biochem. Pharmacol. 73: 237-247 (2007). *

• Park JH, Kim JH, Kim WH, Kim DS, Park TS, Baek HS. Association of the endothelial nitric oxide synthase (ecNOS) gene polymorphism with carotid atherosclerosis in type 2 diabetes. Diabetes Res. Clin. Pract. 72: 322-327 (2006).

• Park JY, Farrance IK, Fenty NM, Hagberg JM, Roth SM, Mosser DM, Wang MQ, Jo H, Okazaki T, Brant SR, Brown MD. NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. Am. J. Physiol. Heart Circ. Physiol. 293: H2320-H2327 (2007). *

• Park SS, Lillehoj HS, Allen PC, Park DW, FitzCoy S, Bautista DA, Lillehoje EP. Immunopathology and cytokine responses in broiler chickens coinfected with Eimeria maxima and Clostridium perfringens with the use of an animal model of necrotic enteritis. Avian Dis. 52: 14-22 (2008).

• Parra G, Quiroz Y, Salazar J, Bravo Y, Pons H, Chavez M, Johnson RJ, Rodriguez-Iturbe B. Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70. Kidney Int. Suppl. 111: S55-S59 (2008).

• Pascual M, Lopez-Nevot MA, Caliz R, Koeleman BP, Balsa A, Pascual-Salcedo D, Martin J. Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism. Genes Immun. 3: 299-301 (2002). *

• Pattacini L, Casali B, Boiardi L, Pipitone N, Albertazzi L, Salvarani C. Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway. Rheumatology (Oxford) 46: 1252-1257 (2007). *

• Paukkeri EL, Leppanen T, Sareila O, Vuolteenaho K, Kankaanranta H, Moilanen E. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. Br. J. Pharmacol. 152: 1081-1091 (2007). *

• Peairs A, Dai R, Gan L, Shimp S, Rylander MN, Li L, Reilly CM. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell. Mol. Immunol. Feb 8 [Epub ahead of print] (2010).

• Pena JA, Li SY, Wilson PH, Thibodeau SA, Szary AJ, Versalovic J. Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis. Appl. Environ. Microbiol. 70: 558-568 (2004). *

• Pena-Dos-Santos DR, Severino FP, Pereira SA, Rodrigues DB, Cunha FQ, Vieira SM, Napimoga MH, Clemente-Napimoga JT. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. Neuroscience 163: 1211-1219 (2009).

• Perales MS, Alejandre J, Palomino-Morales RJ, Torres C, Linares A. Influence of cholesterol and fish oil dietary intake on nitric oxide-induced apoptosis in vascular smooth muscle cells. Nitric Oxide Dec 26 [Epub ahead of print] (2009).

• Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A, Galvez J. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J. Appl. Microbiol. 103: 836-844 (2007). *

• Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, Olivares M, Xaus J, Zarzuelo A, Galvez J. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int. J. Colorectal Dis. 21: 737-746 (2006). *

• Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E, Mantelli B, Bronte V, Zanovello P. Role of arginine metabolism in immunity and immunopathology. Immunobiology 212: 795-812 (2008).

• Perez AR, Fontanella GH, Nocito AL, Revelli S, Bottasso OA. Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation. Clin. Exp. Immunol. 157: 291-299 (2009). *

• Perl A. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity Dec 17 [Epub ahead of print] (2009).

• Perner A, Andresen L, Normark M, Fischer-Hansen B, Sorensen S, Eugen-Olsen J, Rask-Madsen J. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Gut 49: 387-394 (2001). *

• Persson YA, Blomgran-Julinder R, Rahman S, Zheng L, Stendahl O. Mycobacterium tuberculosis-induced apoptotic neutrophils trigger a pro-inflammatory response in macrophages through release of heat shock protein 72, acting in synergy with the bacteria. Microbes Infect. 10: 233-240 (2007). *

• Pertovaara M, Antonen J, Hurme M. Endothelial nitric oxide synthase +894 polymorphism is associated with recurrent salivary gland swelling and early onset in patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 66: 1400-1401 (2007). *

• Petersson J, Schreiber O, Steege A, Patzak A, Hellsten A, Phillipson M, Holm L. eNOS involved in colitis-induced mucosal blood flow increase. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1281-G1287 (2007). *

• Piccoli JC, Gottlieb MG, Castro L, Bodanese LC, Manenti ER, Bogo MR, Peres A, Rocha MI, Cruz IB. Association between 894G>T endothelial nitric oxide synthase gene polymorphisms and metabolic syndrome. Arq. Bras. Endocrinol. Metabol. 52: 1367-1373 (2008). *

• Piepenbrink MS, Hussain I, Marsh JA, Dietert RR. Developmental immunotoxicology of di-(2-ethylhexyl)phthalate (DEHP): age-based assessment in the female rat. J. Immunotoxicol. 2: 21-31 (2005).

• Piepoli AL, De Salvatore G, De Salvia MA, Mitolo CI, Siro-Brigiani G, Marzullo A, Grattagliano I, Mitolo-Chieppa D, Palasciano G, Portincasa P. Indomethacin-induced ileitis is associated with tensiometric, vascular and oxidative changes in the experimental rat model. Eur. J. Clin. Invest. 35: 271-278 (2005).

• Pieracci FM, Barie PS. Iron and the risk of infection. Surg. Infect. (Larchmt.) 6 Suppl. 1: s41-s46 (2005).

• Pilette C, Kirstetter P, Sogni P, Cailmail S, Moreau R, Lebrec D. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats. J. Gastroenterol. Hepatol. 11: 1-6 (1996).

• Pilichos CJ, Kouerinis IA, Zografos GC, Korkolis DP, Preza AA, Gazouli M, Menenakos EI, Loutsidis AE, Zagouri F, Gorgoulis VG, Fotiadis CI. The effect of nitric oxide synthases inhibitors on inflammatory bowel disease in a rat model. In Vivo 18: 513-516 (2004).

• Pinelis VG, Sorokina EG. Autoimmune mechanisms of modulation of the activity of glutamate receptors in children with epilepsy and craniocerebral injury. Vestn. Ross. Akad. Med. Nauk. 12: 44-51 (2008).

• Piraino G, Cook JA, O'Connor M, Hake PW, Burroughs TJ, Teti D, Zingarelli B. Synergistic effect of peroxisome proliferator-activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. Shock 26: 146-153 (2006). *

• Pissetti CW, Correia D, Braga T, Faria GE, Oliveira RF, Ribeiro BM, Rodrigues DB, Rodrigues V. Association between the plasma levels of TNF-alpha, IFN-gamma, IL-10, nitric oxide and specific IgG isotypes in the clinical forms of chronic Chagas disease. Rev. Soc. Bras. Med. Trop. 42: 425-430 (2009).

• Pizato N, Bonatto S, Piconcelli M, de Souza LM, Sassaki GL, Naliwaiko K, Nunes EA, Curi R, Calder PC, Fernandes LC. Fish oil alters T-lymphocyte proliferation and macrophage responses in Walker 256 tumor-bearing rats. Nutrition 22: 425-432 (2006). *

• Ponferrada A, Caso JR, Alou L, Colon A, Sevillano D, Moro MA, Lizasoain I, Menchen P, Gomez-Lus ML, Lorenzo P, Cos E, Leza JC, Menchen L. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. Gastroenterology 132: 1791-1803 (2007). *

• Ponomarev ED, Maresz K, Tan Y, Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J. Neurosci. 27: 10714-10721 (2007).

• Popp FC, Renner P, Eggenhofer E, Slowik P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl. 15: 1192-1198 (2009).

• Porras M, Martin MT, Teran E, Mourelle M, Vergara P. The nitric oxide donor LA-419 [S-(6-Nitro-oxi-hexahydro-furo[3,2-b]furan-3-1-il)thioacetate] prevents intestinal dysmotility, bacterial translocation, and inflammation in a rat model of enteritis. J. Pharmacol. Exp. Ther. 324: 740-748 (2008). *

• Porras M, Martin MT, Torres R, Vergara P. Cyclical up-regulated iNOS and long-term down-regulated nNOS are the basis for relapse and quiescent phases in a rat model of IBD. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G423-G430 (2006). *

• Porter DW, Wolfarth M, Young SH, Rao MK, Meighan T, Barger M, Andrew ME, Huffman LJ. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages. J. Toxicol. Environ. Health A. 70: 1967-1976 (2007). *

• Potapovich AI, Pastore S, Kostyuk VA, Lulli D, Mariani V, De Luca C, Dudich EI, Korkina LG. alpha-Fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes. Br. J. Pharmacol. 158: 1236-1247 (2009). *

• Prasad P. The role of nitric oxide in gastrointestinal health and disease. Gastroenterology 127: 1014 (2004). *

• Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J. Am. Coll. Surg. 202: 407-417 (2006). *

• Ptasinska A, Wang S, Zhang J, Wesley RA, Danner RL. Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway. FASEB J. 21: 950-961 (2007). *

• Puca AA, Andrew P, Novelli V, Anselmi CV, Somalvico F, Cirillo NA, Chatgilialoglu C, Ferreri C. Fatty acid profile of erythrocyte membranes as possible biomarker of longevity. Rejuvenation Res. 11: 63-72 (2008).

• Puddu GM, Cravero E, Arnone G, Muscari A, Puddu P. Molecular aspects of atherogenesis: new insights and unsolved questions. J. Biomed. Sci. 12: 839-853 (2005). *

• Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42: 349-361 (2008).

• Qiu H, Liu S, Xie C, Long J, Feng Z. Regulating immunity and inhibiting tumor growth by the recombinant peptide sPD-1-CH50. Anticancer Res. 29: 5089-5094 (2009).

• Qiu L, Ding L, Huang J, Wang D, Zhang J, Guo B. Induction of copper/zinc-superoxide dismutase by CCL5/CCR5 activation causes tumour necrosis factor-alpha and reactive oxygen species production in macrophages. Immunology 128: e325-e334 (2009). *

• Qu F, Qin XQ, Cui YR, Xiang Y, Tan YR, Liu HJ, Peng LH, Zhou XY, Liu C, Zhu XL. Ozone stress down-regulates the expression of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial cells. Chem. Biol. Interact. 179: 219-226 (2009). *

• Qu W, Zhou Y, Shao C, Sun Y, Zhang Q, Chen C, Jia J. Helicobacter pylori proteins response to nitric oxide stress. J. Microbiol. 47: 486-493 (2009).

• Quan J, Piao L, Wang X, Li T, Yin X. Rossicaside B protects against carbon tetrachloride-induced hepatotoxicity in mice. Basic Clin. Pharmacol. Toxicol. 105: 380-386 (2009).

• Quan J, Yin X, Xu H. Boschniakia rossica prevents the carbon tetrachloride-induced hepatotoxicity in rat. Exp. Toxicol. Pathol. Oct 14 [Epub ahead of print] (2009).

• Queiroz LS, Nascimento MS, Cruz AK, Castro AJ, Moura MD, Baseia IG, Araujo RM, Benevides NM, Lima LF, Leite EL. Glucans from the Caripia montagnei mushroom present anti-inflammatory activity. Int. Immunopharmacol. Oct 2 [Epub ahead of print] (2009).

• Quintana AB, Rodriguez JV, Scandizzi AL, Guibert EE. The benefit of adding sodium nitroprusside (NPNa) or S-nitrosoglutathione (GSNO) to the University of Wisconsin solution (UW) to prevent morphological alterations during cold preservation/reperfusion of rat livers. Ann. Hepatol. 2: 84-91 (2003). *

• Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37: 247-255 (1995). *

• Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36: 718-723 (1995). *

• Racz E, Prens EP. Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy. Expert Rev. Mol. Med. 11: e38 (2009).

• Rahman S, Gudetta B, Fink J, Granath A, Ashenafi S, Aseffa A, Derbew M, Svensson M, Andersson J, Brighenti SG. Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the granulomatous lesions. Am. J. Pathol. 174: 2211-2224 (2009). *

• Rajaiah R, Lee DY, Ma Z, Fan AY, Lao L, Fong HH, Berman BM, Moudgil KD. Huo-Luo-Xiao-Ling Dan modulates antigen-directed immune response in adjuvant-induced inflammation. J. Ethnopharmacol. 123: 40-44 (2009).

• Rajanikant GK, Zemke D, Kassab M, Majid A. The therapeutic potential of statins in neurological disorders. Curr. Med. Chem. 14: 103-112 (2007).

• Ramsaransing GS, Fokkema MR, Teelken A, Arutjunyan AV, Koch M, De Keyser J. Plasma homocysteine levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 77: 189-192 (2006). *

• Ran ZH, Chen C, Xiao SD. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed. Pharmacother. 62: 189-196 (2008).

• Rao R. Oxidative stress-induced disruption of epithelial and endothelial tight junctions. Front. Biosci. 13: 7210-7226 (2008).

• Rasaratnam B, Connelly N, Chin-Dusting JP. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination? Clin. Sci. (Lond.) 107: 425-434(2004). *

• Raso GM, Esposito E, Iacono A, Pacilio M, Cuzzocrea S, Canani RB, Calignano A, Meli R. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. Eur. J. Pharmacol. 604: 125-131 (2009).

• Ray JC, Wang J, Chan J, Kirschner DE. The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. J. Theor. Biol. 252: 24-38 (2008). *

• Rayatzadeh H, Nouri M, Ghasemi M, Kebriaeezadeh A, Mehr SE, Dehpour AR. Effect of metal chelating agents on pentylenetetrazole-induced seizure threshold in cholestatic mice. Seizure 18: 51-56 (2009).

• Razzak A, Aldrich C, Babcock TA, Saied A, Espat NJ. Attenuation of iNOS in an LPS-stimulated macrophage model by omega-3 fatty acids is independent of COX-2 derived PGE(2). J. Surg. Res. 145: 244-250 (2008). *

• Redd S, Ginn S, Ross JM. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes. Histochem. J. 34: 1-12 (2002).

• Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I, Rao CV. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res. 60: 4792-4797 (2000). *

• Reddy RC, Hao Y, Lee SH, Gangireddy SR, Owyang C, Dimagno MJ. Pioglitazone reverses insulin resistance and impaired CCK stimulated pancreatic secretion in eNOS (-/-) mice. Therapy for exocrine pancreatic disorders? Am. J. Physiol. Gastrointest. Liver Physiol. 293: G112-G120 (2007). *

• Rehm KE, Connor RF, Jones GJ, Yimbu K, Mannie MD, Roper RL. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. Immunology 128: 381-392 (2009). *

• Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. J. Hepatol. 51: 865-873 (2009).

• Reilly CM, Olgun S, Goodwin D, Gogal RM Jr, Santo A, Romesburg JW, Ansar Ahmed S, Gilkeson GS. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Eur. J. Immunol. 36: 1296-1308 (2006). *

• Reinders CI, Hellstrom PM, Bjork J, Weitzberg E, Lundberg JO. Effect of intravenous L-NMMA on nitric oxide production in collagenous colitis. Scand. J. Gastroenterol. 39: 32-36 (2004). *

• Reinders CI, Herulf M, Ljung T, Hollenberg J, Weitzberg E, Lundberg JO, Hellstrom PM. Rectal mucosal nitric oxide in differentiation of inflammatory bowel disease and irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 3: 777-783 (2005).

• Reinders CI, Jonkers D, Jansson EA, Stockbrugger RW, Stobberingh EE, Hellstrom PM, Lundberg JO. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scand. J. Gastroenterol. 42: 1151-1157 (2007). *

• Reiner E, Tedeschi-Reiner E, Stajminger G. The role of omega-3 fatty acids from fish in prevention of cardiovascular diseases. Lijec. Vjesn. 129: 350-355 (2007).

• Rejdak K, Petzold A, Kocki T, Kurzepa J, Grieb P, Turski WA, Stelmasiak Z. Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis. J. Neural Transm. 114: 1011-1015 (2007). *

• Repa JJ, Li H, Frank-Cannon TC, Valasek MA, Turley SD, Tansey MG, Dietschy JM. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J. Neurosci. 27: 14470-14480 (2007).

• Resta-Lenert S, Barrett KE. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology 122: 1070-1087 (2002). *

• Resta-Lenert S, Smitham J, Barrett KE. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G153-G162 (2005). *

• Rettori V, Fernandez-Solari J, Mohn C, Zubilete MA, de la Cal C, Prestifilippo JP, De Laurentiis A. Nitric oxide at the crossroad of immunoneuroendocrine interactions. Ann. N. Y. Acad. Sci. 1153: 35-47 (2009). *

• Reungjui S, Roncal CA, Sato W, Glushakova OY, Croker BP, Suga S, Ouyang X, Tungsanga K, Nakagawa T, Johnson RJ, Mu W. Hypokalemic nephropathy is associated with impaired angiogenesis. J. Am. Soc. Nephrol. 19: 125-134 (2008). *

• Reynolds J, Norgan VA, Bhambra U, Smith J, Cook HT, Pusey CD. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J. Am. Soc. Nephrol. 13: 359-369 (2002). *

• Reynolds PD, Middleton SJ, Shorthouse M, Hunter JO. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system. Aliment. Pharmacol. Ther. 9: 491-495 (1995).

• Rezaie A, Ghorbani F, Eshghtork A, Zamani MJ, Dehghan G, Taghavi B, Nikfar S, Mohammadirad A, Daryani NE, Abdollahi M. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta1 in relation to disease activity in Crohn's disease patients. Ann. N. Y. Acad. Sci. 1091: 110-122 (2006). *

• Rezaie A, Khalaj S, Shabihkhani M, Nikfar S, Zamani MJ, Mohammadirad A, Daryani NE, Abdollahi M. Study on the correlations among disease activity index and salivary transforming growth factor-beta1 and nitric oxide in ulcerative colitis patients. Ann. N. Y. Acad. Sci. 1095: 305-314 (2007). *

• Ribbons KA, Thompson JH, Liu X, Pennline K, Clark DA, Miller MJ. Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur. J. Pharmacol. 323: 245-254 (1997). *

• Ricciotti E, Dovizio M, Di Francesco L, Anzellotti P, Salvatore T, Di Francesco A, Sciulli MG, Pistritto G, Monopoli A, Patrignani P. NCX 4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of IkappaB-alpha degradation in human monocytes. J. Immunol. Jan 11 [Epub ahead of print] (2010).

• Richards DB, Bareille P, Lindo EL, Quinn D, Farrow SN. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial. Respir. Med. Nov 25 [Epub ahead of print] (2009).

• Richir MC, Ellger B, Teerlink T, Siroen MP, Visser M, Spreeuwenberg M, Girbes AR, van der Hoven B, van den Berghe G, Wilhelm AJ, de Vries TP, van Leeuwen PA. The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients. Pharmacol. Res. 60: 519-524 (2009). *

• Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, Vitek MP, Roberts DD, Wink DA. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc. Natl. Acad. Sci. U.S.A. 104: 16898-16903 (2007). *

• Rife T, Rasoul B, Pullen N, Mitchell D, Grathwol K, Kurth J. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease. J. Neurosci. Res. 87: 2319-2325 (2009).

• Rigas B. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia. Curr. Opin. Gastroenterol. 23: 55-59 (2007).

• Risques RA, Rabinovitch PS, Brentnall TA. Cancer surveillance in inflammatory bowel disease: new molecular approaches. Curr. Opin. Gastroenterol. 22: 382-390 (2006).

• Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE. Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes. Pharmacogenet. Genomics 18: 699-707 (2008).

• Robroeks CM, Rosias PP, van Vliet D, Jobsis Q, Yntema JB, Brackel HJ, Damoiseaux JG, den Hartog GM, Wodzig WK, Dompeling E. Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children. Pediatr. Allergy Immunol. 19: 652-659 (2008). *

• Robson AA. Preventing diet induced disease: bioavailable nutrient-rich, low-energy-dense diets. Nutr. Health 20: 135-166 (2009).

• Rockey DC. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin. Liver Dis. 21: 337-349 (2001).

• Rodrigues DB, Pereira SA, dos Reis MA, Adad SJ, Caixeta JE, Chiba AM, Sousa RA, Rodrigues V Jr. In situ detection of inflammatory cytokines and apoptosis in pemphigus foliaceus patients. Arch. Pathol. Lab. Med. 133: 97-100 (2009).

• Rodriguez WE, Sen U, Tyagi N, Kumar M, Carneal G, Aggrawal D, Newsome J, Tyagi SC. PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice. Int. J. Biol. Sci. 4: 236-244 (2008). *

• Rodriguez-Sosa M, Satoskar AR, Calderon R, Gomez-Garcia L, Saavedra R, Bojalil R, Terrazas LI. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infect. Immun. 70: 3656-3664 (2002). *

• Roediger WE. Review article: nitric oxide (NO) from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis. Aliment. Pharmacol. Ther. 27: 531-541 (2008). *

• Roll GR, Rabl C, Ciovica R, Peeva S, Campos GM. A controversy that has been tough to swallow: is the treatment of achalasia now digested? J. Gastrointest. Surg. Sep 17 [Epub ahead of print] (2009). *

• Rolla G. Is nitric oxide the ultimate mediator in hepatopulmonary syndrome? J. Hepatol. 38: 668-670 (2003). *

• Rolla G, Brussino L, Scappaticci E, Morello M, Innarella R, Rosina F, Bucca C. Source of exhaled nitric oxide in primary biliary cirrhosis. Chest 126: 1546-1551 (2004). *

• Rollo EE, Laskin DL, Denhardt DT. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J. Leukoc. Biol. 60: 397-404 (1996). *

• Romagnani P, Annunziato F, Baccari MC, Parronchi P. T cells and cytokines in Crohn's disease. Curr. Opin. Immunol. 9: 793-799 (1997).

• Romanowska M, Al Yacoub N, Seidel H, Donandt S, Gerken H, Phillip S, Haritonova N, Artuc M, Schweiger S, Sterry W, Foerster J. PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J. Invest. Dermatol. 128: 110-124 (2008). *

• Romero JM, Bizzozero OA. Extracellular S-nitrosoglutathione, but not S-nitrosocysteine or NO, mediates protein S-nitrosation in rat spinal cord slices. J. Neurochem. 99: 1299-1310 (2006).

• Ropponen KM, Kellokoski JK, Lipponen PK, Eskelinen MJ, Alanne L, Alhava EM, Kosma VM. Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis. Scand. J. Gastroenterol. 35: 1204-1211 (2000). *

• Rose C, Felipo V. Limited capacity for ammonia removal by brain in chronic liver failure: potential role of nitric oxide. Metab. Brain Dis. 20: 275-283 (2005).

• Rosignoli F, Roca V, Meiss R, Leceta J, Gomariz RP, Perez Leiros C. Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis. Clin. Exp. Immunol. 142: 411-418 (2005). *

• Rossi GP, Pitter G. Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies? Ann. N. Y. Acad. Sci. 1069: 34-50 (2006). *

• Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J. Leukoc. Biol. 81: 49-58 (2007). *

• Royal W 3rd, Leander M, Chen YE, Major EO, Bissonnette RP. Nuclear receptor activation and interaction with morphine. J. Neuroimmunol. 157: 61-65 (2004).

• Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, Santambrogio P, Arosio P, Ramm GA. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49: 887-900 (2009).

• Rudic J, Jesic R, Culafic D, Sarenac-Kovac R, Bulat V, Cvejic T. Sepsis as a cause of intrahepatic cholestasis. Srp. Arh. Celok. Lek. 137: 278-281 (2009).

• Rueda B, Lopez-Nevot MA, Pascual M, Ortega E, Maldonado J, Lopez ML, Koeleman BP, Martin J. Polymorphism of the inducible nitric oxide synthase gene in celiac disease. Hum. Immunol. 63: 1062-1065 (2002).

• Rumi G, Tsubouchi R, Nishio H, Kato S, Mozsik G, Takeuchi K. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats. J. Physiol. Pharmacol. 55: 823-836 (2004). *

• Russo CD, Polak PE, Mercado PR, Spagnolo A, Sharp A, Murphy P, Kamal A, Burrows FJ, Fritz LC, Feinstein DL. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J. Neurochem. 99: 1351-1362 (2006). *

• Rutgers A, Heeringa P, Tervaert JW. The role of myeloperoxidase in the pathogenesis of systemic vasculitis. Clin. Exp. Rheumatol. 21 (6 Suppl. 32): S55-S63 (2003).

• Ruth MR, Taylor CG, Zahradka P, Field CJ. Abnormal immune responses in fa/fa Zucker rats and effects of feeding conjugated linoleic acid. Obesity (Silver Spring) 16: 1770-1779 (2008). *

• Rutherford AE, Pratt DS. Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 22: 209-214 (2006). *

• Rytcr SW, Choi AM. Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models. Novartis Found. Symp. 280: 165-175 (2007).

• Saad B, Abouatta BS, Basha W, Hmade A, Kmail A, Khasib S, Said O. Hypericum triquetrifolium-derived factors downregulate the production levels of LPS-induced nitric oxide and tumor necrosis factor-alpha in THP-1 cells. Evid. Based Complement. Alternat. Med. Sep 14 [Epub ahead of print] (2008). *

• Sadowski T, Steinmeyer J. Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. J. Rheumatol. 28: 336-340 (2001).

• Saha RN, Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal. 8: 929-947 (2006).

• Saidi S, Mallat SG, Almawi WY, Mahjoub T. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene polymorphisms and the risk of ischemic stroke. Acta Neurol. Scand. 121: 114-119 (2010).

• Saijo F, Milsom AB, Bryan NS, Bauer SM, Vowinkel T, Ivanovic M, Andry C, Granger DN, Rodriguez J, Feelisch M. On the dynamics of nitrite, nitrate, and other biomarkers of nitric oxide production in inflammatory bowel disease. Nitric Oxide Dec 14 [Epub ahead of print] (2009).

• Saini A, Harjai K, Mohan H, Punia RP, Chhibber S. Long-term flaxseed oil supplementation diet protects BALB/c mice against Streptococcus pneumoniae infection. Med. Microbiol. Immunol. Nov 17 [Epub ahead of print] (2009). *

• Sajad M, Zargan J, Chawla R, Umar S, Sadaqat M, Khan HA. Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase. Mol. Cell. Biochem. 328: 183-188 (2009). *

• Sakazaki F, Ueno H, Nakamuro K. 17beta-Estradiol enhances expression of inflammatory cytokines and inducible nitric oxide synthase in mouse contact hypersensitivity. Int. Immunopharmacol. 8: 654-660 (2008).

• Salama RH, Nassar AY, Nafady AA, Mohamed HH. A novel therapeutic drug (copper nicotinic acid complex) for non-alcoholic fatty liver. Liver Int. 27: 454-464 (2007). *

• Salazar-Montes A, Ruiz-Corro L, Sandoval-Rodriguez A, Lopez-Reyes A, Armendariz-Borunda J. Increased DNA binding activity of NF-kappaB, STAT-3, SMAD3 and AP-1 in acutely damaged liver. World J. Gastroenterol. 12: 5995-6001 (2006). *

• Salimi S, Firoozrai M, Nourmohammadi I, Shabani M, Mohebbi A. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J. Med. Res. 124: 683-688 (2006).

• Sanchez Y, de Dios Rosado J, Vega L, Elizondo G, Estrada-Muniz E, Saavedra R, Juarez I, Rodriguez-Sosa M. The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis. J. Biomed. Biotechnol. 2010: 505694 (2010). *

• Sanchez-Fidalgo S, Cardeno A, Villegas I, Talero E, la Lastra CA. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur. J. Pharmacol. Feb 1 [Epub ahead of print] (2010). *

• Sand E, Themner-Persson A, Ekblad E. Mast cells reduce survival of myenteric neurons in culture. Neuropharmacology 56: 522-530 (2009).

• Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189: 241-246 (2006).

• Sangiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 24: 87-138 (2005).

• Santucci L, Wallace J, Mencarelli A, Farneti S, Morelli A, Fiorucci S. Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis. Gastroenterology 128: 1243-1257 (2005). *

• Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, Gamallo C, Jones EA, Moreno-Otero R. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J. Hepatol. 37: 723-729 (2002). *

• Saraswathy S, Rao NA. Photoreceptor mitochondrial oxidative stress in experimental autoimmune uveitis. Ophthalmic Res. 40: 160-164 (2008).

• Sarban S, Isikan UE, Kocabey Y, Kocyigit A. Relationship between synovial fluid and plasma manganese, arginase, and nitric oxide in patients with rheumatoid arthritis. Biol. Trace Elem. Res. 115: 97-106 (2007).

• Sareila O, Hamalainen M, Nissinen E, Kankaanranta H, Moilanen E. Orazipone inhibits activation of inflammatory transcription factors NF-kappaB and STAT1 and decreases inducible nitric oxide synthase expression and nitric oxide production in response to inflammatory stimuli. J. Pharmacol. Exp. Ther. 324: 858-866 (2008). *

• Sareila O, Korhonen R, Auvinen H, Hamalainen M, Kankaanranta H, Nissinen E, Moilanen E. Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli. Br. J. Pharmacol. 155: 884-895 (2008). *

• Sari I, Kebapcilar L, Alacacioglu A, Bilgir O, Yildiz Y, Taylan A, Yuksel A, Kozaci DL. Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis. Intern. Med. 48: 1363-1368 (2009). *

• Sasaki M, Bharwani S, Jordan P, Elrod JW, Grisham MB, Jackson TH, Lefer DJ, Alexander JS. Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic. Biol. Med. 35: 1679-1687 (2003).

• Sasaki M, Ikeda H, Haga H, Manabe T, Nakanuma Y. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J. Pathol. 205: 451-459 (2005). *

• Sassa MF, Saturi AE, Souza LF, Ribeiro LC, Sgarbi DB, Carlos IZ. Response of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology 128: 301-309 (2009). *

• Saw CL, Huang Y, Kong AN. Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid. Biochem. Pharmacol. 79: 421-430 (2010). *

• Sawa T, Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 14: 91-100 (2006). *

• Scadding G, Scadding GK. Update on the use of nitric oxide as a noninvasive measure of airways inflammation. Rhinology 47: 115-120 (2009).

• Scerbo MJ, Rupil LL, Bibolini MJ, Roth GA, Monferran CG. Protective effect of a synapsin peptide genetically fused to the B subunit of Escherichia coli heat-labile enterotoxin in rat autoimmune encephalomyelitis. J. Neurosci. Res. 87: 2273-2281 (2009).

• Schaer DJ, Alayash AI. Clearance and control mechanisms of hemoglobin from cradle to grave. Antioxid. Redox Signal. Sep 29 [Epub ahead of print] (2009).

• Schliess F, Haussinger D. Hepatic encephalopathy and nitric oxide. J. Hepatol. 34: 610-612 (2001). *

• Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, Hammock BD. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc. Natl. Acad. Sci. U.S.A. 102: 9772-9777 (2005). *

• Schnorr O, Schuier M, Kagemann G, Wolf R, Walz M, Ruzicka T, Mayatepek E, Laryea M, Suschek CV, Kolb-Bachofen V, Sies H. Arginase-1 overexpression induces cationic amino acid transporter-1 in psoriasis. Free Radic. Biol. Med. 38: 1073-1079 (2005).

• Schopfer FJ, Lin Y, Baker PR, Cui T, Garcia-Barrio M, Zhang J, Chen K, Chen YE, Freeman BA. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl. Acad. Sci. U.S.A. 102: 2340-2345 (2005). *

• Schrader M, Fahimi HD. Mammalian peroxisomes and reactive oxygen species. Histochem. Cell Biol. 122: 383-393 (2004).

• Schreiber S. The complicated path to true causes of disease: role of nuclear factor kappaB in inflammatory bowel disease. Gut 54: 444-445 (2005). *

• Schubert ML. Gastric secretion. Curr. Opin. Gastroenterol. 23: 595-601 (2007).

• Schubert R, Kitz R, Beermann C, Rose MA, Lieb A, Sommerer PC, Moskovits J, Alberternst H, Bohles HJ, Schulze J, Zielen S. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int. Arch. Allergy Immunol. 148: 321-329 (2008).

• Schuller-Levis G, Gordon RE, Wang C, Park SY, Park E. Protection of bleomycin-induced fibrosis and inflammation by taurine. Int. Immunopharmacol. 9: 971-977 (2009).

• Schuppan D, Jia JD, Brinkhaus B, Hahn EG. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 30: 1099-1104 (1999). *

• Schwacha MG, Thobe BM, Daniel T, Hubbard WJ. Impact of thermal injury on wound infiltration and the dermal inflammatory response. J. Surg. Res. 158: 112-120 (2010). *

• Seguin-Devaux C, Devaux Y, Latger-Cannard V, Grosjean S, Rochette-Egly C, Zannad F, Meistelman C, Mertes PM, Longrois D. Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo. Am. J. Physiol. Endocrinol. Metab. 283: E525-E535 (2002). *

• Seguin-Devaux C, Hanriot D, Dailloux M, Latger-Cannard V, Zannad F, Mertes PM, Longrois D, Devaux Y. Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression. Mol. Cell. Endocrinol. 245: 67-76 (2005).

• Selcoki Y, Uz E, Bayrak R, Sahin S, Kaya A, Uz B, Karanfil A, Ozkara A, Akcay A. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats. Toxicology 239: 53-59 (2007). *

• Selimoglu MA, Ertekin V, Turkan Y, Akcay F. Serum nitric oxide levels in children with Wilson's disease. Int. J. Clin. Pract. 61: 1530-1534 (2007).

• Selmi C, Zuin M, Biondi ML, Invernizzi P, Battezzati PM, Bernini M, Meda F, Gershwin ME, Podda M. Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity. J. Gastroenterol. Hepatol. 18: 1150-1155 (2003). *

• Selvaraj RK, Klasing KC. Lutein and eicosapentaenoic acid interact to modify iNOS mRNA levels through the PPARgamma/RXR pathway in chickens and HD11 cell lines. J. Nutr. 136: 1610-1616 (2006). *

• Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, Jalan R. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl. 10: 1109-1119 (2004). *

• Seo SK, Jeong HY, Park SG, Lee SW, Choi IW, Chen L, Choi I. Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection. Immunology 123: 90-99 (2008). *

• Seril DN, Liao J, Yang GY. Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis. Mol. Carcinog. 46: 341-353 (2007). *

• Serio KJ, Luo C, Luo L, Mao JT. TNFalpha downregulates the leukotriene C4 synthase gene in mononuclear phagocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L215-L222 (2007). *

• Serrano NC, Paez C, Correa PA, Anaya JM. Endothelial nitric oxide synthase gene polymorphism is associated with systemic lupus erythematosus. J. Rheumatol. 31: 2163-2168 (2004).

• Servetnyk Z, Krjukova J, Gaston B, Zaman K, Hjelte L, Roomans GM, Dragomir A. Activation of delF508 CFTR in CF airway epithelial cell lines and CF nasal epithelial cells by S-nitrosoglutathione. Respir. Res. 7: 124 (2006). *

• Seto SW, Lam TY, Leung GP, Au AL, Ngai SM, Chan SW, Kwan YW. Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice. Eur. J. Pharmacol. 572: 40-48 (2007).

• Sezer E, Ozugurlu F, Ozyurt H, Sahin S, Etikan I. Lipid peroxidation and antioxidant status in lichen planus. Clin. Exp. Dermatol. 32: 430-434 (2007). *

• Sha Y, Pandit L, Zeng S, Eissa NT. A critical role for CHIP in the aggresome pathway. Mol. Cell. Biol. 29: 116-128 (2009). *

• Shah V. Molecular mechanisms in the pathogenesis of cirrhotic portal hypertension: focus on nitric oxide. J. Gastroenterol. Hepatol. 19: S145-S149 (2004). *

• Shahid M, Francis J, Majid DS. Tumor necrosis factor-alpha induces renal vasoconstriction as well as natriuresis in mice. Am. J. Physiol. Renal Physiol. 295: F1836-F1844 (2008). *

• Shale M, Kaplan GG, Panaccione R, Ghosh S. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut 58: 737-741 (2009). *

• Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J. Biol. Chem. 273: 27467-27473 (1998). *

• Shao DZ, Lin M. Platonin inhibits LPS-induced NF-kappaB by preventing activation of Akt and IKKbeta in human PBMC. Inflamm. Res. 57: 601-606 (2008). *

• Sharma NS, Wallenstein EJ, Novik E, Maguire T, Schloss R, Yarmush ML. Enrichment of hepatocyte-like cells with upregulated metabolic and differentiated function derived from embryonic stem cells using S-nitrosoacetylpenicillamine. Tissue Eng. Part C. Methods 15: 297-306 (2009).

• Sharma P, Kumar S, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis. 5: 1 (2006). *

• Sharma R, Li DZ. Role of dendritic cells in atherosclerosis. Asian Cardiovasc. Thorac. Ann. 14: 166-169 (2006).

• Sharma S, Jaffe A, Dixon G. Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis. Paediatr. Drugs 9: 107-118 (2007).

• Sharma S, Sharma M, Bose M. Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells. Immunol. Cell Biol. 87: 226-234 (2009). *

• Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J. Hepatol. 40: 247-254 (2004). *

• Shen CL, Peterson J, Tatum OL, Dunn DM. Effect of long-chain n-3 polyunsaturated fatty acid on inflammation mediators during osteoblastogenesis. J. Med. Food 11: 105-110 (2008).

• Shen Z, Chen L, Hao F, Wu J. Transcriptional regulation of Foxp3 gene: multiple signal pathways on the road. Med. Res. Rev. 29: 742-766 (2009).

• Sheu JR, Fong TH, Liu CM, Shen MY, Chen TL, Chang Y, Lu MS, Hsiao G. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br. J. Pharmacol. 143: 193-201 (2004). *

• Shi D, Das J, Das G. Inflammatory bowel disease requires the interplay between innate and adaptive immune signals. Cell Res. 16: 70-74 (2006). *

• Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S, Rachmilewitz D. Variable response to probiotics in two models of experimental colitis in rats. Inflamm. Bowel Dis. 8: 399-406 (2002). *

• Shimada K, Okabe TA, Mikami Y, Hattori M, Fujita M, Kishimoto C. Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide. J. Mol. Cell. Cardiol. Feb 16 [Epub ahead of print] (2010).

• Shin EK, Kwon HS, Kim YH, Shin HK, Kim JK. Chrysin, a natural flavone, improves murine inflammatory bowel diseases. Biochem. Biophys. Res. Commun. 381: 502-507 (2009). *

• Shin H, Mally M, Kuhn M, Paroz C, Cornelis GR. Escape from immune surveillance by Capnocytophaga canimorsus. J. Infect. Dis. 195: 375-386 (2007). *

• Shin SJ, Lim JH, Chung S, Youn DY, Chung HW, Kim HW, Lee JH, Chang YS, Park CW. Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats. Hypertens. Res. 32: 835-845 (2009).

• Shintani T, Iwabuchi T, Soga T, Kato Y, Yamamoto T, Takano N, Hishiki T, Ueno Y, Ikeda S, Sakuragawa T, Ishikawa K, Goda N, Kitagawa Y, Kajimura M, Matsumoto K, Suematsu M. Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion. Hepatology 49: 141-150 (2009). *

• Shuto Y, Kataoka M, Higuchi Y, Matsuura K, Hijiya N, Yamamoto S. Roles of CD14 in LPS-induced liver injury and lethality in mice pretreated with Propionibacterium acnes. Immunol. Lett. 94: 47-55 (2004).

• Siegmund B, Sennello JA, Lehr HA, Senaldi G, Dinarello CA, Fantuzzi G. Interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR gamma delta T cells and interleukin-18-binding protein. Eur. J. Immunol. 34: 2356-2364 (2004). *

• Signorello MG, Segantin A, Passalacqua M, Leoncini G. Homocysteine decreases platelet NO level via protein kinase C activation. Nitric Oxide 20: 104-113 (2009).

• Sikiric P, Seiwerth S, Brcic L, Blagaic AB, Zoricic I, Sever M, Klicek R, Radic B, Keller N, Sipos K, Jakir A, Udovicic M, Tonkic A, Kokic N, Turkovic B, Mise S, Anic T. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response. Inflammopharmacology 14: 214-221 (2006).

• Silva MS, Sanchez-Fidalgo S, Talero E, Cardeno A, Silva MA, Villegas W, Brito AR, Lastra CA. Antiinflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in Tnbs colitis model. J. Ethnopharmacol. Jan 15 [Epub ahead of print] (2010).

• Silveira MG, Torok NJ, Gossard AA, Keach JC, Jorgensen RA, Petz JL, Lindor KD. Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study. Am. J. Gastroenterol. 104: 83-88 (2009). *

• Silvestri M, Bontempelli M, Giacomelli M, Malerba M, Rossi GA, Di Stefano A, Rossi A, Ricciardolo FL. High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation? Clin. Exp. Allergy 36: 1373-1381 (2006). *

• Simka M, Rybak Z. Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. Med. Hypotheses 71: 293-297 (2008).

• Simon R, Samuel CE. Innate interferon response in macrophage and epithelial cells infected with wild-type compared to DNA adenine methylase and flagellin mutant Salmonella enterica serovar Typhimurium. J. Interferon Cytokine Res. 27: 317-328 (2007).

• Sin JI. Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression. Immunology 128: e707-e717 (2009).

• Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306 (1998). *

• Singh AK, Jiang Y, Gupta S. Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation. Toxicol. Mech. Methods. 17: 331-347 (2007).

• Singh D, Aggarwal A, Maurya R, Naik S. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytother. Res. 21: 905-913 (2007). *

• Singh K, Chaturvedi R, Asim M, Barry DP, Lewis ND, Vitek MP, Wilson KT. The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappa B activation. J. Biol. Chem. 283: 16752-16761 (2008). *

• Singh R, Manjunatha U, Boshoff HI, Ha YH, Niyomrattanakit P, Ledwidge R, Dowd CS, Lee IY, Kim P, Zhang L, Kang S, Keller TH, Jiricek J, Barry CE 3rd. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322: 1392-1395 (2008). *

• Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41: 5-15 (2005). *

• Siroen MP, van der Sijp JR, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PA. The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 41: 559-565 (2005). *

• Siroen MP, Warle MC, Teerlink T, Nijveldt RJ, Kuipers EJ, Metselaar HJ, Tilanus HW, Kuik DJ, van der Sijp JR, Meijer S, van der Hoven B, van Leeuwen PA. The transplanted liver graft is capable of clearing asymmetric dimethylarginine. Liver Transpl. 10: 1524-1530 (2004). *

• Sixt S, Beer S, Bluher M, Korff N, Peschel T, Sonnabend M, Teupser D, Thiery J, Adams V, Schuler G, Niebauer J. Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur. Heart J. Sep 30 [Epub ahead of print] (2009).

• Skinn AC, Macnaughton WK. Nitric oxide inhibits cyclic AMP-dependent CFTR trafficking in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G739-G744 (2005). *

• Skrzypek F, Cenci E, Pietrella D, Rachini A, Bistoni F, Vecchiarelli A. Dectin-1 is required for human dendritic cells to initiate immune response to Candida albicans through Syk activation. Microbes Infect. 11: 661-670 (2009). *

• Sloka JS, Stefanelli M. The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult. Scler. 11: 425-432 (2005). *

• Smeets RL, Veenbergen S, Arntz OJ, Bennink MB, Joosten LA, van den Berg WB, van de Loo FA. A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. Arthritis Rheum. 54: 1518-1528 (2006). *

• Smerud HK, Fellstrom B, Hallgren R, Osagie S, Venge P, Kristjansson G. Gluten sensitivity in patients with IgA nephropathy. Nephrol. Dial. Transplant. 24: 2476-2481 (2009).

• Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. 352: 2163-2173 (2005). *

• Smith JR, Rosenbaum JT, Williams KA. Experimental melanin-induced uveitis: experimental model of human acute anterior uveitis. Ophthalmic Res. 40: 136-140 (2008).

• Smith KJ. Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathol. 17: 230-242 (2007). *

• Sodhi A, Tarang S, Kesherwani V. Concanavalin A induced expression of Toll-like receptors in murine peritoneal macrophages in vitro. Int. Immunopharmacol. 7: 454-463 (2007).

• Song BJ, Moon KH, Olsson NU, Salem N Jr. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J. Hepatol. 49: 262-273 (2008).

• Soon RK, Yee HF Jr. Stellate cell contraction: role, regulation, and potential therapeutic target. Clin. Liver Dis. 12: 791-803, viii (2008).

• Southey A, Tanaka S, Murakami T, Miyoshi H, Ishizuka T, Sugiura M, Kawashima K, Sugita T. Pathophysiological role of nitric oxide in rat experimental colitis. Int. J. Immunopharmacol. 19: 669-676 (1997).

• Souza MH, Lemos HP, Oliveira RB, Cunha FQ. Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice. Gut 53: 791-796 (2004). *

• Spanier AJ, Kahn RS, Hornung RW, Wang N, Sun G, Lierl MB, Lanphear BP. Environmental exposures, nitric oxide synthase genes, and exhaled nitric oxide in asthmatic children. Pediatr. Pulmonol. 44: 812-819 (2009).

• Spencer HL, Daniels I, Shortland J, Long RG, Murray IA. Effect of a gluten-free diet on plasma nitric oxide products in coeliac disease. Scand. J. Gastroenterol. 39: 941-945 (2004). *

• Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, Berry D, Steward W, Dennison A. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur. J. Cancer 45: 2077-2086 (2009). *

• Spirli C, Fabris L, Duner E, Fiorotto R, Ballardini G, Roskams T, LaRusso NF, Sonzogni A, Okolicsanyi L, Strazzabosco M. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology 124: 737-753 (2003). *

• Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ, Perretti M, Serhan CN. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461: 1287-1291 (2009). *

• Staines DR. Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides? Med. Hypotheses 70: 413-418 (2008).

• Stanley AC, Dalton JE, Rossotti SH, Macdonald KP, Zhou Y, Rivera F, Schroder WA, Maroof A, Hill GR, Kaye PM, Engwerda CR. VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog. 4: e1000158 (2008). *

• Steer SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med. 3: e17 (2006). *

• Stefanakis N, Ziroyiannis P, Trygonis S, Lamnissou K. Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease. Nephron. Clin. Pract. 110: c101-c106 (2008).

• Stein RB, Lichtenstein GR, Rombeau JL. Nutrition in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 2: 367-371 (1999).

• Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu. Rev. Nutr. 24: 539-577 (2004). *

• Stoffels B, Schmidt J, Nakao A, Nazir A, Chanthaphavong RS, Bauer AJ. Role of interleukin 10 in murine postoperative ileus. Gut 58: 648-660 (2009).

• Storm van's Gravesande K, Omran H. Primary ciliary dyskinesia: clinical presentation, diagnosis and genetics. Ann. Med. 37: 439-449 (2005).

• Stosic-Grujicic S, Cvjeticanin T, Stojanovic I. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice. Mol. Immunol. 47: 79-86 (2009). *

• Struben VM, Sewbalak WV, Wieringa MH, Mantingh CJ, van den Toorn LM, Bakker M, Feenstra L, de Jongste JC. Nasal nitric oxide in cystic fibrosis with and without humming. Eur. J. Clin. Invest. 37: 140-144 (2007). *

• Su L, Sun Y, Ma F, Lu P, Huang H, Zhou J. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol. Lett. 125: 151-155 (2009).

• Suarez I, Bodega G, Fernandez B. Glutamine synthetase in brain: effect of ammonia. Neurochem. Int. 41: 123-142 (2002).

• Sue YM, Chung CP, Lin H, Chau Y, Jen CY, Li HF, Chang CC, Juan SH. PPARdelta-mediated p21/p27 induction via increased CBP nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells. Am. J. Physiol. Cell Physiol. 297: C321-C329 (2009). *

• Suetsugu H, Iimuro Y, Uehara T, Nishio T, Harada N, Yoshida M, Hatano E, Son G, Fujimoto J, Yamaoka Y. Nuclear factor kappaB inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury. Gut 54: 835-842 (2005). *

• Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P, Sundaresan P. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol. Vis. 12: 336-341 (2006). *

• Sugiyama A, Sato A, Shimizu H, Ando K, Takeuchi T. PEGylated lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in rats. J. Vet. Med. Sci. Nov 27 [Epub ahead of print] (2009).

• Suh HS, Zhao ML, Rivieccio M, Choi S, Connolly E, Zhao Y, Takikawa O, Brosnan CF, Lee SC. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response. J. Virol. 81: 9838-9850 (2007). *

• Suh N, Wang Y, Honda T, Gribble GW, Dmitrovsky E, Hickey WF, Maue RA, Place AE, Porter DM, Spinella MJ, Williams CR, Wu G, Dannenberg AJ, Flanders KC, Letterio JJ, Mangelsdorf DJ, Nathan CF, Nguyen L, Porter WW, Ren RF, Roberts AB, Roche NS, et al. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res. 59: 336-341 (1999). *

• Suliburk JW, Ward JL, Helmer KS, Adams SD, Zuckerbraun BS, Mercer DW. Ketamine induced hepatoprotection: the role of heme oxygenase-1. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G1360-G1369 (2009). *

• Sulikowska B, Czarny J, Rosc D, Odrowaz-Sypniewska G, Manitius J, Sliwka DM. Some metabolic and genetic risk factors and the progression of IgA nephropathy - preliminary report. Pol. Merkur. Lekarski. 21: 132-135 (2006).

• Sun BW, Sun Y, Sun ZW, Chen X. CO liberated from CORM-2 modulates the inflammatory response in the liver of thermally injured mice. World J. Gastroenterol. 14: 547-553 (2008). *

• Sun L, Ke Y, Zhu CY, Tang N, Tian DK, Gao YH, Zheng JP, Bian K. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats. Chin. Med. J. (Engl.) 121: 2305-2311 (2008).

• Sun WY, Wei W, Gui SY, Wu L, Wang H. Protective effect of extract from Paeonia lactiflora and Astragalus membranaceus against liver injury induced by bacillus Calmette-Guérin and lipopolysaccharide in mice. Basic Clin. Pharmacol. Toxicol. 103: 143-149 (2008).

• Sung B, Park S, Yu BP, Chung HY. Amelioration of age-related inflammation and oxidative stress by PPARgamma activator: suppression of NF-kappaB by 2,4-thiazolidinedione. Exp. Gerontol. 41: 590-599 (2006). *

• Sung TS, La JH, Kim TW, Yang IS. Alteration of nitrergic neuromuscular transmission as a result of acute experimental colitis in rat. J. Vet. Sci. 7: 143-150 (2006). *

• Suri R, Paraskakis E, Bush A. Alveolar, but not bronchial nitric oxide production is elevated in cystic fibrosis. Pediatr. Pulmonol. 42: 1215-1221 (2007).

• Suschek CV, Schnorr O, Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? Curr. Mol. Med. 4: 763-775 (2004).

• Susick L, Senanayake T, Veluthakal R, Woster PM, Kowluru A. A novel histone deacetylase inhibitor prevents IL-1beta induced metabolic dysfunction in pancreatic beta-cells. J. Cell. Mol. Med. 13: 1877-1885 (2009). *

• Suzuki E, Umezawa K. Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Biomed. Pharmacother. 60: 578-586 (2006).

• Svec J, Musílkova J, Bryndova J, Jirasek T, Mandys V, Kment M, Pacha J. Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia. Inflamm. Bowel Dis. Dec 21 [Epub ahead of print] (2009).

• Swamy MV, Citineni B, Patlolla JM, Mohammed A, Zhang Y, Rao CV. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr. Cancer 60 Suppl. 1: 81-89 (2008).

• Szabo GV, Kunstar A, Acsady G. Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes. Pathol. Oncol. Res. 15: 631-637 (2009).

• Szelenyi J, Selmeczy Z, Brozik A, Medgyesi D, Magocsi M. Dual beta-adrenergic modulation in the immune system: stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochem. Int. 49: 94-103 (2006).

• Tadokoro CE, Vallochi AL, Rios LS, Martins GA, Schlesinger D, Mosca T, Kuchroo VK, Rizzo LV, Abrahamsohn IA. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi. J. Autoimmun. 23: 103-115 (2004).

• Tagkalidis PP, Gibson P, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J. Clin. Pathol. 60: 382-387 (2007). *

• Taimr P. Fibrogenesis, hepatic stellate cells and immune system. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 26. September 12 - 13 (2003). *

• Takagi T, Naito Y, Tomatsuri N, Handa O, Ichikawa H, Yoshida N, Yoshikawa T. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade. Redox. Rep. 7: 283-289 (2002). *

• Takahashi N, de Jager VC, Gluck A, Letzkus M, Hartmann N, Staedtler F, Ribeiro-Dias F, Heuvelmans-Jacobs M, van den Berg WB, Joosten LA. The molecular signature of oxidative metabolism and the mode of macrophage activation determine the shift from acute to chronic disease in experimental arthritis: critical role of interleukin-12p40. Arthritis Rheum. 58: 3471-3484 (2008). *

• Takahashi N, Vanlaere I, de Rycke R, Cauwels A, Joosten LA, Lubberts E, van den Berg WB, Libert C. IL-17 produced by Paneth cells drives TNF-induced shock. J. Exp. Med. 205: 1755-1761 (2008). *

• Takahashi T, Ono H, Ono Y, Ishimitsu T, Matsuoka H. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). Int. Heart J. 48: 637-647 (2007).

• Talero E, Sanchez-Fidalgo S, Calvo JR, Motilva V. Chronic administration of galanin attenuates the TNBS-induced colitis in rats. Regul. Pept. 141: 96-104 (2007).

• Tan BH, Wong PT, Bian JS. Hydrogen sulphide: a novel signaling molecule in the central nervous system. Neurochem. Int. Aug 21 [Epub ahead of print] (2009).

• Tanaka H, Uchida Y, Kaibori M, Hijikawa T, Ishizaki M, Yamada M, Matsui K, Ozaki T, Tokuhara K, Kamiyama Y, Nishizawa M, Ito S, Okumura T. Na+/H+ exchanger inhibitor, FR183998, has protective effect in lethal acute liver failure and prevents iNOS induction in rats. J. Hepatol. 48: 289-299 (2008).

• Tani C, Mosca M, d'Ascanio A, Versari D, Virdis A, Ghiadoni L, Taddei S, Salvetti A, Bombardieri S. Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. Reumatismo 58: 212-218 (2006).

• Tappaz ML. Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem. Res. 29: 83-96 (2004). *

• Tarkowski A. Infectious arthritis. Best Pract. Res. Clin. Rheumatol. 20: 1029-1044 (2006).

• Tattoli I, Travassos LH, Carneiro LA, Magalhaes JG, Girardin SE. The nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin. Immunopathol. 29: 289-301 (2007). *

• Tavakoli S, Hajrasouliha AR, Jabehdar-Maralani P, Ebrahimi F, Sadeghipour H, Dehghani M, Shafaroodi H, Dehpour AR. Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide. Eur. J. Pharmacol. 542: 148-153 (2006). *

• Taysi S, Sari RA, Dursun H, Yilmaz A, Keles M, Cayir K, Akyuz M, Uyanik A, Guvenc A. Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease. Clin. Rheumatol. 27: 1529-1534 (2008). *

• Tazi KA, Barriere E, Moreau R, Heller J, Sogni P, Pateron D, Poirel O, Lebrec D. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 122: 1869-1877 (2002). *

• Tazi KA, Barriere E, Moreau R, Poirel O, Lebrec D. Relationship between protein kinase C alterations and nitric oxide overproduction in cirrhotic rat aortas. Liver 22: 178-183 (2002).

• Tegenge MA, Bicker G. Nitric oxide and cyclic GMP signal transduction positively regulates the motility of human neuronal precursor (NT2) cells. J. Neurochem. 110: 1828-1841 (2009).

• Teissier E, Nohara A, Chinetti G, Paumelle R, Cariou B, Fruchart JC, Brandes R, Shah A, Staels B. Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties. Circ. Res. 95: 1174-1182 (2004). *

• Teixeira-Salum TB, Rodrigues DB, Gervasio AM, Souza CJ, Rodrigues Jr V, Loyola AM. Distinct Th1, Th2 and Treg cytokines balance in chronic periapical granulomas and radicular cysts. J. Oral Pathol. Med. Jan 21 [Epub ahead of print] (2010).

• Tessarolli V, Gasparoto TH, Lima HR, Figueira EA, Garlet TP, Torres SA, Garlet GP, Da Silva JS, Campanelli AP. Absence of TLR2 influences survival of neutrophils after infection with Candida albicans. Med. Mycol. May 25 [Epub ahead of print] (2009).

• Tesse A, Al-Massarani G, Wangensteen R, Reitenbach S, Martinez MC, Andriantsitohaina R. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins. J. Pharmacol. Exp. Ther. 324: 539-547 (2008). *

• Texereau J, Fajac I, Hubert D, Coste J, Dusser DJ, Bienvenu T, Dall'ava-Santucci J, Dinh-Xuan AT. Reduced exhaled NO is related to impaired nasal potential difference in patients with cystic fibrosis. Vascul. Pharmacol. 43: 385-389 (2005). *

• Texereau J, Marullo S, Hubert D, Coste J, Dusser DJ, Dall'Ava-Santucci J, Dinh-Xuan AT. Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Thorax 59: 156-158 (2004). *

• Thalheimer U, Triantos C, Samonakis D, Patch D, Burroughs AK, Riddell A, Perry D. Endogenous heparinoids in acute variceal bleeding. Gut 54: 310-311 (2005). *

• Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, Sullivan ME, Dole W, Rutledge JC. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol. Genomics 11: 21-30 (2002). *

• Thomas GL, Bohner CM, Williams HE, Walsh CM, Ladlow M, Welch M, Bryant CE, Spring DR. Immunomodulatory effects of Pseudomonas aeruginosa quorum sensing small molecule probes on mammalian macrophages. Mol. Biosyst. 2: 132-137 (2006). *

• Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 117: 1085-1089 (2000). *

• Tian J, Kim SF, Hester L, Snyder SH. S-Nitrosylation/activation of COX-2 mediates NMDA neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 105: 10537-10540 (2008). *

• Tilg H, van Montfrans C, van den Ende A, Kaser A, van Deventer SJ, Schreiber S, Gregor M, Ludwiczek O, Rutgeerts P, Gasche C, Koningsberger JC, Abreu L, Kuhn I, Cohard M, LeBeaut A, Grint P, Weiss G. Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 50: 191-195 (2002). *

• Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TY, Fung ML, Nanji AA. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol. Histopathol. 24: 1161-1169 (2009). *

• Tisdale MJ. Cancer cachexia. Curr. Opin. Gastroenterol. Nov 13 [Epub ahead of print] (2009).

• Tiwari RL, Singh V, Barthwal MK. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med. Res. Rev. 28: 483-544 (2007). *

• Tjarnlund A, Rodriguez A, Cardona PJ, Guirado E, Ivanyi J, Singh M, Troye-Blomberg M, Fernandez C. Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice. Int. Immunol. 18: 807-816 (2006). *

• Toell A, Kroncke KD, Kleinert H, Carlberg C. Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands. J. Cell. Biochem. 85: 72-82 (2002). *

• Tomiyama K, Ikeda A, Ueki S, Nakao A, Stolz DB, Koike Y, Afrazi A, Gandhi C, Tokita D, Geller DA, Murase N. Inhibition of Kupffer cell-mediated early proinflammatory response with carbon monoxide in transplant-induced hepatic ischemia/reperfusion injury in rats. Hepatology 48: 1608-1620 (2008). *

• Tong L, Moudgil KD. Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Res. Ther. 9: R70 (2007). *

• Tong X, Zheng S, Jin J, Zhu L, Lou Y, Yao H. Triptolide inhibits cyclooxygenase-2 and inducible nitric oxide synthase expression in human colon cancer and leukemia cells. Acta Biochim. Biophys. Sin. (Shanghai) 39: 89-95 (2007). *

• Tonini M, Vicini R, Cervio E, De Ponti F, De Giorgio R, Barbara G, Stanghellini V, Dellabianca A, Sternini C. 5-HT(7) receptors modulate peristalsis and accommodation in the guinea pig ileum. Gastroenterology 129: 1557-1566 (2005). *

• Tontonoz P, Nagy L. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease. Curr. Opin. Lipidol. 10: 485-490 (1999).

• Torer N, Ozenirler S, Yucel A, Bukan N, Erdem O. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. Scand. J. Gastroenterol. 42: 1095-1101 (2007). *

• Trajkovic V, Stosic-Grujicic S, Samardzic T, Markovic M, Miljkovic D, Ramic Z, Mostarica Stojkovic M. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol. 119: 183-191 (2001).

• Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 20: 220-230 (2004). *

• Trauner M, Nathanson MH, Rydberg SA, Koeppel TA, Gartung C, Sessa WC, Boyer JL. Endotoxin impairs biliary glutathione and HCO3- excretion and blocks the choleretic effect of nitric oxide in rat liver. Hepatology 25: 1184-1191 (1997). *

• Travis SP, Jewell DP. Salicylates for ulcerative colitis - their mode of action. Pharmacol. Ther. 63: 135-161 (1994).

• Trebicka J, Hennenberg M, Laleman W, Shelest N, Biecker E, Schepke M, Nevens F, Sauerbruch T, Heller J. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology 46: 242-253 (2007). *

• Trebicka J, Hennenberg M, Schulze Probsting A, Laleman W, Klein S, Granzow M, Nevens F, Zaagsma J, Heller J, Sauerbruch T. Role of beta(3)-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis. Hepatology 50: 1924-1935 (2009).

• Treiber G, Csepregi A, Malfertheiner P. The pathophysiology of portal hypertension. Dig. Dis. 23: 6-10 (2005).

• Trepicchio WL, Dorner AJ. The therapeutic utility of interleukin-11 in the treatment of inflammatory disease. Expert Opin. Investig. Drugs 7: 1501-1504 (1998).

• Trepicchio WL, Wang L, Bozza M, Dorner AJ. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J. Immunol. 159: 5661-5670 (1997).

• Tripathi P. Nitric oxide and immune response. Indian J. Biochem. Biophys. 44: 310-319 (2007).

• Tripathi P, Tripathi P, Kashyap L, Singh V. The role of nitric oxide in inflammatory reactions. FEMS Immunol. Med. Microbiol. 51: 443-452 (2007). *

• Trombone AP, Ferreira Jr SB, Raimundo FM, de Moura KC, Avila-Campos MJ, Silva JS, Campanelli AP, De Franco M, Garlet GP. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. J. Periodontal Res. 44: 443-451 (2009).

• Tsoi VL, Hill KE, Carlson NG, Warner JE, Rose JW. Immunohistochemical evidence of inducible nitric oxide synthase and nitrotyrosine in a case of clinically isolated optic neuritis. J. Neuroophthalmol. 26: 87-94 (2006).

• Tsotsonava T, Virsaladze D, Khitarishvili K, Sanikidze T, Tananashvili D. Comparative analysis of blood redox parameters according thyroid function of patients with autoimmune thyroid diseases. Georgian Med. News 146: 32-34 (2007).

• Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Tanoue K, Sugimachi K. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model. Scand. J. Gastroenterol. 35: 1097-1105 (2000). *

• Tsuhako MH, Augusto O, Linares E, Chadi G, Giorgio S, Pereira CA. Tempol ameliorates murine viral encephalomyelitis by preserving the blood-brain barrier, reducing viral load and lessening inflammation. Free Radic. Biol. Med. Dec 22 [Epub ahead of print] (2009).

• Tsuji K, Kwon AH, Yoshida H, Qiu Z, Kaibori M, Okumura T, Kamiyama Y. Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats. J. Hepatol. 42: 94-101 (2005). *

• Tuckova L, Flegelova Z, Tlaskalova-Hogenova H, Zidek Z. Activation of macrophages by food antigens: enhancing effect of gluten on nitric oxide and cytokine production. J. Leukoc. Biol. 67: 312-318 (2000). *

• Tuin A, Huizinga-Van der Vlag A, van Loenen-Weemaes AM, Meijer DK, Poelstra K. On the role and fate of LPS-dephosphorylating activity in the rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G377-G385 (2006). *

• Tumurkhuu G, Koide N, Hiwasa T, Ookoshi M, Dagvadorj J, Noman AS, Iftakhar-E-Khuda I, Naiki Y, Komatsu T, Yoshida T, Yokochi T. ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production and protects mice from lethal endotoxic shock. Innate Immun. Dec 18 [Epub ahead of print] (2009).

• Turnbull CM, Marcarino P, Sheldrake TA, Lazzarato L, Cena C, Fruttero R, Gasco A, Fox S, Megson IL, Rossi AG. A novel hybrid aspirin-NO-releasing compound inhibits TNF-alpha release from LPS-activated human monocytes and macrophages. J. Inflamm. (Lond.) 5: 12 (2008). *

• Tuygun AK, Keser M, Tuygun A, Ketenci B, Sensoz Y, Balci AY, Karaci AR, Kizilay M, Yurtseven N, Yekeler I. Effects of endothelial nitric oxide synthase, interleukin-6 gene polymorphisms and asymmetric dimethylarginine levels on risk factors and lesion sites in peripheral artery disease. J. Int. Med. Res. 37: 1003-1010 (2009).

• Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Nawata H. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells. Hepatology 33: 91-99 (2001). *

• Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA. S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517 (2006). *

• Ueyama J, Kitaichi K, Nadai M, Iwase M, Tomyo N, Kanazawa H, Suzuki R, Takagi K, Takagi K, Hasegawa T. Effect of pioglitazone on endotoxin-induced decreases in hepatic drug-metabolizing enzyme activity and expression of CYP3A2 and CYP2C11. Eur. J. Pharmacol. 498: 257-265 (2004). *

• Ueyama J, Nadai M, Zhao YL, Kanazawa H, Takagi K, Kondo T, Takagi K, Wakusawa S, Abe F, Saito H, Miyamoto K, Hasegawa T. Effect of thalidomide on endotoxin-induced decreases in activity and expression of hepatic cytochrome P450 3A2. Biol. Pharm. Bull. 31: 1596-1600 (2008). *

• Uhm WS, Lee HS, Chung YH, Kim TH, Bae SC, Joo KB, Kim TY, Yoo DH. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus 11: 227-233 (2002).

• Ulrich S, Hersberger M, Fischler M, Nussbaumer-Ochsner Y, Treder U, Russi EW, Speich R. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease. Respiration Jun 24 [Epub ahead of print] (2009).

• Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13: 1185-1192 (2007). *

• Uppington H, Menager N, Boross P, Wood J, Sheppard M, Verbeek S, Mastroeni P. Effect of immune serum and role of individual Fcgamma receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages. Immunology 119: 147-158 (2006). *

• Urtasun R, de la Rosa LC, Nieto N. Oxidative and nitrosative stress and fibrogenic response. Clin. Liver Dis. 12: 769-790, viii (2008).

• Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran M. Versatile effects of sildenafil: recent pharmacological applications. Pharmacol. Rep. 59: 150-163 (2007). *

• Vafeiadou K, Vauzour D, Spencer JP. Neuroinflammation and its modulation by flavonoids. Endocr. Metab. Immune Disord. Drug Targets 7: 211-224 (2007).

• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 39: 44-84 (2007). *

• Vallance BA, Dijkstra G, Qiu B, van der Waaij LA, van Goor H, Jansen PL, Mashimo H, Collins SM. Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G865-G874 (2004). *

• Valles SL, Dolz-Gaiton P, Gambini J, Pallardo FV, Vina J. Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARgamma expression in cultured astrocytes. Brain Res. Nov 27 [Epub ahead of print] (2009).

• Van Bezooijen RL, Van Der Wee-Pals L, Papapoulos SE, Lowik CW. Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann. Rheum. Dis. 61: 870-876 (2002). *

• Van Crombruggen K, Van Nassauw L, Demetter P, Cuvelier C, Timmermans JP, Lefebvre RA. Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis. Eur. J. Pharmacol. 579: 337-349 (2008). *

• van der Woude CJ, Kleibeuker JH, Jansen PL, Moshage H. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis 9: 123-130 (2004). *

• van der Woude CJ, Moshage H, Homan M, Kleibeuker JH, Jansen PL, van Dekken H. Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. J. Clin. Pathol. 58: 811-814 (2005). *

• van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J. Hepatol. 24: 747-752 (1996). *

• van Strien ME, Mercier D, Drukarch B, Breve JJ, Poole S, Binnekade R, Bol JG, Blits B, Verhaagen J, van Dam AM. Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages. Gene Ther. Feb 25 [Epub ahead of print] (2010).

• Varade J, Lamas JR, Fernandez-Arquero M, Jover JA, de la Concha EG, Martinez A, Fernandez-Gutierrez B, Urcelay E. No role of NOS2A susceptibility polymorphisms in rheumatoid arthritis. Nitric Oxide 21: 171-174 (2009).

• Vardareli E, Dundar E, Angin K, Saricam T, Inal M. Effects of intrarectal and intraperitoneal N(G)-nitro-L-arginine methyl ester treatment in 2,4,6-trinitrobenzenesulfonic acid induced colitis in rats. Exp. Toxicol. Pathol. 55: 271-276 (2003).

• Varela-Rey M, Fernandez-Ramos D, Martinez-Lopez N, Embade N, Gomez-Santos L, Beraza N, Vazquez-Chantada M, Rodriguez J, Luka Z, Wagner C, Lu SC, Martinez-Chantar ML, Mato JM. Impaired liver regeneration in mice lacking glycine N-methyltransferase. Hepatology 50: 443-452 (2009). *

• Varga G, Erces D, Fazekas B, Fulop M, Kovacs T, Kaszaki J, Fulop F, Vecsei L, Boros M. N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat. Neurogastroenterol. Motil. Sep 3 [Epub ahead of print] (2009).

• Varghese J, Ilias-basha H, Dhanasekaran R, Singh S, Venkataraman J. Hepatopulmonary syndrome - past to present. Ann. Hepatol. 6: 135-142 (2007). *

• Vazgiourakis V, Sidiropoulos P, Bertsias G, Koutsounaki E, Fragouli E, Raptopoulou A, Kritikos H, Boumpas DT, Goulielmos GN. Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population. Lupus 16: 867-874 (2007). *

• Vazquez-Chantada M, Ariz U, Varela-Rey M, Embade N, Martinez-Lopez N, Fernandez-Ramos D, Gomez-Santos L, Lamas S, Lu SC, Martinez-Chantar ML, Mato JM. Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation. Hepatology 49: 608-617 (2009). *

• Vazquez-Gil MJ, Mesonero MJ, Flores O, Criado M, Hidalgo F, Arevalo MA, Sanchez-Rodriguez A, Tunon MJ, Lopez-Novoa JM, Esteller A. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation. Life Sci. 75: 717-732 (2004). *

• Velez DR, Hulme WF, Myers JL, Stryjewski ME, Abbate E, Estevan R, Patillo SG, Gilbert JR, Hamilton CD, Scott WK. Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians. Int. J. Tuberc. Lung Dis. 13: 1068-1076 (2009).

• Venkatraman A, Shiva S, Wigley A, Ulasova E, Chhieng D, Bailey SM, Darley-Usmar VM. The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice. Hepatology 40: 565-573 (2004). *

• Vento P, Kiviluoto T, Jarvinen HJ, Karkkainen P, Kivilaakso E, Soinila S. Expression of inducible and endothelial nitric oxide synthases in pouchitis. Inflamm. Bowel Dis. 7: 120-127 (2001). *

• Venturini J, de Camargo MR, Felix MC, Vilani-Moreno FR, de Arruda MS. Influence of tumour condition on the macrophage activity in Candida albicans infection. Scand. J. Immunol. 70: 10-17 (2009). *

• Vera M, Nieto N. Hepatic stellate cells and alcoholic liver disease. Rev. Esp. Enferm. Dig. 98: 674-684 (2006).

• Vercelino R, Crespo I, de Souza GF, Cuevas MJ, de Oliveira MG, Marroni NP, Gonzalez-Gallego J, Tunon MJ. S-Nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats. J. Mol. Med. Jan 9 [Epub ahead of print] (2010). *

• Verhoef J, Hustinx WM, Frasa H, Hoepelman AI. Issues in the adjunct therapy of severe sepsis. J. Antimicrob. Chemother. 38: 167-182 (1996). *

• Verweij WR, Bentala H, Huizinga-van der Vlag A, Miek van Loenen-Weemaes A, Kooi K, Meijer DK, Poelstra K. Protection against an Escherichia coli-induced sepsis by alkaline phosphatase in mice. Shock 22: 174-179 (2004). *

• Vettor R, Pagano C. The role of the endocannabinoid system in lipogenesis and fatty acid metabolism. Best Pract. Res. Clin. Endocrinol. Metab. 23: 51-63 (2009).

• Videla S, Vilaseca J, Medina C, Mourelle M, Guarner F, Salas A, Malagelada JR. Modulatory effect of nitric oxide on mast cells during induction of dextran sulfate sodium colitis. Dig. Dis. Sci. 52: 45-51 (2007). *

• Vincentini O, Maialetti F, Gazza L, Silano M, Dessi M, De Vincenzi M, Pogna NE. Environmental factors of celiac disease: cytotoxicity of hulled wheat species Triticum monococcum, T. turgidum ssp. dicoccum and T. aestivum ssp. spelta. J. Gastroenterol. Hepatol. 22: 1816-1822 (2007). *

• Virsaladze D, Tsotsonava T, Khitarishvili K, Sanikidze T, Tananashvili D. The status of redox system in patients with Graves' disease. Georgian Med. News 142: 22-25 (2007).

• Voetsch B, Jin RC, Bierl C, Benke KS, Kenet G, Simioni P, Ottaviano F, Damasceno BP, Annichino-Bizacchi JM, Handy DE, Loscalzo J. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene. A novel risk factor for arterial ischemic stroke among young adults and children. Stroke 38: 41-49 (2007). *

• von Knethen A, Soller M, Brune B. Peroxisome proliferator-activated receptor gamma (PPARgamma) and sepsis. Arch. Immunol. Ther. Exp. (Warsz.) 55: 19-25 (2007).

• Vuolteenaho K, Moilanen T, Knowles RG, Moilanen E. The role of nitric oxide in osteoarthritis. Scand. J. Rheumatol. 36: 247-258 (2007). *

• Vuppugalla R, Mehvar R. Hepatic disposition and effects of nitric oxide donors: rapid and concentration-dependent reduction in the cytochrome P450-mediated drug metabolism in isolated perfused rat livers. J. Pharmacol. Exp. Ther. 310: 718-727 (2004). *

• Vural P, Degirmencioglu S, Erden S, Gelincik A. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis. Int. Immunopharmacol. 9: 212-215 (2009).

• Wali RK, Khare S, Tretiakova M, Cohen G, Nguyen L, Hart J, Wang J, Wen M, Ramaswamy A, Joseph L, Sitrin M, Brasitus T, Bissonnette M. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol. Biomarkers Prev. 11: 1653-1662 (2002). *

• Wallace JL. Acetaminophen hepatotoxicity: NO to the rescue. Br. J. Pharmacol. 143: 1-2 (2004). *

• Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schuffer W, Fassbender K. Role of the Toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 20: 947-956 (2007). *

• Walzer N, Hirano I. Achalasia. Gastroenterol. Clin. North Am. 37: 807-825 (2008).

• Wanchu A, Khullar M, Sud K, Sakhuja V, Thennarasu K, Sud A, Bambery P. Serum and urine nitrite and citrulline levels among patients with systemic lupus erythematosus: a possible addition to activity parameters? J. Clin. Rheumatol. 7: 10-15 (2001).

• Wang CH, Lee WJ, Ghanta VK, Wang WT, Cheng SY, Hsueh CM. Molecules involve in the self-protection of neurons against glucose-oxygen-serum deprivation (GOSD)-induced cell damage. Brain Res. Bull. 79: 169-176 (2009).

• Wang D, Lu Z, Hu L, Zhang Y, Hu X. Macrolide antibiotics aggravate experimental autoimmune encephalomyelitis and inhibit inducible nitric oxide synthase. Immunol. Invest. 38: 602-612 (2009).

• Wang F, Liu HM, Irwin MG, Xia ZY, Huang Z, Ouyang J, Xia Z. Role of protein kinase C beta2 activation in TNF-alpha-induced human vascular endothelial cell apoptosis. Can. J. Physiol. Pharmacol. 87: 221-229 (2009).

• Wang GY, Meng W, Ji B, Du XH, Zhao J. Expression of inducible nitric oxide synthase in transplanted rat liver and its inhibitory effect. Hepatobiliary Pancreat. Dis. Int. 4: 360-363 (2005). *

• Wang H, Xu DX, Lu JW, Zhao L, Zhang C, Wei W. N-Acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Acta Pharmacol. Sin. 28: 1803-1809 (2007). *

• Wang H, Xu DX, Lv JW, Ning H, Wei W. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in d-galactosamine-sensitized mice. Toxicology 237: 49-57 (2007). *

• Wang H, Zhang R, Wen S, McCafferty DM, Beck PL, Macnaughton WK. Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis. J. Mol. Med. 87: 435-445 (2009). *

• Wang L, Zhou Y, Peng J, Zhang Z, Jiang DJ, Li YJ. Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury. Can. J. Physiol. Pharmacol. 86: 97-104 (2008).

• Wang M, Harhaji L, Lamberth K, Harndahl M, Buus S, Heegaard NH, Claesson MH, Nissen MH. Modified human beta 2-microglobulin (desLys(58)) displays decreased affinity for the heavy chain of MHC class I and induces nitric oxide production and apoptosis. Scand. J. Immunol. 69: 203-212 (2009). *

• Wang N, Lu JG, He XL, Li N, Qiao Q, Yin JK, Ma QJ. Effects of ischemic postconditioning on reperfusion injury in rat liver grafts after orthotopic liver transplantation. Hepatol. Res. 39: 382-390 (2009). *

• Wang SH, Zhang C, Lasbury ME, Liao CP, Durant PJ, Tschang D, Lee CH. Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia. Microbes Infect. 10: 334-341 (2008). *

• Wang W, Bansal S, Falk S, Ljubanovic D, Schrier RW. Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 297: F1032-F1037 (2009). *

• Wang WW, Smith DL, Zucker SD. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40: 424-433 (2004). *

• Wang X, Lu Y, Cederbaum AI. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice. Hepatology 42: 400-410 (2005). *

• Wang X, Zhao L, Han T, Chen S, Wang J. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice. Eur. J. Pharmacol. 578: 339-348 (2008). *

• Wang XH, Wang K, Zhang F, Li XC, Qian XF, Cheng F, Li GQ, Fan Y. Alleviating ischemia-reperfusion injury in aged rat liver by induction of heme oxygenase-1. Transplant. Proc. 36: 2917-2923 (2004).

• Wang XW, Tan NS, Ho B, Ding JL. Evidence for the ancient origin of the NF-KB/IKB cascade: its archaic role in pathogen infection and immunity. Proc. Natl. Acad. Sci. U.S.A. 103: 4204-4209 (2006). *

• Wang Y, Wang Y, Wang DW. Bezafibrate up-regulate endothelial nitric oxide gene expressions via peroxisome proliferator-activated receptors alpha-dependent and independent pathways in cultured Bovine endothelial cells. Zhonghua Xin Xue Guan Bing Za Zhi 34: 530-536 (2006).

• Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 48: 1632-1643 (2008). *

• Wang YH, Shen YC, Liao JF, Li CH, Chou CY, Liou KT, Chou YC. Anti-inflammatory effects of dimemorfan on inflammatory cells and LPS-induced endotoxin shock in mice. Br. J. Pharmacol. 154: 1327-1338 (2008). *

• Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33: 105-136 (2003).

• Weismuller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. The challenges in primary sclerosing cholangitis: aetiopathogenesis, autoimmunity, management and malignancy? J. Hepatol. 48: S38-S57 (2008). *

• Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Munzel T, Daiber A. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (aldh-2) activity: implications for mitochondrial oxidative stress and nitrate tolerance. J. Biol. Chem. 282: 792-799 (2007). *

• Wereszczynska-Siemiatkowska U, Kosel J, Siemiatkowski A. Interleukin 18 as a new immunomodulator of some digestive tract diseases. Pol. Merkuriusz. Lek. 16: 282-284 (2004).

• Westerholt A, Himpel S, Hager-Gensch B, Maier S, Werner M, Stadler J, Doehmer J, Heidecke CD. Intragraft iNOS induction during human liver allograft rejection depresses cytochrome P450 activity. Transpl. Int. 17: 370-378 (2004).

• Wheatley C, Phil Oxon D. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med. Hypotheses 67: 124-142 (2006).

• Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J. Cell. Mol. Med. 13: 488-507 (2009).

• Wiedermann U, Chen XJ, Enerback L, Hanson LA, Kahu H, Dahlgren UI. Vitamin A deficiency increases inflammatory responses. Scand. J. Immunol. 44: 578-584 (1996).

• Wiest R, Groszmann RJ. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin. Liver Dis. 19: 411-426 (1999).

• Winer N, Sowers JR. Diabetes and arterial stiffening. Adv. Cardiol. 44: 245-251 (2007).

• Wing F, Raina N, Richardson R. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in cirrhotic patients with ascites who have failed vasoconstrictor therapy. Gut Aug 25 [Epub ahead of print] (2009).

• Winter H, van den Engel NK, Ruttinger D, Schmidt J, Schiller M, Poehlein CH, Lohe F, Fox BA, Jauch KW, Hatz RA, Hu HM. Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines. J. Transl. Med. 5: 56 (2007). *

• Wolthers KR, Scrutton NS. Cobalamin uptake and reactivation occurs through specific protein interactions in the methionine synthase-methionine synthase reductase complex. FEBS J. 276: 1942-1951 (2009). *

• Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M; International Ascites Club. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54: 718-725 (2005). *

• Wood KJ, Sawitzki B. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27: 183-187 (2006). *

• Wright MM, Schopfer FJ, Baker PR, Vidyasagar V, Powell P, Chumley P, Iles KE, Freeman BA, Agarwal A. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc. Natl. Acad. Sci. U.S.A. 103: 4299-4304 (2006). *

• Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, Gershwin ME, Van De Water J. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 38: 1018-1025 (2003). *

• Wu D, Pae M, Ren Z, Guo Z, Smith D, Meydani SN. Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice. J. Nutr. 137: 1472-1477 (2007). *

• Wu LC, Fan NC, Lin MH, Chu IR, Huang SJ, Hu CY, Han SY. Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators. J. Agric. Food Chem. 56: 2341-2349 (2008). *

• Wu M, Tsirka SE. Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis. Glia 57: 1204-1215 (2009).

• Xi H, Katschke KJ Jr, Helmy KY, Wark PA, Kljavin N, Clark H, Eastham-Anderson J, Shek T, Roose-Girma M, Ghilardi N, van Lookeren Campagne M. Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J. Exp. Med. Dec 28 [Epub ahead of print] (2009). *

• Xiao BG, Ma CG, Xu LY, Link H, Lu CZ. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Mol. Immunol. 45: 1191-1196 (2008). *

• Xiao X, Su G, Brown SN, Chen L, Ren J, Zhao P. Peroxisome proliferator-activated receptors gamma and alpha agonists stimulate cardiac glucose uptake via activation of AMP-activated protein kinase. J. Nutr. Biochem. Jun 29 [Epub ahead of print] (2009). *

• Xing B, Xin T, Hunter RL, Bing G. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J. Neuroinflammation 5: 4 (2008). *

• Xiong H, Zhu C, Li F, Hegazi R, He K, Babyatsky M, Bauer AJ, Plevy SE. Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. J. Biol. Chem. 279: 10776-10783 (2004). *

• Xu DX, Chen YH, Wang JP, Sun MF, Wang H, Wei LZ, Wei W. Perinatal lipopolysaccharide exposure downregulates pregnane X receptor and Cyp3a11 expression in fetal mouse liver. Toxicol. Sci. 87: 38-45 (2005). *

• Xu DX, Wei W, Sun MF, Wu CY, Wang JP, Wei LZ, Zhou CF. Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane X receptor and its target gene CYP3a in mouse liver. Free Radic. Biol. Med. 37: 10-22 (2004).

• Xu DZ, Lu Q, Deitch EA. Nitric oxide directly impairs intestinal barrier function. Shock 17: 139-145 (2002). *

• Xu J, Drew PD. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 171: 135-144 (2006).

• Xu L, Guo YS, Liu YL, Wu SY, Yang C, Wu DX, Wu HR, Zhang YS, Li CY. Oxidative stress in immune-mediated motoneuron destruction. Brain Res. 1302: 225-232 (2009).

• Xu MG, Men LN, Zhao CY, Zhao X, Wang YX, Meng XC, Shen DR, Meng BY, Zhang Q, Wang T. The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease. Eur. J. Pediatr. Jun 23 [Epub ahead of print] (2009).

• Xue Y, Wang Y, Feng DC, Xiao BG, Xu LY. Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-kappaB pathway. Acta Pharmacol. Sin. 29: 245-251 (2008).

• Yamamoto K, Akbar SM, Masumoto T, Onji M. Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC). Clin. Exp. Immunol. 114: 94-101 (1998). *

• Yamamoto K, Ninomiya Y, Iseki M, Nakachi Y, Kanesaki-Yatsuka Y, Yamanoue Y, Itoh T, Nishii Y, Petrovsky N, Okazaki Y. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis. Biochem. Biophys. Res. Commun. 367: 566-572 (2008). *

• Yan G, You B, Chen SP, Liao JK, Sun J. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ. Res. 103: 591-597 (2008). *

• Yanagawa Y, Iwabuchi K, Onoe K. Co-operative action of interleukin-10 and interferon-gamma to regulate dendritic cell functions. Immunology 127: 345-353 (2009). *

• Yanagida H, Yanase H, Sanders KM, Ward SM. Intestinal surgical resection disrupts electrical rhythmicity, neural responses, and interstitial cell networks. Gastroenterology 127: 1748-1759 (2004). *

• Yanagisawa N, Shimada K, Miyazaki T, Atsumi K, Kitamura Y, Sumiyoshi K, Kiyanagi T, Iesaki T, Inoue N, Daida H. Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. Lipids Health Dis. 7: 48 (2008). *

• Yang CW, Hung CC, Wu MS, Tian YC, Chang CT, Pan MJ, Vandewalle A. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int. 69: 815-822 (2006). *

• Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590 (2008). *

• Yang T, Wu J, Wang C, Liu Q, Ma X, Peng J, Kaku T, Liu K. Protective effect of JBP485 on concanavalin A-induced liver injury in mice. J. Pharm. Pharmacol. 61: 767-774 (2009).

• Yang TC, Zhang SW, Sun LN, Wang H, Ren AM. Magnolol attenuates sepsis-induced gastrointestinal dysmotility in rats by modulating inflammatory mediators. World J. Gastroenterol. 14: 7353-7360 (2008). *

• Yang W, Benjamin IS, Moore K, Portmann B, Alexander B. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat. Eur. J. Pharmacol. 461: 41-48 (2003). *

• Yang X, Ding YL. Relationship of the occurrence of fetal distress and change of umbilical cord and expression of vasoactive substance in umbilical vein in intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 43: 85-89 (2008).

• Yang YY, Huang YT, Lee KC, Lee FY, Lee TY, Hou MC, Lin HC, Lee SD. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. Clin. Sci. (Lond.) 116: 71-79 (2009). *

• Yang Z, Kaye DM. Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension. Hum. Mutat. 30: 328-333 (2009).

• Yang Z, Venardos K, Jones E, Morris BJ, Chin-Dusting J, Kaye DM. Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1. Contribution to hypertension and endothelial dysfunction. Circulation 115: 1269-1274 (2007. *

• Yao XM, Chen H, Li Y. Protective effect of bicyclol on liver injury induced by hepatic warm ischemia/reperfusion in rats. Hepatol. Res. 39: 833-842 (2009). *

• Ye XJ, Tang B, Ma Z, Zhou J, Myers LK, Kang AH, Cremer MA. The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances. Clin. Exp. Immunol. 149: 553-560 (2007). *

• Ye Y, Lin Y, Manickavasagam S, Perez-Polo JR, Tieu BC, Birnbaum Y. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS- and iNOS- knockout mice. Am. J. Physiol. Heart Circ. Physiol. 295: H2436-H2446 (2008). *

• Yee LJ, Knapp S, Burgner D, Hennig BJ, Frodsham AJ, Wright M, Thomas HC, Hill AV, Thursz MR. Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection. Genes Immun. 5: 183-187 (2004). *

• Yee SB, Bourdi M, Masson MJ, Pohl LR. Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease. Chem. Res. Toxicol. 20: 734-744 (2007). *

• Yeh CC, Santella RM, Hsieh LL, Sung FC, Tang R. An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int. J. Cancer 124: 1565-1571 (2009). *

• Ying L, Hofseth AB, Browning DD, Nagarkatti M, Nagarkatti PS, Hofseth LJ. Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation. Cancer Res. 67: 9286-9293 (2007). *

• Yip KH, Huang Y, Waye MM, Lau HY. Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines. Int. Immunopharmacol. 8: 764-768 (2008).

• Yokoyama K, Mitomi H, Kobayashi K, Katsumata T, Saigenji K, Okayasu I. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis. Hepatogastroenterology 48: 401-407 (2001).

• Yoneda M, Hotta K, Nozaki Y, Endo H, Tomeno W, Watanabe S, Hosono K, Mawatari H, Iida H, Fujita K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Kubota K, Shimamura T, Saito S, Maeyama S, Wada K, Nakajima A. Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease. Hepatol. Res. 39: 963-971 (2009). *

• Yoon JH, Gores GJ. Diagnosis, staging, and treatment of cholangiocarcinoma. Curr. Treat. Options Gastroenterol. 6: 105-112 (2003).

• Yoon JW, Jun HS. Viruses in type 1 diabetes: brief review. ILAR J. 45: 343-348 (2004).

• Yoon SB, Lee YJ, Park SK, Kim HC, Bae H, Kim HM, Ko SG, Choi HY, Oh MS, Park W. Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J. Ethnopharmacol. 125: 286-290 (2009).

• Yoshida T, Haga S, Numata Y, Yamashita K, Mikami T, Ogawa T, Ohkusa T, Okayasu I. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis. Int. J. Cancer 118: 1395-1403 (2005). *

• You J, Nguyen AV, Albers CG, Lin F, Holcombe RF. Wnt pathway-related gene expression in inflammatory bowel disease. Dig. Dis. Sci. 53: 1013-1019 (2008). *

• Youn HS, Lim HJ, Lee HJ, Hwang D, Yang M, Jeon R, Ryu JH. Garlic (Allium sativum) extract inhibits lipopolysaccharide-induced Toll-like receptor 4 dimerization. Biosci. Biotechnol. Biochem. 72: 368-375 (2008). *

• Yu H, Nasr SZ, Deretic V. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect. Immun. 68: 2142-2147 (2000). *

• Yu Y, Correll PH, Vanden Heuvel JP. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim. Biophys. Acta 1581: 89-99 (2002). *

• Yu Y, Lucitt MB, Stubbe J, Cheng Y, Friis UG, Hansen PB, Jensen BL, Smyth EM, FitzGerald GA. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 106: 7985-7990 (2009). *

• Yuan GJ, Zhou XR, Gong ZJ, Zhang P, Sun XM, Zheng SH. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. World J. Gastroenterol. 12: 2375-2381 (2006). *

• Yudkin JS. Inflammation, obesity, and the metabolic syndrome. Horm. Metab. Res. 39: 707-709 (2007).

• Yuen DY, Dwyer RM, Matthews VB, Zhang L, Drew BG, Neill B, Kingwell BA, Clark MG, Rattigan S, Febbraio MA. Interleukin-6 attenuates insulin mediated increases in endothelial cell signaling, but augments skeletal muscle insulin action via differential effects on TNF-alpha expression. Diabetes 58: 1086-1095 (2009). *

• Yuhas Y, Berent E, Cohen R, Ashkenazi S. Role of NF-kappaB activation and PPARgamma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells. Antimicrob. Agents Chemother. 53: 1539-1545 (2009). *

• Yun KJ, Koh DJ, Kim SH, Park SJ, Ryu JH, Kim DG, Lee JY, Lee KT. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation. J. Agric. Food Chem. 56: 10265-10272 (2008). *

• Zager RA, Johnson AC, Lund S. 'Endotoxin tolerance': TNF-alpha hyper-reactivity and tubular cytoresistance in a renal cholesterol loading state. Kidney Int. 71: 496-503 (2007). *

• Zalewska A, Wyczolkowska J, Narbutt J, Sysa-Jedrzejowska A. Nitric oxide levels in plasma and fibroblast cultures of psoriasis vulgaris patients. J. Dermatol. Sci. 48: 237-240 (2007).

• Zammiti W, Mtiraoui N, Mahjoub T. Lack of consistent association between endothelial nitric oxide synthase gene polymorphisms, homocysteine levels and recurrent pregnancy loss in Tunisian women. Am. J. Reprod. Immunol. 59: 139-145 (2008). *

• Zamora R, Grishin A, Wong C, Boyle P, Wang J, Hackam D, Upperman JS, Tracey KJ, Ford HR. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G643-G652 (2005). *

• Zapater P, Cano R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C, Moreu R, Bellot P, Horga JF, Munoz C, Perez J, Garcia-Penarrubia P, Perez-Mateo M, Such J, Frances R. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology 137: 1669-1679.e1 (2009). *

• Zarate-Blades CR, Bonato VL, da Silveira EL, E Paula MO, Junta CM, Sandrin-Garcia P, Fachin AL, Mello SS, Cardoso RS, de Sa Galetti FC, Coelho-Castelo AA, Ramos SG, Donadi EA, Sakamoto-Hojo ET, da Silva Passos GA, Silva CL. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy. J. Gene Med. 11: 66-78 (2009).

• Zariwala MA, Knowles MR, Omran H. Genetic defects in ciliary structure and function. Annu. Rev. Physiol. 69: 423-450 (2007). *

• Zeidler D, Zahringer U, Gerber I, Dubery I, Hartung T, Bors W, Hutzler P, Durner J. Innate immunity in Arabidopsis thaliana: lipopolysaccharides activate nitric oxide synthase (NOS) and induce defense genes. Proc. Natl. Acad. Sci. U.S.A. 101: 15811-15816 (2004). *

• Zeitlin PL. Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking? Mol. Pharmacol. 70: 1155-1158 (2006). *

• Zelawski W, Witalinska-Labuzek J, Stadnicki A. A role of kallikrein-kinin system in gut diseases. Wiad. Lek. 58: 331-334 (2005).

• Zetterquist W, Marteus H, Kalm-Stephens P, Nas E, Nordvall L, Johannesson M, Alving K. Oral bacteria - the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis. Respir. Med. 103: 187-193 (2009).

• Zhai Z, Haney D, Wu L, Solco A, Murphy PA, Wurtele ES, Kohut ML, Cunnick JE. Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro. Food Agric. Immunol. 18: 221-236 (2007). *

• Zhang F, Liu F, Yan M, Ji H, Hu L, Li X, Qian J, He X, Zhang L, Shen A, Cheng C. Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells. J. Neuroimmunol. Nov 24 [Epub ahead of print] (2009).

• Zhang J, Luo B, Tang L, Wang Y, Stockard CR, Kadish I, Groen TV, Grizzle WE, Ponnazhagan S, Fallon MB. Pulmonary angiogenesis in rat experimental hepatopulmonary syndrome. Gastroenterology 136: 1070-1080 (2009). *

• Zhang L, Wu HS, Chen Y, Guo XJ, Wang L, Wang CY, Zhang JH, Tian Y. Role of nitric oxide in Toll-like receptor 2 and 4 mRNA expression in liver of acute hemorrhagic necrotizing pancreatitis rats. World J. Gastroenterol. 12: 485-488 (2006). *

• Zhang LB, Zhu HX, Lun YN, Yan DM, Yu LY, Du BR, Zhu X. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing. Cell. Mol. Immunol. 4: 359-367 (2007). *

• Zhang R, Ma A, Urbanski SJ, McCafferty DM. Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma. Carcinogenesis 28: 1122-1130 (2007). *

• Zhang X, Chen S, Li L, Wang Q, Le W. Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1(G93A) transgenic mice. Neuropharmacology 54: 1112-1119 (2008).

• Zhang ZY, Zhang Z, Fauser U, Schluesener HJ. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline. J. Cell. Mol. Med. 13: 341-351 (2009). *

• Zhang-Gandhi CX, Drew PD. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 183: 50-59 (2007).

• Zhao C, Wood MW, Galyov EE, Hopken UE, Lipp M, Bodmer HC, Tough DF, Carter RW. Salmonella typhimurium infection triggers dendritic cells and macrophages to adopt distinct migration patterns in vivo. Eur. J. Immunol. 36: 2939-2950 (2006). *

• Zhao J, Liu T, Ma L, Yan M, Zhao Y, Gu Z, Huang Y. Protective effect of acteoside on immunological liver injury induced by Bacillus Calmette-Guerin plus lipopolysaccharide. Planta Med. 75: 1463-1469 (2009).

• Zhao L, Cuff CA, Moss E, Wille U, Cyrus T, Klein EA, Pratico D, Rader DJ, Hunter CA, Pure E, Funk CD. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J. Biol. Chem. 277: 35350-35356 (2002). *

• Zheng DM, Kitamura T, Ikejima K, Enomoto N, Yamashina S, Suzuki S, Takei Y, Sato N. Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: role of intracellular calcium and nitric oxide. Hepatology 44: 1278-1287 (2006). *

• Zheng L, Sinniah R, I-Hong Hsu S. Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum. Pathol. 37: 637-647 (2006).

• Zhou HY, Shin EM, Guo LY, Zou LB, Xu GH, Lee SH, Ze KR, Kim EK, Kang SS, Kim YS. Anti-inflammatory activity of 21(alpha, beta)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque. Eur. J. Pharmacol. 572: 239-248 (2007).

• Zhou JF, Xiao WQ, Zheng YC, Dong J, Zhang SM. Increased oxidative stress and oxidative damage associated with chronic bacterial prostatitis. Asian J. Androl. 8: 317-323 (2006).

• Zhou LW, Wang YL, Yan XT, He XH. Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model. Saudi Med. J. 29: 368-373 (2008).

• Zhou R, Tang W, Ren YX, He PL, Zhang F, Shi LP, Fu YF, Li YC, Ono S, Fujiwara H, Yang YF, Zuo JP. (5R)-5-hydroxytriptolide (LLDT-8) attenuated collagen-induced arthritis in DBA/1 mice via suppressing IFN-gamma production and its related signaling. J. Pharmacol. Exp. Ther. 318: 35-44 (2006). *

• Zhou X, Yang W, Li J. Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappa B activation, inducible nitric oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J. Biol. Chem. 281: 31337-31347 (2006). *

• Zhou Y, Zhou X, Wang X. 1,25-Dihydroxyvitamin D(3) prevented allergic asthma in a rat model by suppressing the expression of inducible nitric oxide synthase. Allergy Asthma Proc. 29: 258-267 (2008).

• Zhou Z, French DL, Ma G, Eisenstein S, Chen Y, Divino CM, Keller G, Chen SH, Pan PY. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells Jan 13 [Epub ahead of print] (2010). *

• Zhu X, Zhao H, Graveline AR, Buys ES, Schmidt U, Bloch KD, Rosenzweig A, Chao W. MyD88 and NOS2 are essential for Toll-like receptor 4 (TLR4)-mediated survival effect in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 291: H1900-H1909 (2006). *

• Zhu XY, Daghini E, Chade AR, Lavi R, Napoli C, Lerman A, Lerman LO. Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci. 83: 801-809 (2008). *

• Zhuge J, Cederbaum AI. Inhibition of the mitochondrial permeability transition by cyclosporin A prevents pyrazole plus lipopolysaccharide-induced liver injury in mice. Free Radic. Biol. Med. 46: 406-413 (2009).

• Zimmermann H, Kurzen P, Klossner W, Renner EL, Marti U. Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledocho-jejunostomy in the rat. J. Hepatol. 25: 567-573 (1996). *

• Zingarelli B, Hake PW, Burroughs TJ, Piraino G, O'Connor M, Denenberg A. Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology 113: 509-517 (2004). *

• Zintzaras E, Papathanasiou AA, Stefanidis I. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis. Genet. Med. 11: 695-706 (2009).

Number of references = 1545

www psc-literature.org